var title_f24_35_25136="Bilateral cryptorchidism";
var content_f24_35_25136=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F73353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F73353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bilateral cryptorchidism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 400px; height: 255px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This patient with bilateral cryptorchidism had a 46,XX karyotype and ovotesticular disorder of sex development.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Christopher P Houk, MD and Lynne L Levitsky, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_35_25136=[""].join("\n");
var outline_f24_35_25136=null;
var title_f24_35_25137="Contents: Primary care endocrinology";
var content_f24_35_25137=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?23/51/24382\">",
"       Adult Primary Care and Internal Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Primary care endocrinology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Primary care endocrinology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Calcium and magnesium disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/58/13220\">",
"           Causes and treatment of hypermagnesemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/41/15000\">",
"           Causes of hypomagnesemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/19/1338\">",
"           Clinical manifestations of primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/26/5545\">",
"           Diagnosis and differential diagnosis of primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/28/20934\">",
"           Diagnostic approach to hypercalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/13/34005\">",
"           Diagnostic approach to hypocalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/22/28007\">",
"           Etiology of hypercalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/25/24984\">",
"           Etiology of hypocalcemia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/63/11254\">",
"           Evaluation and treatment of hypomagnesemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/16/2310\">",
"           Hypercalcemia in granulomatous diseases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/48/41734\">",
"           Hypercalcemia of malignancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/41/30361\">",
"           Pathogenesis and etiology of primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/60/18377\">",
"           Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/29/470\">",
"           Regulation of magnesium balance",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/8/23685\">",
"           Relation between total and ionized serum calcium concentration",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/45/16085\">",
"           Significance of hypomagnesemia in cardiovascular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/37/42580\">",
"           Signs and symptoms of magnesium depletion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/9/32914\">",
"           Symptoms of hypermagnesemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/42/16041\">",
"           Treatment of hypercalcemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/37/44632\">",
"           Treatment of hypocalcemia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Diabetes mellitus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/0/3078\">",
"           Alpha-glucosidase inhibitors and lipase inhibitors for treatment of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/60/29641\">",
"           Blood glucose self-monitoring in management of adults with diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/4/11332\">",
"           Case illustrating blood glucose monitoring in type 2 diabetes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/8/4232\">",
"           Cases illustrating problems with intensive insulin therapy for diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/7/12402\">",
"           Cases illustrating the effects of exercise in intensive insulin therapy for diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/11/36023\">",
"           Classification and clinical features of diabetic retinopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/33/14874\">",
"           Classification of diabetes mellitus and genetic diabetic syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/55/4986\">",
"           Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/7/18551\">",
"           Clinical manifestations and diagnosis of diabetic polyneuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/15/30970\">",
"           Coronary artery revascularization in patients with diabetes mellitus and multivessel coronary artery disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/54/38758\">",
"           Diagnosis of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/35/22071\">",
"           Diagnostic dilemmas in hypoglycemia: Illustrative cases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/50/20265\">",
"           Effects of exercise in diabetes mellitus in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/34/16934\">",
"           Epidemiology and classification of diabetic neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/28/38341\">",
"           Erectile dysfunction in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/45/11993\">",
"           Estimation of blood glucose control in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/12/11464\">",
"           Evaluation of the diabetic foot",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/55/15225\">",
"           General principles of insulin therapy in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/34/11817\">",
"           Glycemic control and vascular complications in type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/25/7578\">",
"           Glycemic control and vascular complications in type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/57/28569\">",
"           Heart failure in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/39/24184\">",
"           Hypoglycemia in adults without diabetes mellitus: Diagnostic approach",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/35/43577\">",
"           Initial management of blood glucose in type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/20/24906\">",
"           Insulin therapy in adults with type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/24/30089\">",
"           Insulin therapy in type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/39/26233\">",
"           Management of diabetes mellitus in hospitalized patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/28/37321\">",
"           Management of diabetic foot lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/63/27641\">",
"           Management of hypoglycemia during treatment of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/62/37866\">",
"           Medical management and follow-up of gestational diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/19/20794\">",
"           Medical management of type 1 and type 2 diabetes mellitus in pregnant women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/26/38312\">",
"           Metformin in the treatment of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/49/42777\">",
"           Microalbuminuria in type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/33/39449\">",
"           Microalbuminuria in type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/53/22358\">",
"           Musculoskeletal complications in diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/2/25641\">",
"           Nutritional considerations in type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/18/14634\">",
"           Nutritional considerations in type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/63/30714\">",
"           Overview of diabetic nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/38/36458\">",
"           Overview of medical care in adults with diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/60/41928\">",
"           Pathogenesis and prevention of diabetic polyneuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/42/23210\">",
"           Pathogenesis of type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/31/36346\">",
"           Pathogenesis of type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/21/32087\">",
"           Prediction of type 1 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/27/36281\">",
"           Pregnancy risks in women with type 1 and type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/31/42487\">",
"           Prepregnancy evaluation and management of women with type 1 or type 2 diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/38/32362\">",
"           Prevention and treatment of diabetic retinopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/63/9210\">",
"           Screening and diagnosis of diabetes mellitus during pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/32/42501\">",
"           Screening for diabetic retinopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/46/35559\">",
"           Sulfonylureas and meglitinides in the treatment of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/50/21290\">",
"           Thiazolidinediones in the treatment of diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/48/15114\">",
"           Treatment of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/48/40714\">",
"           Treatment of diabetic nephropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/43/12986\">",
"           Treatment of diabetic neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/45/21210\">",
"           Treatment of hypertension in patients with diabetes mellitus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/42/682\">",
"           Treatment of type 2 diabetes mellitus in the elderly patient",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Menopause and its treatment",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/45/44761\">",
"           Clinical manifestations and diagnosis of menopause",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/34/40486\">",
"           Continuous postmenopausal hormone therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/38/41576\">",
"           Managing the side effects of tamoxifen",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/53/25434\">",
"           Menopausal hot flashes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/36/29258\">",
"           Postmenopausal hormone therapy and cardiovascular risk",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/11/11449\">",
"           Postmenopausal hormone therapy and the risk of breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/53/16218\">",
"           Preparations for postmenopausal hormone therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/42/40615\">",
"           Treatment of menopausal symptoms with hormone therapy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/47/27384\">",
"           Causes and evaluation of gynecomastia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/63/9206\">",
"           Clinical features of the carcinoid syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/9/6294\">",
"           Epidemiology and pathogenesis of gynecomastia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/47/760\">",
"           Management of gynecomastia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/49/17174\">",
"           Multiple endocrine neoplasia type 1: Definition and genetics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/29/14810\">",
"           Overview of the treatment of endometriosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/46/13034\">",
"           Physiology and clinical use of melatonin",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Obesity",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/9/8345\">",
"           Dietary therapy for obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/4/33866\">",
"           Drug therapy of obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/21/3418\">",
"           Etiology and natural history of obesity",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/35/30266\">",
"           Health hazards associated with obesity in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/45/13016\">",
"           Overview of therapy for obesity in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/41/21144\">",
"           Role of physical activity and exercise in obese adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/20/12615\">",
"           Screening for and clinical evaluation of obesity in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Osteoporosis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/56/40842\">",
"           Bisphosphonates in the management of osteoporosis in postmenopausal women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/10/43173\">",
"           Calcitonin in the prevention and treatment of osteoporosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/56/12170\">",
"           Calcium and vitamin D supplementation in osteoporosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/55/11128\">",
"           Diagnosis and evaluation of osteoporosis in postmenopausal women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/45/32473\">",
"           Epidemiology and etiology of osteoporosis in men",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/52/39754\">",
"           Overview of the management of osteoporosis in postmenopausal women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/53/3929\">",
"           Pathogenesis of osteoporosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/54/42855\">",
"           Pathogenesis, clinical features, and evaluation of glucocorticoid-induced osteoporosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/4/11333\">",
"           Pharmacology of bisphosphonates",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/36/17994\">",
"           Prevention and treatment of glucocorticoid-induced osteoporosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/28/40393\">",
"           Screening for osteoporosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/58/31657\">",
"           Treatment of osteoporosis in men",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/21/3417\">",
"           Treatment of vitamin D deficiency in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/28/44487\">",
"           Use of biochemical markers of bone turnover in osteoporosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pituitary and adrenal disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/46/28391\">",
"           Adrenal steroid biosynthesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/13/5338\">",
"           Approach to the patient with hypertension and hypokalemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/3/16435\">",
"           Basic principles in the laboratory evaluation of adrenocortical function",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/55/26489\">",
"           Causes and pathophysiology of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/0/40969\">",
"           Causes of primary adrenal insufficiency (Addison's disease)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/50/3880\">",
"           Causes of secondary and tertiary adrenal insufficiency in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/1/37911\">",
"           Clinical features of primary aldosteronism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/0/33800\">",
"           Clinical manifestations of adrenal insufficiency in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/32/15878\">",
"           Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/60/24520\">",
"           Craniopharyngioma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/61/31703\">",
"           Determinants of glucocorticoid dosing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/41/37528\">",
"           Dexamethasone suppression tests",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/46/44777\">",
"           Diagnosis of adrenal insufficiency in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/48/22282\">",
"           Epidemiology and clinical manifestations of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/31/31225\">",
"           Establishing the cause of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/25/21913\">",
"           Establishing the diagnosis of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/44/9930\">",
"           Etiology, diagnosis, and treatment of hypoaldosteronism (type 4 RTA)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/37/22103\">",
"           Glucocorticoid withdrawal",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/30/25059\">",
"           Hypothalamic-pituitary axis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/43/12981\">",
"           Incidentally discovered sellar masses (pituitary incidentalomas)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/47/27386\">",
"           Major side effects of systemic glucocorticoids",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/48/23302\">",
"           Normal adrenarche",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/63/1016\">",
"           Overview of the treatment of Cushing's syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/42/23208\">",
"           Pharmacologic use of glucocorticoids",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/62/21481\">",
"           Premature adrenarche",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/8/18569\">",
"           The adrenal incidentaloma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/47/42745\">",
"           Treatment of adrenal insufficiency in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/16/40199\">",
"           Treatment of primary aldosteronism",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Reproductive and sexual function",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/3/36919\">",
"           Amenorrhea and infertility associated with exercise",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/57/22424\">",
"           Diagnosis and treatment of delayed puberty",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/2/2089\">",
"           Etiology, diagnosis, and treatment of primary amenorrhea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/56/34697\">",
"           Etiology, diagnosis, and treatment of secondary amenorrhea",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/49/32533\">",
"           Evaluation of male sexual dysfunction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/56/17287\">",
"           Overview of infertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/44/42696\">",
"           Overview of male sexual dysfunction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/57/42904\">",
"           The sexual history and approach to the patient with sexual dysfunction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/36/2630\">",
"           Transsexualism: Epidemiology, pathophysiology, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/36/30282\">",
"           Treatment of male sexual dysfunction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/25/8602\">",
"           Treatment of transsexualism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/35/21050\">",
"           Use of androgens and other hormones to enhance athletic performance",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Thyroid disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/62/3046\">",
"           Cardiovascular effects of hypothyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/10/14503\">",
"           Clinical manifestations of hypothyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/7/26744\">",
"           Diagnosis of and screening for hypothyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/57/26520\">",
"           Diagnosis of hyperthyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/53/28506\">",
"           Diagnostic approach to and treatment of thyroid nodules",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/0/4103\">",
"           Disorders that cause hyperthyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/47/42744\">",
"           Disorders that cause hypothyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/33/3608\">",
"           Laboratory assessment of thyroid function",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/56/28550\">",
"           Lipid abnormalities in thyroid disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/60/14279\">",
"           Overview of the clinical manifestations of hyperthyroidism in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/17/44313\">",
"           Overview of the management of differentiated thyroid cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/15/248\">",
"           Postpartum thyroiditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/22/23913\">",
"           Subclinical hyperthyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/48/3850\">",
"           Subclinical hypothyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/25/12696\">",
"           Thionamides in the treatment of Graves' disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/39/44663\">",
"           Thyroid function in nonthyroidal illness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/0/22535\">",
"           Thyroid hormone suppressive therapy for thyroid nodules and benign goiter",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/34/33320\">",
"           Thyroid hormone synthesis and physiology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/41/21143\">",
"           Treatment of Graves' hyperthyroidism",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/26/35239\">",
"           Treatment of Graves' orbitopathy (ophthalmopathy)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/53/43865\">",
"           Treatment of hypothyroidism",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-BF9C86D979-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f24_35_25137=[""].join("\n");
var outline_f24_35_25137=null;
var title_f24_35_25138="Grasping cone specimen";
var content_f24_35_25138=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F59404&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F59404&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Removing the cervical (uterine cervix) cone specimen",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 416px; height: 327px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Partially released cone specimen is gently grasped with an Allis clamp, avoiding the mucosal surfaces.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_35_25138=[""].join("\n");
var outline_f24_35_25138=null;
var title_f24_35_25139="Pedunculated polyp endoloop II";
var content_f24_35_25139=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F68387&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F68387&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Colonic polypectomy using an endloop",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 346px; height: 307px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEzAVoDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5Uoq3pGn3GrarZ6dYp5l3dzJBCn952YKB+ZFfQvxn8K6BcfDq5Twt/ZEl54NuYrS5axx50sDIkbvPhRl/PRvUBcn1oA+b61NG0W51VyIRtQfxsDitvwd4bTUJRNfK3kegHWvV/DugR28KpEgVR0yOledjcwjh1ZbnuZdlEsRadXSP5nm9p8NL+5Axe26k9trH+lbFv8GNSmP/ACFLNR7o3+Fe0aZpwiQfKNx74rdtbbHC9vavnp55iL+6/wAD3JZLg4rWP4s8HX4Faiwz/bVl/wB+3/wqwnwB1J8Y1ywwe/lv/hX0FbRlG+YgrjjjmrsVuvmbTtVSMmsZ53jEtJfgjiqZZhI7L8T54H7PGplQw1/T8H/plJ/hTD+z3qfIXXrBiPSKT/Cvoq9u4rOLnDegNZT6heaiwit18uIf3eAB7mnTznGS3l+CJp5PSmua2ne54LJ8AtQjUl9fsFI7GNx/Ss+b4K3cYO3XLFyPSN69/wBRi84BBIpKjGQSc1n/AGHkBmIHTg4rpeZYxO3Nf5I66WSYRq8k/vPCh8G745/4m9n/AN8P/hR/wpu+76xZD6o/+Fe8PYQxo5ZkRlAOC/LAnAx69arPawmNg2Ce2fX2pTzfFQ+J/gjeOR4JrSL+9niY+DF78udasQp/iMb8fpVeX4QX8b4Gq2bD1Cv/AIV7lHp4UEo7DtycjNOukdrRLdba0DKQTOqsJW9m5wfyoWcYl/a/BB/YWDvpFv5nhQ+Ed3uw2sWYPf5HOP0qdfg1fOMrrFmRjIxG/I/KvXzvGVlhBKjqO9RS7oZN1tL8vVQev0+tP+18Q/tfggeQ4T+X8WePS/CO7jUsdYssAZJ2PgD16Vx/jTwrqXhHWZNO1WLa4G5JF+5Ip6FT3FfScl0ZyzyktO5+Zj3/AA/rXMeI9Pg1XSLjT7jasMqgKxQMYipyrJn7vJOcYyCR6Y68LmtRT/fO6OHF5FBw/cK0vU+dKKvaxptxpN/LaXagSIeCOQw7EHuDVGvok1JXWx8nKLi3GSs0FFfT/wCzhpVhdfDKC4utETUWk8UG2uHGnwXO23NsmfNaQZSFSQxKkEdupr518R2aWviXVbO2lt5ooLuWJJbY/unVXIDJ/skDI9qYihbQmaTHbvVv7HFnhn/Mf4U+FBCm1fvHqanjjZsY4puyR006PN0IF0+I7cGQ59x/hVtdHtz1abGPUdfyqRVwwGSPWrir8vBIyaxlM7YYWHVFVNBgJ+Zpx6cj/CrsfhiyuLqBI5ZLdJ5ViDXEyhY893baMKO7Y4ra0HSrrUpxBYwyzTBWciOIybQBnLDoFzgFjwM5NTXkdnKYW057h4zEDJ5wA/eZOSuP4SNpwehJHQCud1pJnUsHSeiWpz0vhe0SQIJZy24qxDqQMHnBA5HHUVPH4Rsnz++uFGMkll4H5VdjuPs0pyqyHaRz0HvV/S5TdS7zEJIgf9W+QGPqcc4odVpczY44KEmoqOph2fg63uSv72dFY/KSw5/Sqt54atLYFmknPOMbhnP5V3bMLe3uLlyAsIHPuTgcVyk0jzyF2yOwHcCsaWInNt30OitgaFO0VHUZY+G9Dvdojnvo3wMq8iZz3P3ema1ovAGkueZ78f8AA0/+JrKZDx5ZZGHQit7SdaaJlS6LcHAYVFZ1bXhJmlGhhtIzpq5Gfh3pA/5eL4/8DT/4mmt8O9JAyLi+/F0/+JrsIZxPAZYtzRjhmHQH3qF5AXOCcevauD61XX2j0Y5dhJL+GjibnwLp0QJE15+LL/8AE1kXXhe0izskuDj1Zf8ACvRJ9rKQGyKxtRi+XI711UcVUb1ZjWyvDWvGCPO5dLQTLHH5rsx2qo5JPpjFVJrQBT5RYkdjXQal5lvMs8LtHJGwZJEOGVh0IPY1lNK5keRnJkYkljySe5+tezTlzK58ricOqU3EyKtJbIyKSWyRmi5iycqOfSp4v9Un0FW1Y4mrGbW74Y0d9Su1OP3YOSaz9Ps2unBAyN23Hqa9p8GeHxbW0PygHg9K4Mdi1hqd+p62U4B4mpzSXuo1vDekLEI1CgADjHYV3WnWO3bkDk1HpFjkqFGAO9dtoOiG9mRfuoByxBwv1r4erVniJaH2VarDDQu+hBDoztpL34K+UsnlkfxZ9fpTY7Vo8BACT1zXTajHBAxtrPcIV+8CeGYfxflx9KyZCiPluo/hHesavJF2XT8zy6eJnUTb6/kRRRpHkuRn19Kq6jfxwcl1UjjcxAHt/WqetaqsI4HzjoimudlikvbmNnmMyMFd0RSojJ6pz1I/vdCabV0+x20cM5+/M0lvY3d5JpoZGdcc4Owe3ofepbrWA8Sie6BijGFGQAB9BxVe50yxlUfYIbuNBncbiRWJP4AVn3NiQhyMgDOPQetaRxEox9nF+6dkKdOdm9/yG3PiK2icqis5HpwKzZfEkskwWKBUB43vzz/hWRqjqspittrP0PoPem2tmzv+8cufbgV1RjGMbs64UE9S/wD2nqk7MIzCigkA7OcVajN4VJabcWHp0qfT7P7pAAAGMEVtR2IJG0DHbArlrV1sOc4U9DItpJ02eaS6nrt4NTrcuAN4wPatT7Cu4BsZHGKjlsRzjnPFc/tIyM/bQbG29xBIkSvHE6LIHdhkSOuRlM5wBjODjIzUVxZQtZvIgjDGb5Dv/eKME4I6FcY+bsfrioXs2gO5CScZwD0FavhueJtWthcXH2VATmbH3Dg4/A+vauqlPmaj/XzMqi5IucNba9TCOkX0nmvbwtK6AtIsYy6D+8V64965+5JyjEKyrzlV6/X1r0aJfPuo5dNW6j1Ib5OZATK2MsEK4wT83HTA/CsLxDpUs0zXKMkn2gmVZojuWQkbjtI4OMHPpg16EYJLuYKo5Ss9H2/r8zyjxd4di1yyIUolzHkwS9h/sn2P6GvGrq3ltLmSC4jaOaNirKw5Br3++8y1Y7xh89D91vp715H8R5Vn8TO6DH7qMEehxXu5ZUmn7N6o+azzDQt7daSvZnORxb0znvxVmGMIMDqe9R24/c5PrVuKMEgEkcdq9rRI8KnC9h8KbietXI0AC+lNhTk8Vcijx0GR1rnnM9SlSsM2ZIIGFIzz2rT06JOWkyRg4wO/b8KqlVMefw/CtW2h2xgqMDFc056anXCGugum6heafBd29ldz20V0my4EUhUSpz8rY6jk8dKQyhI8LwAODU7QKqbSME9OKzbpz9wevJrK/OzdR5FcSGP7VcLGCRuPzEdhXW21olnb5wA2AAOlVfCemZ8yaRSCoAB9D6flVrxDdi3U7PvD5UH+0a5a1TnkqcTsw8PZrmkYGs3Jup1t4TlIzl/dqppH8hJ+96VLHGqcZyxySfWmk7Qeuc+v610pcq5UYS96XNIMho+g3cDNWo7aLyMtgn17ilnWOZIBHbRwFUIYxsxEhzkMQxODjjjjihHwRkEEDnvRKXYmEXLWSH2N2bKfazkp0JzyAa2/NBBZHz/WqureXZ6FY299LDMziS4hhg2boRIF2PJIMls4b90eVxzjNc3aalLayYYkwHkL3FZyo+01S1NaOMUN3p33OuD7gSenpVa4Qup3fd9ql0+eK6i3owINXp4kMQOK478krM9GU1Je6cBrsWY2GcewrnWUjPH4jpXb69aOLZZWRvKk3BHxwxX7w+oyM/UVy7Q5HI4PNe3hanuHzGY0L1LozWHXFXY0/dr93oO1RywgHrx7dasxr+7T6DtXYpJnkTptPU2vhhpZvZWnIyschX8cCvoDSdNMVtHhMu+ABivLfgRCsmkTllyftjZ/74SvoDS7YyuhQYOMKfSviM8rXrOMnoj63LJKhhIyXUXR7EbSO4PJ7V2IzZwLZQrtQoskj9DIx7H2HHFTaHp0cOZnVTHFwAe5qvf3J3ySTnLE88dK8yP7mg5y3ei9Ov37HBXxLxNWy1S/Mp3GFUuz81zOoXghLBTl2qTWtU8tHAbnPyjrk+lY1jG85d52UsxyDjG0VzwhzW7nrYXDcseeexFb2i3EjyXCszsMA56HP8q37SwidxHCqKzZOM4Ax2yfUkD8asQaX5ULSXMqQRoBvDg7wGztYDvyOn9Kle8ES7oxsUKyYPOVJzyT1POM12+ysveKrYl1Han/AMAZdwWcULOru8nRUC4CeuT3I+grlvFWu+Ro02n2iqs9ywZgqjCRKASueScv19cAd6q+L/G+laJAYCzT3e3ctvHyw/3j0UfWuY0maTVrYX92qLNcL5mzccIuflUevrW8YOlD2trX0N8HQjUlaprbUQ2HlXckat5gRsNJ13Hvj2znn0rXtLX5+mPUVNYWhO3PauitLECQHg57V51fFdz1K2IVNWItNtcr90getbkNoFj3gHd7dqmsrMlwqLj/AAAzWpYoGDFlUrg8H3rxq+Ibeh8/icVdtowjZ/NlkIPfAqB4QSdq8Zrq/soYkkZH8qz7iAB+R0bGMdazjilHdmVPFczOfubNWLFAc4zt64GKwrqIxOJF7cGuxki4bAxn1rCv7fAIJzniuuhi1J2PRwtfWzKNpKHBUj7w2n3B4P6cVflcFLsys8vnKAyH7shBHLehUDgj6HjIrEAZZNoJGzn8K04nMiJvYE4wD04r2KWJlFJHVWpq9zmtf06O4tmVl3g+o6j/ABr52+Ilu1r4nliZmbEaYLdcYr6luURXDSqskQzlCSAeCBkj0OD+FfN/xrge18eXMMoKyJDEGVhtIO3oR2r6PJqvPO3keFxAl9XT81+pk6bp0E2jW00ZZpi0m8EYHAG0fpn8ant7WNI/mGWIxn0qPSbl5tJt4FUKsJfG3uWOST78Y/CrsIA2Z6Z5r3qk3seLhKK5FJlyO0t450+TcdoyvYVNfWS27rt4DruCnqKS1+Zix6seKW5y8i7ickda5pSbO6MEtirbxsxIIGD3NaVruQFWBYLxxUlpAFty20lj+Wav2kAKDAwe4rmq1EddKHVlKc4t94JLdKo6datc3GMZA5b39B+dXNTAEuxeCetdN4I0oOIpJRgMfNb6dqyqVfZU3I2hS55pdEbMdoNN0eNMDcBlj6k9a4K4P2y+LkFo48hfc9zXfeOJDbWjeWThepHUE8VxenRrGrMWwq9D3NcuGfuuozpqLaJXa1JAZRxnjis64jIkYADJPGK7m78P30XhSx8QCPdp08jxB0IPlkNtG/0JOQBXKXcYEgYYDgZNdlOb6nNKKmvdKyK6IDtOB71cs40Uh5c7eWJXG4nHH61XiVpHEZPXGfxq5qxS3sYhGSZGX5+MbWyRj34wc+/tTldvlXUqKUVzMw7pmnuGkYDBY4A4Ge5/GmvGpDccdCatNDujyOMfnmhrVlUnd05IroTtoji5W3zMr6fdf2e7MVPlZ5A6g11EN6txFuVtwboQa5eeEFB2OPzqLQ71rS9a3ckxHkA9qipQVVNrdF0sT7FqL2Z0WqsWs2hJGzd5g9mxgkfUAfkKwXs3VMNGytgHDDHBGR+Ywa2b9g0B2nlv1qppcyXNoSrbmB2HPJBFTT5qcTSpyVZpdzn7q2IYgD60scQ2L9BW1f2wVieO+QKYkSbF57V2U610efXwnvaHoH7OOnfa/Dd3Kc4F8yj6+XH/AI19KaLpaxshbocHPbFfP37Moz4GvgOv9pv/AOioq+lLA5sYwG+YL0zXwWbTVTH1IzekXp+BLqSjhKaj1RZmlSPKR8gE4FcV4v1QWwKoDk9OOp9K2dRuBYx3EsjYjiG4sTgV51q9+dT1EyRymS3UKVyCBuI+bGfyz7V5lKUqjbeyOvKsHzT53sivFHJcTF5TuZjx/hXV+HraK2lhludqQzB1SRhna645A55Bx1GPrWdpNi8oCwoWlb7oA5J9qfqN2kEe9SFiiBwzAAkZyS3bI6fSu6hU5Jc9rnr4ibrP2UWXdXu4Fdtp/dRFhEWyScnJJJ/i9T9K8y8aeLLg5t9Nl24GHmX+S/41Q8TeJn1KUx2bs1r90v03n/4n+dYNxt8je5BJHcdK9enTlOSqVV8v6/IqnRjTjZbnJTg7pCxLO5yzMclj6mvR/BkofS7UBsgDH0rzm9yGODxXWfD/AFAAtY3A2ujbkBOCR3H1B/nXdmFNzw910KwM1Cs4vqeq6dF1BPf0rpbSMHaxOMVzmmSbUwT81dLp0gbjjGPxBr4bFNrYzxrd2bdrEOHb8u1XdOsfOcxxDJAzkmo7RfORflGema1LWAxKx5VjxkHtXn0oKdRe0V49T5uvVaur6j7G2hxILhsFe1ZV/bByWj6d6u3cbIP3fJPaqMplUgMDtHXIoxFSLpxpciVr69Xfv6GdG/NzpmVPDmQj+Idh0rG1KFgwzkdScV0kqnBcnk9sVj6kpJAznjvU4ZHrYao+ZHJahCbaeN2B2y8gd8HoaYDsbYhOc4C1Pq42x55ODk1VCqWDKBvwDn1HpXuLWKZ9BB80E2aVvGZmXLLE748t3yArZBDZ7dOp45r5r+PImPxAmnud5ee3il8xs5kBH3snr0619JzziWWYgNHET+7Qnd5a9lB9BXzt+0PBLD49hM0vmeZp1s6cY2LswF/ACvq+HpRc2lukfN582qCv1Zz+gbItJtsLl3kdmPtwAP0P51rwwRFSuBljgZPSsLw7zYx56BzW+qnGR1Fe/VlaRy4OF6USzLbxW7+XCxlxjaw45psSeZOglGxhnv1qeNc3Mbdiu4fXFS3JTaSq46bSfX0rnc7qx3qlaWiJNwEYB/iOas+ZthZ1GOKjjhIhCNkk9T6U+WNgGQjAYce49a5ZNN3OmELaGYkbX19Ei5zK4Qcep/wr2TwfFDZfa7sxKy2Vs0qK33Wc4VF+vJIHfbXnnhex8zV9+0n7Om8e7Hgf1ruvEupLo/hd4o7gyxALMi7doWdlw2O5K9M9PSuHE1earGEdbfmdCpWpvz/Lqcd431CHzG06GUXB4Esij7uMf1/TmsSC+8l4poflliIdSVDDI9Qcgj61nW+RhmG5pDlsnvnvVxLUFtoyAT0FdsKUaUVBGPN7R8zJ/wC0WFn9kCBUa4M7sCQW4wq4ztCjLHgdT7Cqt0YySGy2cYPQAVPJbksnp6YxVWdC02ADgcCrTTFGFm3HqWtNt7i6uI44IpJZnJ2IkZZjxycDkgAEnHYGovFU1u+reVaztPaq22KVzzIigKG6Dg4yPbGea3tAnl0mY3sK7pRbzW6k/wAHmIU3YxzjJOO9cbeRq10Si/uEAQZ9q0opSdzHEOSult/Vy1sGGzy+cYHpUO4ESq7E5OPpUkPlxspzuLcY9D2/Cku1jikbjHGSa36mD1jczpZTGsgHO35QT+lZEqmO4WQdQck1qXZCiANtLSAuQD05wAfQ8Z+hFU7kByRgKScE1vDQ46q5tOx0dqY5bVWJPTr6e1c7aXH9n61NCM+TK2MHsex/pWlpcm+0Qr/CMH/GsbxAv77zAm1iAc+4pUoXk4vqLETcYRqR6anWyxiRN386YkA2LyOlW7QifTIJ1Xh0BOfcVKg+ReB0rjUnFtHrOKqJM7X9mFseC74Y/wCYi/8A6Kir21NSNvMnlt94hSD0J+vb614h+zIoPgi+ycEajJ/6Kir0DxBOWBiVvlkyM5xwOv4V8RmtJ1MxqepzZfQVajCL7FPxRr9zrmpPbowFhbNj5Okz9mPsB0HTnNPsIcld3SsLR498ZkwQZH3c9q7HT7VpB8rojbGkBY8AAdf6D1oqx1VOPQ92Shh6ShHRGolybG0V4W2yOzIGH3lG0Z/A5xXl/wAR9WM8kWlW7lY2HmT47r/Cv4kEmuy8UarFZ2lxcMnkwkZWIEnHHTPU814w9zNd3k1zck+bOdxPp2AHsBxXfgKPNLney29f6/Q5qVLlXO92SRjLYB+UVDfyqV2KTheM+tThzDC2eu3vWRM5kkAz17D1r14Ru7msn0HT2mwq0iyACETMWG3bkZB9x/Sq2pWN7oWpW4uB5N6scdxsDbjHu5UPjgErg7c8BhnB4rY0+8ng1KK8ZY7h4eEW5y6cDC5HcDrt6cCoLq1thNLHiZYg7bRw7c5ILHgHnGcD1x0rojUsrSOJwk5prod74R8QRanbowIWZOJEJ5U+o9q7/S58nk+4r59to7vTpBeQyssx6t1yPf1r0vwn4jF5byNcvHbzwlAYi/Lhs8pnk4xz6ZHrXzmZZda86OqO+T9tBKekvzPYNMulABB2svTHf610dtcLIvGNxrz7Sr5JWAJ5bjOetdHbXgWIMr5P17V8vrSlsfOYzCO50E25ioAzz1qnqDKrZ4K9D7VQOoyAFdw56Z7VUur4yR4wF9fes6k+ZPuc1PDTuiS4uNwIAGBxmsK8lBDljt561NcXAQYBwAM9awtRvQBgHNPC0pN3Z7OFw7voZWuz5gfa3JPGK47QPFi6h4nm0sw+WI0OyXdnzGXGQB2/+tV7xRqMkOnXMsILNHsQ/wCwz5C5+uDj6GvKdAuWsfFmnzHccXAVznru4P8AOvtMDgFVoTc1rbQ9LEV/YOFOL66+h7/HZ3N1ewrBKUGwu6ld24AE4+p6e1fOvx4kaTx9JuJO22iUZOcAL0r6S06KW4ngggfy5pXESsegLHHPtXgv7Umm2+l/Fe4gtAyxG1hbaTnB28ge1bcN05yryqdErHicQ1kqcaT3e3y/r8DkvC8e/Tkx3kb+ldVa2RKfNnpXO+DkP9nxsOnmN/SvR7a3Rk5U8qCK9zGVXGTHl8P3MX5GJp8JMpVhjywVB+tX20/dL5bDAPBqyIBFqSKp2+YgOMdcHpWxbwpcO5XsdoB7EVw1Kr3PSUOpgx2UouNhG04AJ7Eeoqee0Mcm5+UwVrZuYV8k3HVoiAR7GmapsCKFPB54NS5XGtNyTwbZ7oLmYnDlsZPPAHSsH4l3xlurewQ8InmvjsTwP5V1eiFrbT1dc4PzsB9a811WZru/uLyTrI7ADPQDgD8qwwkfaYl1H0NcU3GlyrqR2DeYwzwQfTtWxEFAOQQRng8YrnLadYpkcE4zyPWr015GA5jJ9Tn1r1pU7s86M3blNC5l3youOQOPepI7cKyFgCT6VkWwvLmRXtrS8lz3jhZh+YFa9vY6wRH/AMS28UYOPMTZn8TipeGqSXuxbNViKdOVpyS9XY0NSm8jRzskVkOT5YJ+R87Rn3wM8Z4NcmEJj2hh681teI7HU5ZhHEtu1vGRtdp4YAwCgZ2luvr3PXvWE+l3qEmWfS1GOh1GL+jV14fCVVHWJ52JzDDuVlNM0LHVLm307VLKzKRWt9s8+PAZmCn5VDEZAzycY7VS1Szmhe1EwIa6RZYgGBDKxwvQ/KcjocHpkVAmn3CswFxprZ/hW/j5/WpbW2vEu4ZVEL+S/mjyruEtuHII5POcHpWzw809jCOKpSVoyRQ1G3n/ALXmtgvmXMLmHbF8+4qcYXHXp2qGe3+zR3S6hHcRXHlK8KbMZYlSN+eQuwkgjOTjtVvTBqGn6oLu6tNTIG8s9m3ly5ZSMq4DBeW9OmfWrniO/u59Rs7w6aZJorOCGQTKABJHH5YKlCNwGFYE854OQMVTpyg0mjF14zb5fvKGknyFaKXaxRiCQwYdexHB+oqvrkIdWHXuOelOiuJ7qaSa7Z3urgmSR3GDvJy35k06/gf7DJcsP3KMYg2er4zj16VDfLM1VpUrPsdF4ZUyeGrL5skp/Uir6wjaPl7etO+GWlzaxpVjY2zA3EyyGFO7tuPyj0HBJJ4ABJNejD4VeKwMJY20idnW4GGHqK8+fN7SVlpdnfTq0o04KUknZbvyOU/Z1mEXgTUMkBf7Qc/+Qo66jXbpvLVSSHuW2gf7P+f51xnwBUy+C7mFOXm1MxjjPVIhn9a63xjD9n8Q2VtkMIw4LL90kNjivn8TR5sfUk9r/odmWNQwkO7RsaVCpCdd2Q2OgK9zntXY3kDWluLKQRhoW3swAyxI4yf93HH51T8H6ha2cAE1osu2RiFJP3DHhsnowLbQF5xyfesvxJqS6ZazTScIilsA5PsP6Vw1KVpc0Xe+n9f8OaSlOtU5WrJfj/X6nFfEO/FzfLaxsWjgwz+hbHA/Ac/jXHY+f26Vq3LPPbtPLgySEu31NUkt2Co7jAkUspzyRnH8xXs0EqcFE32ZXvG3w8E88GqUSDzj1BAwKnl+VnTnr09KetuTKj4+Y8H2rpT5VYH5kRUqjZJ39qtWds/lPK2WbG4hmxu9M09Yz5+G+YDitCC2e5CRojPvIAVBlnJOAoHck9qznOyKSNVLKDVtUTTdMnP9kiQETzJ5fnFV3PcSAnhVG/avHygDqecjWJILO4jvLWCCCNU+yx71yz7sjzTn/loRzkYx2HFXtcul0IXNsz4k8sRSoh6kgM8Zx12sAD2ytcH4jvft1hDPcxzC43u6rnEYiwu1x/eJIkB/CtKFOVWW1l/Wi/U5a9WNCN079v1bPQPD3i42zeXcFtgO3PUV3+m6/FMgaOVWH1614HYzpNbxvFlh1yDyK3LK8lhIMMi7D1H8P5V5+NyqnNtrRnZCUMRFOf3nukmrb0X58hRgZ7VGuoDa4Zsn34NeT2Wtyo5DjI9ia2oNXE0Ibcu8jHWvFq5S4aFLBU+jOvur9cZ3se9cvrOupCpXcWYnOB2OKoajqSeWiRGZpixJ3qFXYVXaRznrv56EbSKwZl3Fnl5cnvXbhsvjDWZUXCmvdWpUuLn7Xdo98062rP8AP5ABcLzyoJALc9/U1yOptHFqrvB5nlRzhovMxv2hvlLY4DY644zXU3hBYheAOTisHVLojTryzeLzFkCvC28qIXDZLlRw5KllG77ueK+lwllokeRjOZ+/ufQekhrgwRwE+a7KsZzj5ieOa8G/agt7i0+JiwXkvmzx2ECs3X+E9+/1r2fQp82FrIMg7EYH0OBXg37Qd7Pf/Eeee6laWT7NCNzegWvL4e5Y4qcGne3yOPiKnJ04zW1/mVfACbrOMMMrvb8+K9KtcfaET/pnnFea+CA0eipOucpMx+o4zXpFiouBIR1KKwPpmvUxyvNs3y23sIX7ISe18vyLsZyjhs/7JOK3NLhCkDAyrOCR3ycipzZi40+4hZese3n0HT9azNOkZbZFUnzQxVsnvXDUqe5Y9WCU7lrXFEFtIUxkAKR6j3/OudvJZhBGqpuJGASe1dn/AGc1zC6OokJBIGfQbifyFY91DEh27V/drnPrV0qkdjlrppWLFgkx0lcYCpGct7YrhrTTUewM85WKIuSzynABJ6AdSa7GJZb23S0BKWgTfO69SBztH5Vzy6Xq/ifW5/LiWPyBuKSNtito+xY/3iOSev4V15dheX35q7k9F3t19Dz8wxru4U2oqHxSfTyXn/VjDkl0jT2ZbaynvnJ5eeTYn4AckfWtPSpNevITPp1tZ2dqM5dLdAq8/wDPR+K14YtI05B/ZsEWs3qc/bbhP9FU9/Lj6v8AUnFEqXF9MLm/le5c8gOcKo9lGFH5V6rxUKXut2faNvxf/DnmxwssQuaMW4vrNu3ygrfjYoXUdywDXniHUZsHDR2pY/kRtUCoLeDS/wC0bf7ZYajcwrIrS+fchiVzztXoTjsTitiYFRED0JJ6VmzSbbhlK/MVOK555hOTsl993+en4HXSyqnFXb+5KK/BX+9nN3+oW0N+6R6Jo8at82/yC5BJ7ZOPypp1S5BI8vTVI6eXYxdPxWmanb5VZRyCoz71QdGBI5OOhx1FdEMTOUVqZVMDThJpLT1f+Zej1W88xsvCOw220Q/ktEt7ePbuWnIB4GI0H9KzgCByCCenenTTF4QFXJX3putUf2gWHpJaxX3C/abnaN1zKG7lTtz+VSTajdFADJyv3eTge1Zxk3Dnjn1pJZiy7R/OtFUn3OV0KS2ivuLVjqD3crpdIrpjkDg9ODn2PPvip720zGzEg8fiBWJBKYbgEYOeMVpz3YMfIJB64PJFZVedzTOnDezVNo7jwQ4t9Isi25CFZWKHDbGJ3Ln0YEg+xrornxFqs9xLMniDV7RJHLi3t7p1jiBOdiDPCjoB6Cq/hbQFm0lYriV4J/I2WVuq7nvLnp5Y7AAkbifXjvU0yaDbyvDda1cw3EbFJI/7OHyMOCvMmeDxXnNy5m09H2PTjGlZRktUuz/yKH7N8oXSUBYqE1QykqcEAJFnB7Guy+JsTWniS2YqygzyrtJ5ALbh9eD1715t8B7yOHSpYXVi0l24VgQAMxpnPc9q9f8Ai5HFfWCahCyl4YoZmwOdwG1gf0ryMWuTGTT6v89B4Bv2FK23K1+I7Q5FW2AJ6HIrkPiTqZmltbWNhtZ9z4PYdP1/lU2n6kUtQQTwCc5rkdYma7vBK+SBhRWWHoWneR6O+xpQALp5DZJHH1qmGZIVJBPTGO46VJIW8rcpxhc47EEVnwTMjp5nTsc10xhuwjK5DIjC6ywPqPzq4rFZUwMgnNSXkW5UlU4fpVdpGI27MhsDPp9K0UuZIJJtFjO6R2Herbat5NpLNI4SaIKV2/KSQDgrjuMcnr0qlbxM6l06jgfWrkVl9piIlTGDgk9Kyly3941jFtHHSXa3cC3F1IrPIzr5WSDGAAQ2cYwSfqdp6Vga/qkl7NJubJOAWUAA44AAHAH0rr9f8JmdS2nyGOT+4x+Rv8K4C7sbuxnlgvYDA6LvKv3HbB75r3MHKjU96D17HzeYutSfLNb9TR8P3Ulvyu7YT8voa6JNQRAH4Ge3QZrltDIETtj7x5FP1acpGqRkiRzgH0FVVoqpUsaYbFOhQUjqY9UWL5nyS3Arq9OspriAeYSkbL/CeTXn10NtqmB0Ir1bRSBaQsBgFQa8fHr2UE49T18JWnVbUi5qFpHc3X2oPGZJwWeFVIFuFwFUZ/hx93B6DtWNqkShc5wTxmuq0izutZuI9KsoIp5pd0kZc4ZCMbiG/u4xkHI6VzOuRG2up7eQAyQStE+GyAykg4PcZFedSc5NSex0Nxjemt1+XT/I527ULGQB17nvxXM6uD8wA5wcV0V4xLEDtWDqKZOSRya9rD6PU4a+qseweELjzfD1i5O7MK5P4V4h8bm3ePJz0/cRf+g16r8OLoDQ4YGPC8DJ7V5T8bRjx3N/1wi/9Brkyql7PMJ+j/NHHnkubBRfmvyJ/A7bvD6IAOJ2zn3Ar0Dw84kTYeGAC4z1xXnHgY7tNVM/8tG7/SvRNKQRWiSDG5etdWPfLKXqb5bFSw8PQ7FW2wNnqc1gwp5eqckbGJY/WtFLgSxRbR8xPzD0qG9jXymmjXJVx0rx03do9WlpuaV9djKxryR0GcZNYLwXEkU0sjYRVLH3FbtjZrJbq5GWznJqe7th/Zl0gALPGQgB6kjHFXh6t2qa32JxEVFcz2RbttHGm2dpbSEJNcRRZLfNtym9ifp6Vg+PIrt/D0kGls9vYo264jT/AFk6nqzt1P8Au9MV7H8RdIFtpy3qD5UEKnHbnaf5iuEZFDElQyN1B9K97Osc8JUpxoq2mr8r7eS7nx3D2C+uRq1MS7++7LpfTV9327ep5Bok0ixxCVPkCHIHQCuksmUxuhYYABB+tR+JdCGmyme35sWbhR/yzJ7fSsqGZojjoD2rzeeNR+0ifU8jUeRl6/bbJGykERk1Q1aCXyFuIgGZcnHqPSi6u49iLEBnGWzWhbTQyQbVK8DkH+db8zjFMy5ehxpYT2ikknA6ehFSG3U4OBjtV3UdKYvNJaYBJyy9j/hWa1xLbp5dxCVYdTiumE7/AAmFRNfEiteWhTcqdAN2f6VnIrOCR19K0pr4SF9oC5QL196p2zIVAyNzPgDpnniuqLdtTknZFG8XLEgKj5zhRgfQVXMhVQGBxjnNXb0qDJ0LKCTjnAHU1lBnuJCltG0r+iLk10Q1WpxVmk9NxkjDfkdegroPBmmS6xqsbmJ5LaBxlUGTI/8ACgHcmmaV4Tu7pw9+3kJwdq8sf8K9l8A6Omm6jp/k2iJKJbU6f5kmyJXYmXLkHPzRRvjryeR0rKtXjbkg7sKWHqQvVmrJdNr/AOSNnR0tPD72Or315ALiyIENuULiQ/P5km9cgOshkVd2A/k8cc13Gg3XiW70PTrhPCuizLNbRyCSWVQ7gqDlvc968r8faqjarfB7az+13Y8ydYyXFpkLsiUjA3oqglxx+8K9q41HUqCVGcVxqSi2mrnoLDTqQUpPV9167Wt33d7mH8MJjb+H5Jl+9HeFh/3ylfQMk8Os+FltRBEGlVi84yXdWH3foP6V86/Dttvh24yp2m5YBu2di8V7V8NpriUw6d5gj+1EQqxYYKMf4vQZFeXmtNuo5x3udGWSTw0L9Ff/AD/A47TrgwrLayffj3IR7jgms0tut4jjv1roviVo03hvxfOkgXbJzlTwWxyR9QQa5WBiExwR9egq4rmXN/XmdsZJ6xejNJJS0W3qMYqrLEXA9ACKfb5VWVsbfUn+VXUhDK65yWz0NJvlZpFWIbVxJAN3DLxgnrThHweArA5FReSYyB2HcmpldXbB6HrUvui2roLCXbM6t/FyPr3q/Pd3KQRQOxMEZZo1wPlLEFj6nOB16dqr/ZAMc57g1cifMZEyjd0B9axnJXujenayTEW8UQgPDFgR7CQ3zE7t288/ex8vpjtnmua8U2cOr2Zib5JU5Rwe/bPqOvFal9bSR5ljBIPVazXAuCdh2urcg10UXyyVSLtY58TQjOLjJXTOHtUksS9vcKFkU5+o9az7ubzNQjL5wrDGPrXb32kNfyZlYcAnKDnH1rKufCYwjQXL5U5Afkf/AFq9mliqV+ab1Z85iMDXUVCnql95fNjNNZfaFizbRzRpK+RhWcnaPx2t+Veh2hC2wXAJAwK89sEuzqVpbSoVgZ9zDdwxAODjvjP6mvTdGs7W8mEd3fQ6ekaNK08wJAAGNqgcsxJ4HoDXkZg78sT1sG+RSnLoP0+e4FzFHaMyXMpMKlX2HDcEZ9+9Zvii0Ol6jcWTSpJJDhJCn3Q2ASv4ZxmrQS3bSIJkmJ1JpiptivCx7fv7vXdxisfxLBLZrHLdOzvOSfmbLNjqTnmuOhTvI6qlTmehg3Lgg9PrWLeZc5C/iKtTzF2xwc0mwFQCPzr16a5DjnaWiOg8F3AjiEYOMVwfxlff41c/9O8X/oNdLpU32a6Xae/rXJfFd/M8Ws3rbxf+g08HTtjOfun+h5+byvg0uzX5Ms+BJAtqg4/1jf0r0PTZMSyDJMbDG0+teU+ELoQuqE4+bNem2U4aIEEZ6ijMab535m+VVU6EV2OjtpSJR0wOfrXSWFut0cMBh1wRiuVtJN+BnOOea63R5SIFf+JTxXztd8h7sdVdF6wiCoINoJQnIH9alhsjJdXEuwmG2XzMj++Qdo/Q1GpP27zFPBGGrq/D1k58L6tcyDJluSPTACKB/M162R4aNTGKo9lr8z57ibEVKWBnyaOVl9+/4Hcauh8Q+BJWiX57qzE0Y/2toZf1xXjxJVtr4KnBU+tew+AJnm8LWsczBng3QH6KcD9MV5t4i04WGpXdmFwsTkx/7h5XH0Bx+FdmcUlWpRrLp+v/AAxjkU/Y1amHl/VtP8jnb+0MsLoU3owwQehrzXVrWSwLK4K4GVZh+levwE7VSQAn1x1on0e21K3MdzEsiMMcj+tfM08UsNPlet+h9FUmmrS+88OtLZ9RvIobYB555FiiUg/M7EAAD68U64lks7hre7jCyxSNFIQc7WU7SuRwcEHkV3+q+ALzTBFeeHppGvI5WkUSOE2AAbNhx94HdknHBFeaa1bXNiywXVpc2oUYHnpjJ9m6HnPSvo6bpVl7rOFVpp+RtJdKjhWxgjJ9wamcQTsFAAyec1ysUzYCl/lzkfWrkFwyyYzxWUqLjqjpi4zNm58P6dNHueBNx79P5Vn/APCJWG75I+P98/jVmO/cAZf8CKmXUSG521n7StHZlPDUnukU18Pafb9bWJmHQkZxWlpunLNOsFpCnmMCduQowASeTgdAajkvFYNnpjORUZugRtYLgHoabq1Jbh7GEVojXC2KW74MjSMFMYQY29+SeCSODgdwR0IrVSK1/wCEbs3u57O2sry4CzXvkyM1tLHgLGoH32ZQzM3IHzLxgZ5aWYKchwV7N3NB1i7sp7FxMzx2Dia3tp2LRI2MghM4HJz71pTqXdmjnr05uNoP+v6/rvX8QRT2T7LuAxPIC6Hqkq5IDxt/Ehxww4NZSS/IuQucelJqOqz3SRfapZHVE2ReYSQqjsmeAM5yBxnNZS3EZAO4fnXoQp9jhqV+VJNmb4F1CytrC5gkWZ715MxjOEVcDn68fyr1HwbcymaFLaCaa437gYiWwo64UDr3Le1fPtvM9vMssR2upr1Hwd4im+zSCyuJoVnURXEcchUuP7rY6jnpSzHCqcW+5wZPi9PZPdbHu3xB0+PxP4GsL+2R5b6MstxOzbiZhjAJ9GXp7YFeFwTNGxWQFdvBVuo9jXq/h2/uIoJdOuBNAyhXaB8p24JX1x61yfxG0OW0uU1JIXjinAMoKkdej/Q+teBgq3JUdCfXb1/4O/qfROioQvF33t6b/ht6GQJPMkO05zyMnJrQ09iWAJ5wea5yyuNpCE8g1r2s2zDL+td1WnbQqMk9UdPaaTPf6fqE8SI8diiyzEnBVDkbsdwMHOK514nt7nBHHatmwuNw+VgMAs6lsBlHO0+vTpV7Xre21Ewz2SgSvGXmVRhRIWJwo9MYriVTkfKzeze+39bmXFISg6Y71cihaaMAAHdwFz1NUrDaBl/4eoq3NG7QXLQqxOz5NvUkjgD3zUSWtgvYFDxEpMhKZwcjkVaPh6LVhF9kUS3UkhjSNOGPAIOenPIx7V2nxD02wh1C7NvOI7m2ig/clQocsvzbcemMn3Nc/o+ntPaXNxYXLrqFtG946AYSKGPOSx7sxKlcehzilBy57R3M44hVKSqbXtv5rqcde6deaHfyJPGJWhZo5UB+ZSOCPQniqS3MTL94DOTtIwc16EYb3XrGfUbiF5nT928u/wD1Yjj3Ev7bRwSeoPU1zFzp9rcybA8cbDg+Z8u0+4PIreNW+soteYRakrXV1vYw7FPO1S3MYDbMsx9OK6SO2uLuV4reLeyRPM/PCIvJY1Fa2NppUDt9pinmJcMkfOAOhz0IOeMelVNSkuNOvJIvtA8x4V3mCXKtHIoO0kexAIol+9lp0JTsrLc3NGuba3s3e5VPM3q6seoHX8a4zxTqT6nqk87E7GYiNT/CvYU6e5YnBPSsucZPPQnNddGHK7swlGyv1K+wiMEDJNSxqccipIkUx4PGOabIQFOO3Fbt30Ofls7sjtVLX6ADPNcX49vrfUPEcslq4kjRFj3joSowceo96ueI9ZNustnatiZ+JXB+6P7o9/WuQr0cNQal7V9jwMzxinH2Ee93/kWLO4a2nVxnAPIr1DQrtbu0iZW5x+leT1u+GNWNjceVI2In6E/wmtcTS9pG63RhluL9jPkk9Ge1aWVMwAOe/NdjpcyqiRlgG5x7151oV2kgViecV3GkTW8ksDXfmeUGAfy8btvqM8Zr5THYZydz7OhWXLqbkzspUxng816l8P4Bf+D7yBurTyAH0JAI/nXkayPtYKpkRWIAxhsV6d8Jr0CW7s2LAyRpOqHsR8rf+y13ZInSqXPMz+CrYRr+v61NX4d3LA31nJ8rIwcKeufut/IfnVb4macc22oxrn/ljJx+Kn+Y/EVYaAaX46RyzLFdZII6Et1B/wCBAfmK6nV7FNS024tJOBKhUNjO09j+Bwa9idD2tKpQfnb56o8KOI9hiKeI6NK/5P8AzPGoIg5AYkc8EdQa3YoH82RisabSMhcYB9qyNjw3TxSqBNGxjZf9oda0rB9xAJ+UA8dxXylXCc3uy0kj6au3JXT0NByFQeYockdPSsq80q21CExyojIw5jdQy/ka2FiDFXUFkzjIqwLMo5KZAPA4rz6kMTT21SOBVvZ7PU8o1/4XaZOTJbq9k4/59zgH/gJyPyxXHX3w+1K1JaymiuFHRXXY359K+gby1kVlLLuJ49agmiiC4dAzDg1rSzKrTVpv7zpp4pNaq58w3lhf2c229tJ4cZyzKSv/AH0OKrpIG+7k456d6+htV0+HAKgYPVcVQi02JJSBEhVucbRVPPYLeP4npQnBxvc8KnujGU3YI6nPXFEt3bygbAd/cZ7+te8SaFpt1zc2Vu6+hjFc/f8AgLQrhvMWxjjb/pizJn8jVUs9w83aUWiee7smeQTXACMomCS4O1ifun1xS+IdRsb7WjH4atrlreSKPZCWaaUybQXzx2bI444z3r2O18C6Jbwu50mGRUI3yuu/BPTJOa1pYvCPgXR7vXNba1ghh6Wdmi+ZOx+6uV7n0/E4xXdQzWnUlyUoNt7Xsv8AP7kceKkoL2kpbdr/AJf57HgHifTr7RfDlvceJL14UUuNP01ZNzbn5c+irnBbHU8cZrz1J5WRWLtkjJ5qx428SXPivxHdapcr5aSMRDAG3LBHn5UH09e5ye9U4v8AVJ/uivqMJSqU4fvX7z7bLyR8jjMUq8/c0ijNq9pOozaZeJPCTweVzjP49j71RorpaTVmcsJyhJSi7NHf2HxGmtZhM1k80uSWZ7kkvnrklea63XvjoNd0yG21Lw55s8cfked9u4aP0ZfL5I7HNeKqjMMqpI9hThDKekb/APfJrinl2Gm+aUfxf+Z6CzTGaWlt5L/I6J/FALkpZlRnjMuSB6fd5q1F41aNVH2HOP8Apt/9jXKeRN/zyk/75NL9mn/54yf98mtnhqT0aEsyxkdVL8F/kdrF8QDGB/xLc/8Abf8A+xq/afFGS2bK6Xkg5H+k4/8AZK87FrOekEv/AHyaPs82ceTJn/dNZSwGGlvH8X/maLN8ctp/gv8AI9EuPieks3mpoojc8ti64P8A45Vq2+LksDoV0gEKQcfaPT/gFeZizum6W8x+iGnjTr09LO4P/bM/4VDy7CWs4/i/8x/2rj39r8F/kelar8XZNQv3uTo4j3AAILnIGB/uVDF8V5ohIF0sgSLtYC6xuHofl5HA49q89/svUP8Anxuv+/Tf4UDStQ/58br/AL9N/hS/s/B/yr73/mJZpj19p/cv8j1uw+PGo2Og3OjwaWgsLhZFkjM6nIf73Pl5rk7r4hNczmaTTiZGJZma43Fj6k7eTXIf2VqJ/wCXC6/79N/hS/2TqP8Az4XX/flv8KtYTDLZfi/8yVmOMi207N/3V/kdWvj9ljEa6cAuS3+u5599vSoz45z/AMw4D1/f9f8Ax2uWbTL9etlcj6xN/hUbWlyn37eVfqhFWsLh+i/EP7Txv834L/I6tvG2Rxp+D6+d/wDY1E3jHccixx/22/8Asa5byJf+eT/98mgW8xbAikJ9ApqlhaK6fiJ5njH9r8F/kdQvjAqMfYvr+9/+xqG58VySROsNsI5CMBy+7b74x1rnRBKTgRuT/umoyCCQRg1Sw1JO6RnLMcS1Zy/Bf5CsSzEsck8kmm0VJsAZwxOF9B74rc4SOin4T+83/fP/ANejCf3m/wC+f/r0AdFo/iqbT4Ujkh87ZwCJNpx78Guos/in9nRVbRy5XoftWP8A2SvOIIkllVN7DPfb/wDXq8umwt/y9MP+2X/16554SlU1lE76eYYqKUYy28l/kemQ/GgxkH+wiSDnP2z/AO11reH/ANoGTR9Zhv18PGUJuDR/b9u4EdM+X64P4V5FFpMDE7rxlABIPk5yew+93pYtHhc/8fbAevlD/wCKqKeDoUnzQjZ/M0njMZWjySldP0Pfdc/aiTVYYgfBrQzQvvjkXVckH/vz/nArSj/a3YRqH8F7mA5P9q4yfp5NfOg0KLP/AB+Njt+66/8Aj1WF8MwscC/fP/XD/wCyrdygndnOsNiJxUEtF6Hr2t/tFw6lqL3cXhH7O8gG8DUt25hxn/VDtgVUj/aC2A/8UznP/T//APaq80j8IwyBiNRfg4/49+v/AI9Tf+ETh34/tCTGcZ+zj/4uuWdHDTlzyWvzO6EswhFQjsv8J67aftJ/Z8Z8KF8f9RHH/tKrp/ai5yPCBH/cT/8AtNeKy+FIU/5iDn/t3H/xdR/8IxDtJ+3ycf8ATuP/AIqs3g8HLVx/MynTxsneS/I9vb9qMMPm8H5Pr/af/wBpqtJ+0vE5OfBx5/6if/2mvGJPDMKDIvnP/bD/AOyqF/D8Sji8cn08n/7KolleBqbwv83/AJkcmLh/SPXJ/wBoVJSceFioP/URz/7SqAftAYH/ACLR/wDA/wD+115A+lQqcfam/wC/Q/8AiqnttFtpzg3zq3p5AP8A7NWMuH8terp/jL/MuGNxt+RS/I9XHx/I6eG8D0F//wDa6UftAc8eGuP+v/8A+115l/wi8OCRfuQP+ncf/FVEfDkIOPtr+37gf/FVCyLK+lP8Zf5m/t8x7/8ApJ6dN8fHkBH/AAjuB6fbuP8A0XXnnxB8cXvjK8iaaIWtjAP3Vsr7gGPVicDJP04H64uo6ULSLzEmeVAcMfLxj9azcJ/eb/vn/wCvXbhcrwmGkqlGFn6t/mzjxOMxU4+yrS09F+gytKL/AFSf7oqhhP7zf98//XpwfAwJZMfT/wCvXonAdn8I/Clh4q13UxrElyNN0nTLjVbiK1IE06xAfu0JBAJLDt0B+tUtZh0PV7+3m8OaXfaVaGPEsFzdC4+cE8o+1TjGOo65rM8Lazqvh7WbfU9CvJbK+izsmjwcAjBBB4II7EYrpdb8T6v4muIrjWblZ5Yo/LTZBHCqrknAVFVRySeneplLlR04ah7WWuxBBBZ28ZjjDswHDZ4B+lSxEgLhmznrVWEY5P8A+ur0KMTnBx2OO/pXFUnc+kw9FQVkW4HYMcOx4qdGdlwC2fXPFMt0OMD1q6hMTo5hSUJwY3ztIPrg5965JTszuUNB2nCWVc7mBJx171BqCMk52M27Ayc989609MV2laOMZOCoI6jH8X1rQh0csLi4keD7KjpAxEq795UOAE+8eCMkd8+lZxm3N2QSUIRTm7FXwzOjO4up5VQNsTaed3XJ9q9AtLcC3LCaRienPAry25jFhfkgbcEEZNek+HLpJ7ZPmyjjH0NefmEdFKJ6WDm2mm9jfs+YH8wv5owq/SrClyOWP50lgm1iZDnA4p0qlDkKev514078qZtJpyaELMi4y3X1qKSdhkbmJx60krMc4PP6VDOo52529T61ipMqMV1M7UZiVJEjemMmvOPFruzBPNbLGu91GTAZyMHHU1wp06fxBrYgtJrdSgdppJ38uO3jUgGSRzwF5HTJr28tTckzmx0406b5nZHNtEVjBDE+x71CLl+EllmURhjEY/vK2CQM+hYjPfHSrl2ognljSSOdUkZBJESVfBI3Ke6nGQfQ1m3SEKWDN+Fe9HezPEmtOaBTuGYO3lSOQDw2MfpWLrEO9jOFO8/fOOvv9a7XW/EEusW8az2dlC6SsyywIVKRn7sCjOBGvOB1z3rnLksSdxOK6qcmnqeXWpKpB8ya+45epW+/N/nuKkvIPKclATGehx+lRt9+b/PcV1Hhyi4uzPQfhx4d8P33gXxt4j8R2t9eDQvsPlW9rdC33+fK0bZYo/TAI47Ed8jM+KvhO18IeJobTTbma40+8s4L+2M4AlSOVchZMcbhz068dKoeE/GuveE7XULbQ7qGK31DyzdRTWkNwkvlklMiVGHBYnj+grP1bV7/AMQazPqWtXct5fTndJNKclsDAHsAAAAOABQCVyK3i8rBP3j+lW4BuPt7moVQswA5Jq2OEAAwe9EnbQ7KNO+o4Hd937o45qzHtBAbrTIIwrD0z0qzEhccg/X0rCUkehSpPcepVeVGV6jPOa0Yh5khw4Ys2dxGOKoIhwQc+wq7Cp3gL949TXPN3PQp02kbkNkqYWSZVjxlnXnJ7KPeqkKo92qlwi5PzN0FMt0ZZl5IUHPWpNTUBVIXBbOaxb1NYrTUpXTjzn2ncBxkVGpKKQwx6U08Db3Y1I6ZHAwRwRVXBq2pC8gKjJ60zIEb5UtxnC9T7VK8bdOgxmoVwwPl4z71SaM5plPX7NbK9kiS5guY0ICywkmNwQDkZwe+PzrIV2UkgnIPWtvXZY5LthAJRGzEr5rAuF7AkcZx6VjSRneQf0rtpSvHU8bEU7SujX0zUwx8qfGezetabxA8rnn0rkifQ4NbGjakd6w3ByM4Un+VZVqX2onVhcTqoTL3kbty4DDkEeorltb0xrGUPGCbd/uk9j6GvQ4YACZQm5cc4rV1DwrJdWkrLGtzZsB+8i5GD0I7g/WuFY2NKXvPRnoYnLliKdlv0PE6K09f0e50W/a2uVOCNyORjevrWZXqxkppSjsfJzhKnJwmrNGnaJmJQBkkVs26jbg9KoaepNtHyelbYjKAbgcAVhWl0PewVL3UxYo8tgZIHHPatWziO3YCQvXr36ZqtaxjaGxyeta9um1ACcZ6159WZ7FONtCCBUDNubgNjFXDH5jBUzknpn71RBUSbdtyFHTH61pCIRQtPnaqIWZ8Z4rnk9TpjZI2tBsrWK6kluZQoTy2+zrxJOC2H2sflUKgLEnrwBT9f08aTqdzAs8V4sUscn2mJfvqUJXBPIysnzL0yPatu4uE0I6cdEuru11pLIQ6nMhUxguFkXyzyM4OCRxj3zXN6pcRwWeyMYQnj69aiq1TcYfa6/1f9DDDuVVupe8Xtf16Kysuzu73MXWnil81igO4gqPTjtWt4TlltD5NwQAw3KO+ePyOD+ODVLQ7Fr28SWRBJHCwbYejn0J9K6n7HaQ2t1fX24NAyiKOMEA785YEcfIBnYcZ9eOcatSLXsjupxdP3zrbGVJEBZ2JxyK0DIjoy8c8Dmue0yUmFWifekg4Kn5XH+HStGWWVlXeBuUY+UAZx647+9eNV5ovbQ65U+Z3FmIJwp471C2QCc9fxo8xXUEZ5GKbv2qcKWNcvU0UbaHNeJrnbFJtyMDr615vF81xI7cpu4+tdj41meKIAHa7HAH8zXFlhEEDNjFfR4CFqV+5xYuScvQknKbgCM+ozVGbaxPykj36Gr8LxS/LkEnOadLb5QlQQPTFdyly6M450+fWJz8sZH3R90bW5yCaoyg7sHp7Vvz28k7Kv7sMgVVyoXIB6ZHU/wCHtWRInWuynNM8yvSZkzKJI2U5AbqPesyRCJbkf3c5/wC+hW7Km7A/hBzisO54ubrH94/+hV2wdzwMZCzTZWq1aR8726dKZaQGeTH8I6mtWO1bK5XCEZH0rTbU56cOZk1tCR8zcZ9RUiKXy2PlqcxP5PyghScE0+OPJRRgc9hXNKfU9qnS2SH20RKknG38+KtCM8bdvzDgdas2Ns05CQRs7DqqjJOOensASacECyFcAbjuBz2rnbud0YpEKwsPvdc/lWpo2mXd607WcBlFvA91M2QoSNB8xJJ7ZHHU54FX/DujHWL5Io54RMZQot2JDsgwXZT0xt3HqPut7Uviu2TT7+4tbPz7eBiszWknAjYAlOQzbvlbIOScNgkmsm9bG6d9I7kCJl1C8B0wM9CevNM8QCMXTx2zs8QbCMwwSB3I/wA9q0vsaJLlbtXgWyXUFfzBnY65SNuMeZkgFR746VixTFrhpWBduSQPSlyu+pKlFpSi7ooxwkMN38RyKnaM7sKfrx0qxPKuH2xKRKhUF1zjkHI9Dx19zVnSLG51G6a30+2lurkoWEcQ5KgZPHcVLk+puop7GNdbsg9B0qtb8eZ6dqv3ZVlyOvTH86p24PlhsjJJIzWkXoYTjrYqTx+ZdYH3u1Vbu1yxA5GetXj/AMfRHIwe3rT548g49a6YStY4KkLtnPyRlSc9PaoidpA7ZzxWjeR9SoFUgnOT06ZrpjK6OGpCzsjrvCerhitpcvhmGEY9D7GvV/Ck5sHdMq8TnY69Vde/9CK+elYoA6lhIGyOeK9p+GWqprFkscrA3UQw2Opx0NeBnOFtTdRLTqe7lWL9o/Yz3G/GvRrQeCnv1YNcRXKBd3VQ2QcfkM/QV8/V9IfG6Dy/h3MecC4iH86+b614fm5YV3d9X+h4+f2+t6dkdzp9pALSxYw7We3VyMnk7jz+OBWxcxfaHAVQCeSB2rK0FnlsrVpGLN5YUE+g4AretlILEjqODXRWqNSZ62DpL2MfQv6ZaxmERhckjGanuLONZyoOV6A+tMsCc7R2q5cxglWzjaM5HavPnUb3PRUOWWhSvLY741VcZIyR2GK6LToE3Q+dCZUDqZIw23cmfmUHsSO/asiJWukEiLyjZIz2rodPKlhKOVweB6VhUqNIpxb0J/EkkE8lotjZCysLKDyIIN+9sElmZ27sSfyArjtUkE86RKchRubH6V02rXKJBNIoOwjAPvWL4csvtV1ErpnzW3E+1QqradWfQ1o0VTSpxOo8NaWILZFZcs4DN9ap/EO5/s/RhaQE/aLokKpPAHdvy/nXaWlrnhRgAZ+przHxJJ/bHiO8kZsw23+jwjPXb94j6nP4AVzYWDqT9rU9ToqzsuSJY+HutkINOvJFbyFAi3ddo7Z9q9CDI/CE4PSvF7y2exl+0wqQ4+YV6X4P1SHUrON1Jyo+YHqDSzOk7e1p7MVCXu8kt0b8NuWcBQaluY1gizgZx/k1oB1jiyFCn1rL1aTfI20YAGMeleDCo3KxUJyqS8jyf4g3eNRihHMhG/HoM4H9a5eFVYs0uSf61e11zdeIb6fPG8oD14XjFUnjBHzZJPOM9q+3w8PZ0ox8jz68nOo2RTyKhzDncOQQOlbWiahDe5jICyr95TWM0ZVc7R0z161RaRreVJ4cb4zuwD19Qa3dNVFy9Tl9pKnLmex1N5ZqdzAcdQaxLm3Bc8Yrpba5j1GySWIY3AHBPPuKo3dt1DD5u+K56dVxdpHdOiqsbo5aWEKGBB/LpXLXg/068UD+Nhj/AIFXc3cJU55rkQinWL7cPuu5H13162GlzHyua0+XlRb0i1C7FfABOWNbEB+3NMyKBGzqieyisqQssCqn3nGT9K29J/0SNG6hedp6FhW9WVkcuFpOUrroXtXh8mwSCJRsjcB2/wBrGf61n2yY+f8AiJwKgE0kzszOzB2LEE8Z+lW4mLYwSS38/WuWZ61HQ6bTdSt9CtYnsYre5u7qCeC5kuFJCiRFBjMZ67CMrIMBicY+WsWGEXTgZZUQDaCeamsUDKC4DO3BJ7Vd2BRhQA3c4rBysdMKSj6s39BtrjSvCkms6fDIt9bXH2kX8EiBrWzIMMisC24uSSVVQPvAk9BUHjDQbfT7q7k0q6ivNFFwba2uY3D5IUHD4GATliPUAkZArDtrR7q8ghjiDXNw4iQthQzEgY3HjqR9KsSvLIl5H5czQxxb1wGKLIGCiQ44OAWUE8fNRzxnpYlUqlGXM5XXb+vw6FyG5itvCWo2qxO8t5dQtvKqYwsasSM9RJlh042k5rG0sANtYhWZtoLcKDnHPsPWtm4l/wCJRpmmKirDDLNcs+Tukkk2jcfoqKB+NTweHrmRf7QhktJYLG1GpTxGUkLCHA2Pj7rk/wAGdxGaUX0RU3vKRJptpoN74u0+0mnuho7bjcTOFjYlY3ZtvYAlQAT1/GodX8OvYRP9p4uTbx3iww5f7PE5IAmbjY4G3jBzuHIq3pepW2oeLba/1toUsyWMoFsssccSxkJEkRBBUfKqrgn8eaqxWyy2V9catcot/ZQBFs5323DSsRjtltnOVPIAA6AVDSbY4zmpr02/r+vQ5S9jKQswGcDFRQJtjjYAlSB8w7Va1KUNby9uwI7VYtYl+yowLZ2D5ccHinzOMdTRrmloY5UC4k6hW5Bpk8nytjINSkrHduXHHUA+namzESgkcMxzj0FdUNjhm7tpFMRb0YemBmokit003URPGGnHlC3yrfId3zHIOOnHOfbmrrxsrMNpBOMgjBrZsILWTwD4nFxsN2lzYmAfKHAJlDdeSvqB3wTxWnMcs4XWpwRKlWHOeo5/Ot7wFrLaN4nsbgk+Q7iKVR3B4rGkDNHISsZ24+ZjhvoOeevPXpUC8k9cdMg9K2qU41YOEtmccakqNRTjuj6Q+PEIPwnnmHI+1QYP/fVfLNe5+JPFo174BCyuWP2+0uII2J/jCkjP16V4ZXmZPQlh6Eqct1JjzSftK/P0aVj1PQLG2Gi6Y0cpZ2hMkpxjBJICj8v1rbt4xJGqcfL3rnfDrEaJYgH/AJZnP5muhsCQigjk8VhXlZyPp8JT/dQXkvyJbFMS5IO3OT7elXUYZIkX5WOM+ua0bCJTEHZBnHFRXqMk8PyY3EmuKWup2pq9iPToTE0rKuVzyP61ditn+zFw5TcTx1qW2tme2PbnmraoY4irgbUHU1yVat5WRrCLtdnN6q7ziO3Ixz29K3fCduoupZm+5Euwcdzyf6Vlw2/n6o7Y+VK6fRIQmlI2MGVs59iaVapaFjppQ3Zo3upf2doV7cgYMaErk98YA/PFec6ZCIoYjIQx+9z39c1v+ObsG2sbJWCieYvIO5Re35n9KxZgE5QrwNq56ZPrRhlL2XNLqZSSdRok1iGOeSVljaOOUs0ak5wmTgZ746Zqn4XuhoOqGO4R/LmZdkgb5VHOdwxkk/LznjB610WovZE6ellFcyQRQQpciRgGZwf3mwjOFYdM9CelZXj9rO6vbm40m2a1s2cmGNjk4zxx24wMc9PeumCUounJ6MycrtNRa/rZ+p6RCJXTK/MuM8dKpapmCBywKkDJqp4K1HzbAKxJz2xwOxFT+NrwRaLdui5YRHA/CvKll6pzVn1NoVHe9tDxUqGlmYHdudjn15oEbGIsFIUdyas6cgkiCAAD73PoKbcyCOIxjHzcZHavptU7HErctzMugwAJ6EZ2n1qg0ZJPI5rSvSs0+1cKqjv3qtEmSQMAY6VvF2OKolJljwjcG31M2cjfupcsgJ6MOf1rtbq2DweYFGSOfevNrgeXcQyLuDIwb5Tg8HsfWvR9F1CLUdOSSNdqtn5Cckc9CfWuXGws1VXXc6cuq2TovpsYF9bEZJHI4IrzwjbrepD0dx/4+K9f1CzIjyQTleteRyr/AMVBqi/9NZB/5Erqy2fM5I8zP4WVP1NGylcTRFgpC/L93kg9jXQ6o8CaLarAhExR5ZD7lioH5D9awLFAZU3cc1t66bcW9stvv81bZFuARj95vYnHtt212VJXkkcWHp8sLmZFGdwIB3AZ4q/p6gsHcjJ4xjpVaNtgLfp71dsIwZ+fuMM/WspvQ6qcdTWhgUuTjDEVKIRlieoHekQ+WEVQTIeFX1qzBslQ7hl84Yehrjk3c7YrQrpGstugKKVQlR6tk5Of5VaWMtukikYKflIU4DDPQj6/yotYhK3mEFVQ4AB6n1NFsuy6TaSoY7znge4okl0Kje2o+4TFwcnaiqByM81JYeJdT0+LyNN1K4tbQyLcNDGRsZ1IILAjnlRx3xWVql5iScKT1PvWIlxglgxwOCPWtIJ20MZqLdpHe6F4km0nxPcau6KBfO32tIYlOxXcPuhVvlV1ZQVzkDFcx59pbaiN8E1zZ72HlecI5GBBC5fBwckE8c4Nauj+G9R1azSeV1s4HGU3Ludx67ew+tR+IPBmpafAbi3P26BRlgi4df8AgPf8K544uip+zlNX/r5Gjw8lFzjHochezMIn3/Mxxk9ATW1bsRYxFR8pT+lc9ekCLk/NnDIRgqe1alrdY0uIN129fauurG8VYxpTtJ37FJwqx5cHk4H1rS0SKJf9JlkdJYV863AiWQSTqwKhw3G3ucg9MY5rNjDTKSckAEgenqa0IVSO3wX4IwTnoTWzdlY5kru5X1G6nu724u7+VpbqaVpZZW6yM3JPp+Hao/tlyNHlsEk22k0y3Mke0Zd1UqpLYzgBm4zjnOM1Zvgnk7TycZFYM07eQkeQOCDitI66mE7LSxRmXO88DnH1qoAQR9KmZsZGfyqHPvzXVFM86q02W21F49BvbBhmKeVJV/2XXIz+IP6VgVeuj+5Iz3HWqNLlSbt1OWtJyaT6Hp3hqM/2Rp74yNmOPqa6iCAb1yD5eegPNZXhZD/wjOnPtziPj65NdG64gjZB15Br5rEzbk/Vn3OC+CPovyNCBdunOpHIUn61K6SJHA10QRnhhxzUKTtJaFkTG7hvY1pXU260VDFkbCHrldZKKT3OxUnzXQsL4sW8sg4OSc0k4LWcpYHee3pU+kQI1oiFV3P8x5q9fWeWXHKvzx2x2rgnNczaOqnBLQ5yP9zYTyHAcqcfy/ma6eSL7OtpBgfKo/QVk3dpt8iAAEPKi89xuHFaHi25/s+0mnHJWPC/XtUzvUhp1Zs7JpLzOB1y7XUNauHUgrAPJTnuCc/rUumWs93OqLayT8EeXHkscDJP0HXPpWVaoY4488szZJ9Se9djo8LQROVZkLoY3KtglSOVOOx7jvXpy5aUVHojgcm7yW7M+zB2HkHI45qnqcbTyFUU4VOAa3Utn81toBXJIAHP0qwLDdPaRJb4kMI5Ukm5Jc7XA/8AHABnO2sIyV3I6JaJIi+He1bN0IfzEJDE9m9BjtW/4hgN/ol1bwgeZJGVVvfFZnghYo9d1XTJmMUow+w/KwGdrfkRj2rstcntYLaNmVY5iHLbY9ikZG0+h49Pxqas1Co5S0fQ5XNO0Frc+cbdjBIdykbfvp7jqKva8ZodVFjcL++tF8ry+8fO7afcZPB57U4p9s8UQwWDES3kyp+8TaI3Z+2MnA4O7g9eKJhbvHc3/wBvN3ezXFx5rKC3C7QkpY84dmbk+nqa9+MeZKTPMdXlfJcyInV7iVmQ7ieAvQVGFyWAODjirVtFJLcRw2aGS4chEjjG5pHJ4AA6mrmj6RLqH2nENy0ccU5DxJu2zJGXVX9FODk9uK0auc7qKCcpPQ5m4w0rDHT1re+HNwWW7iOBscMBn1/+uKy4ruS0tLqaAx7rqBoSxXcQjYzj0PGM+hNT/DqQjWJ4eMPDnHup/wDr0V481Cd+hFCry4uHnf8AE9Cupd1qcYyBkV4xJhvEmrE8DzZD/wCRBXr94DGrEjKAc47V5NcRGHxdrcTEFo55lypyMiXsa5sq0cjo4gS/dW7s0LJcyAge9a2pW+21YjJJweaz9PQtNyOnNdFep5ung45IArrqy5ZIww8OaGxzeSF6DJ7VqacDIECcOh6VUktjyw64xVmz3xzZA+bjI6HFNu8dAhFxlqb2nIGJmIy5OOT90elWBGyCR1YglunY+5FR28oEqSo37uXqAO9aFwEMasOOhI9K5J3ex2RaWo2xVfJUoMbhk1X1RfL27cgx8gn0q7bR+TGX3FsHGM9jVHVCWmkH8Kjn646UJaibOTuGdywYHuSfavS/BHwofUrPTtT1SY+TcKs620YyDGeV3t7jB2j161y/hzRDrmp/ZVEohCHzWj6qOijn1OBX1zpPhiDTdFtrO2GxIECoo7YHA/pXn5riq9OHs8N8XXyRyVqsaNpz67HEXXheZbVJFjUquEVgaz7izMML+agUKQuc8k+w716bZ2LkBJnZVTlV6555rTudIs7+28u5t43XHccj6V8thsJicVJqHTvv/XqH9tOm0qmq8j571HwzpWswlby1heRBhZCvzD05rzXxB4QlsEkjstxjTIRSc19E614Iu7e7lOjS74iN2yU9PYGvP/ENrc2jype20kc3TbjI+oNengcXXoy3vHs+5618PjIuVNpu3zPBYZdi7W+XnHNWDdLtaJ2GAeKZ4ytjZ6pNLGGVZCW24+63+B5rnHuJGY9vWvtqcVViprqfPVKrpScZLY1Lu8UFl7dKx3lwMDryMigRyyOAsbu5AICqW4/CtWy8Ka/dgeRo94d3QvGVH61veFNe87HJ+9rP3It+iMM5Y5q7oukX+tX6WWl2slzcNztQcKPVj0Ue5r0nwZ8HNS1K4WXxDJ9is1yWihcNM3oM/dUe/Ne6eHPDeleH7NoNLs4LWIAb9n3nPOCxPLfjXHiczpUlaLu/wN6OW1Ju9X3V+J87+OPAS+FPA7TXRWfUXnjEkqj5VBz8qe3v3rymvpj9oJ1bwRL5f3RcRZP518z0stxDxNKU276v9DmzejGjWUIKysv1PafCSH/hF9Mxna8Rz7cmunsrZ5VWPA2r39qw/BqD/hEtKJAP7k8n6mu08MiOS2cMBn7teBi6ri5W7v8AM+ywMV7KD8l+SKEcJhuTC2P3pBH1romgX5CACDx+dV9StBGI51I3o4JPbFbFvF5sSfKAQ3IJ7V50588VJHouyVyh9he1mj2jKDIRuwz2NXbu3IRGBymcVrxWwnh8qT061XvSr6dIhGySOQfln/ChR5o3Zgq7bSOelObqD7oxKGy3QYBNUPiyES/tLKDzBGfmYOpDcKM5HUfMSR7Yq848y6VeAoJySfasv4hi7l1+G5v1b7TIoWQEYOSAQfxBBrTCTUZcj33/ADLrJuScX0f5o42yUfbI43xtLAH2+ldXbSNAh3EZxznpXMSxbbxhwpzlSa2oZhPFhyvmHgr616E7SRz2akjY065EcrFlG5e3tSard+XdRPASWCgRgE5HOQBj3yRiqltlFKuDuBzz19qw5NZNvrNvdRxlmtyxUB9vz7SFbI6YJB/CsoYdt26FzrJe8typourSS/Eq0kTpcMlq67uzNknP15969x1vQ7jVNF2KrvNCxwpHyqO4GfX2r528JK8fxB0SOFRITe28aKOCx3gV9yQ6ZbNayw+T8khO4k/e967cVhJVeVUt7L8D53E5i8PLXufGOqWElpqKahYSPDcxN5iOOGVuxHoRXLyQNDAVgPyH5cZwevT8xXsPxV0Gbw9rbF8NY3rv5bf3XH3lPvg5/OvPbm0V2DKo3GuijUcYq51OMKy549TnNOvrjS9QgvLOR4Lu3ffEwIDI+CMjII4z6VNqOpRR3d7baFJdR6fOGDy3GBcSRyBS6SsDhl3LkD15q1rOnoLcYOH45HX8KwJopIoSgibHcjnNdtKcZq6OLEUZKWquiDU5lwsakAdau+BWCeJIgCMGNxj14rJkhnkk3LDKTjsh4rY8I2FzFrEM8kbJEoZSfR9pIU/qce1a1VFUZRv0ZyUXOWKhK2l0el3/AO6RCADnj6147t3+LdY7fvpT/wCRa9hucNApU5K9q8fhAPivWOePMl/9GCvPy1NKR6mdtP2SXc6PTUXDMeScVvRW+63Kj7prm7AkyADkg11Vo6tDzxketPEtqSNcLZ0zLe3b5lTHtTPs8jMs2wnBwyjritCU/u2fYR6H29av2Fm3k7JOAygg981MZtLU0nFPUzIl3qfK4XvGT0P9K0LeRd4W4YoW7tjBqzDo6yMQ6Ak/NnvT7fTkiaVdgxvHA7VXOmL2ZYNrttwiSqXB3EZ6iszUI1eOXymaVwMnAOPz71pPHb/a1WThiv5elKsDRXMkcrnnoGPDDtg1ClYbp3Rd+Buo21p41S0vRtF6oWMvwPMXnafqCce4r61TBX618W6tpoVlkhRkYEMCDhlIOQQexr6B+DnjyTXdP/szWJN2q2o2s56yr2f/AB96iokpe0XzPHzLDTnFTXQ9QZVHXFKCR92sC+v83bW1vukl3Dr0FJqWtCwxCDmYDliOK+e/tqlCcrwatpp37HmLCVJWS3ZuBQu4sMZ5Neb/ABAEd6cxopXJUADv3Jrqf7etpQpu4J40IwCpwCe9cxrN/wDardbeNFhtUctGo5OT3J7muDGY6M7Qpy0vtZ3b89FZb9/Tt6eWUalGspyWx4t4l8BRaqpAllRieSPmx9Kz9I+FWl20vmai891jkJI21fxAr1m7voIUEVvGN6jBPXPrWdHFNdTN5cMj59q9JZlVhRUITbfl/mfS+wpVX7WpBfMzdM0fT7ErHa2sESA9EQCtuBUDAKmRnkj+talp4Xvpfm8naMZ3GuhsPCkkUG6ZgpC/dHU/WvOqYyvGL5UzGvmFCCtzGBCZF2+VEWHQKP4vrV46TPslFww3cBlXv36+3euitrS3tywVlDIhbk9fp71larqKH5Iscd68uVepJKU279DzliZVZ2po8Z/aDt1j+HlyUOQLqH/2avlyvq39oTb/AMKtuNuP+PyHP/j1fKVffcKzc8E2/wCZ/kjws3k5YjXsj2/wfexnwppsKjdIkHzL7bjXc+FSr20zrjk54rzbwbcLFoFqcAnycdOTya73wrceWQMALKvA7Z9K58wppOTXc+uy6b9lBeS/I6S6HmjyQAVlXGak0yTzILZmOJoiyHnqw/z+tLpcZd0R8fIhAz3z0qK+iktL4gFfKnxIv+yw+9XmwfJCSZ6js3yHVqnmQrLCRvGCMH881jXhJ1C5VwFX+IfQVseHHLjay5DcZBxUOtWqm6eZQAki4wD0xVU3empM86nPkquDONtZFkvJGAG1WB/DNT+OCr3enZQhtgJ3Nu3OqhSQT2Pp2p8VoLaKWXcMsw4Hp7VN4pt1udLtbuP/AF1sSX91IA/Q4pV3H6wrbW/Q2o8yjFy8zh9Vt90XmgDchFFrErNIdoJLbh2OD71bWSGaCZMjKnDD/PanWgVY2QgcDb+VddKfL7jNaivFTRQ1e68vYPMbrgZ6iuYuJUMsh6Ejj61q+InVoiB1VuDXLahLtlz6YzXp0aZwVJo0fDU62PjDSdRmJEVpewXEjDqEVxuP5Zr71TGxcdMV8BaYrXIeNThpFMY46seB+pr7205JY7C2S4bfMsSq7AYywHJr0cK7zafY+azmKXJJdb/ocj8T/CqeKPDV7ZRKgu8Ce2ZuizL938Dyp9ia+UpsW1pNMG8uZJPKe0kBEiOM7wR22kYP1FfcLoHGDXzV8c/CNto/jNdfW3322qhY3QNtQXC/eJ9Cyhf++XJrnqYZxqNN+63dfqZYDHSpXgzyPz2vriT7TLFGTG0g+TALDoigdCe3ak+zEAEhQD0PrWZqc2NRnlgUiLdiMDj5c9fxqk985OHcjB4BNEqOvubHu0a1o2qPU3PK2SxCS4jijLjdIV3beepAySB6CqlpIieIJDFIkqrG3zoCqkZHIB6Z96zjcKR8xHT8qs6CnmGa5YnYcRocZ4HX9aHDlg2y+ZVKkUjpZ9TOGHygAY/GvNIW/wCKl1Y9y8v/AKMFegTiyNl9nSXEpzO08q4HCkCJQOpJOcn0Fec2zEa9qLD+8/8A6GKvBJWlY5M3dpU15nV6OuJCTjB/nW9a/NAygY9Pauf01wPukZ9q3bBGeZQvRzz7etYYjV6nZhElAuQfNblWGQFx710tnB5kUTJtyy+vQ1SawVoI0QY2/LxxnFamkIBbKwGAp691rzq9RxV0dsYqRpQwIcK0eQp6jqBTtUsxGvnQqCzEL+NS27L5wUSbdwxz3q3MY4xB8wJeRGZc/rTpYqMtxuizl9X097aEyKmZActnrmrVhAt1YQF1Uj+IN2BHWrniOZfIdVYbYkJ46VXsnVLdHiPBjHHTjFdHtFKKaIlCzZm6hEYAUVt0a58sMflx6E9jVDw5q9xpur2t1Ygx3CyhdnfB6g+1b1xbSTRbVQyqRgqBk4PFc+tlPDcwzoCCGwr45J7VLrLqCpc+jPdtL1aSS5aeJCZZ3yEXnPFb2m6a1xcgyhpZmO6WRuQMdhWN4A8MX+naal3qxZ9TuEA8ofdgU/w/73qfw7V6Rp9oun2fIBlIy5Hc+lThMsozk6slpufN5hjFCXJQ32v/AF0Ob8WSx2WlrCyqoMgy3p9PfHNcTc7BdTFJBNbg7VkGQrfh6+1YfjnxpBrHjSbTbadDaWRMZfOBLN/EfoPu/UGqq3LxrnkrjOQOOK8PNIt4r2kY6Lb0PdyzAShh4yk9XqdVZG38xEKx+X3+QZP411umSabb5JeNUIHtXk325yPlcA+9MWaR5PndmI6CsniZ7pJHRXyt1lZyse1/8JFpsbFBOhxwAtVr/wARQeWRDkMR949BXmFmGYjk/WtRVLNteViPSuWdWvWvFPQ815PRpy3bNK61FZXcl32/1qjJMzLuJGcdKQQfLkBQBwTVe4VkiLcY7f8A1q4ngZ01do7adOC0ief/AB9nLfDS4QkHN5Ec/nXy7X038dAf+FbXCkcJcQnP1LV8yV97wxHlwb/xP8kfL52ksTZdkekeD5tum2q7wcjG3P1r0TSGzpyKWVWjOVJPoeleQ+Gb1Y4Yk9OM16JpN4pHlSAMSQV4zg1WYUXzM+jyqsp0o26I9P0WczKXU/e647Vc1ZTLFG6AF4zkA9653w5cC3nGSdrHB5rqDIJR1BHrXzFe8Jux7DupKQ7w/qG1ByMbgeOxq/rN006soCldxwUHOD3Pr1/KuYEbW1wTFgI5P03VqysR86k8jn60oVfZu3ToZ1aEfaKaKF1CY7RUUkovQn9au2irc221uQeD6USP5lt5b5Leh6moLSUxSncT7gjFRjG21JFpe5Zbo4XxNpT6LrLyRsRbXCZVSeNwPzD+VZ02pJtV0PA616zqWi2/iDT2t5nIDj5WAGY3HRh/nkV4D4u03UvDWrPZagmHPMUq8pMufvL/AIdRXrZdUji1aT95ficssRGEeVl+9nacFmA29zWYLXzlyec8DFUU1LzR5bHDZwfwragbygp3B0ZQUbaQG45AJ6kdDjvXs2dJHKpKrL3SDRHOmakJLjJjidZUYjqVYNj9K+87K5ivLOC5t3EkMyLIjjoykZBr4v0lIrhgs6jDHvyK+oPgxIT8PdPt2laQ2jSWw3HJVVdgi/gu0fhW+CrqVRx62/I8fPMO404z6J/n/wAMdvWL4s8PWPifRLnTNUi8y3nXBxwyMOQynsQeRW1RXoVaSqx5WfORk4u6Pifxp4Wi8O61e6Xq14TcQQlozBGf3jHOwMTjAKjJxnk4HevPL6OIKXMnIHWvqf8AaX8Ezazb6Zrtg8cUlufst0zA8xsfkb8G4/4Ga8Ej8CgYN7cSXDcnYg2rx+przeeOHfLUlqfU4d1MbSUoR8mcLptvdajKYYiQn8cnZB/j7V3sWnx2ulo5mCRJGAu1NwDHhUYjoxwT0Pb1qeKxhtWht4Wjt4mZVMjA7YwTyzADJA6+tTWi2d7dFdsnlxzor2qsdk4OQX8048sHAHI43celZ1cR7XZaHZQw31Zczd33OVum2kjIIWuOR9ut6g3+2/8A6GK6rUpfNYyhUj3ADCcDjvXH5xqt9n+8/wD6GK7sLHRnlZrVvKD8zqtKLFdw7V13h4LIrNwWByPbiuI0O4AJRvmAPaunsbkWt2rA4icbTXLiYO7R24WpeCaPQY0iZJTLOsJjUOoIyZCey/jjPoDnnBptjcxwXbW+cRy4KnvuyKz3ul8sZOdvC/j0pNPaRrgvI3KjacivK5HazWh6dKaWtzsdRgjS22Qxw5EhbzsEPyMBc5xt4zjGc96qs0Ed5HFNbmUyRnyXZiPKORk478A8H1qGK5mW1QTFdpRtu8Eg5yN4/wBoHp71Wjv45NQLHDNEmQOuDXFCHvux1qdo6jvEnkJpl4sTRh3VGwmflyMkNn+IdwOKq6a6fYQR1YLtJPQYqhrVw92JY8nczA4HerMFu1pBHCh37iBlh0Fdqhyws2Zt8x0mhS+XcwmMAssqyMSM7ihztz2U9x3r0XwL4fh1nVX1m4t4UtraeQxRouFklLbtx9kztAHp61xGixSf2XFMQZHjTygcfcG44BP1J5PJ/CvUfh0ZbnQ7W3jbyraxlkWZ9vE+SThT9T83uMVGFpyqVrRV12+f9fkedms3SoOUNHs35f1p8zt4IBHzjn07CuM+KfimPQNIW3hnVNRvQyQjuFGNz/hkD6kVu6n4jsNP02e/vJxDZoDtc9X/AN0dTnt618zeLPEV14m12a9nTYXYCKJjnyUH3Vz+ZPuTXrYvFU3TdKl6fceHlOXyxFb2lRe7H8fL/MSXTbGSOPOxSRww6j8aw5dSltL4xLKxtycLk8D61qW9tNcIFIZZAMkHjP09qyL7S5Qdw+Y53AAfd/GvIprm92Z9iv3eqZrwarvK7v5V0Olr50m7kqf5Vw1mjKwjbgjgg8EV6B4bukaFUBIZT6ZPTpXNiMKuhssTdWOjtZFCogUEnjLdqviAox3KC7eoxiotPeJjmUMSuCNw4/8Ar1buZSzthFZwAeaqjSUVqeXUk+ayQqQdYkIIB5x0561Q1tFtwhkbIGAAO30qzZziJizHeSMBfT3NQXOLu88xmzBAcqcfebH8hSrxUoNdWKmnGd3sjzv48Js+FdxuPP2qAD6fNXyzX0f+0Drlong9dNklxe3c6Sxwjk7Ezlj6Dt7n6GvnCvfyGPLhErW1Z8tnP+9PXoi1Y3RtZ1fkrnkV6R4e1ASiFgQR2INeW1raDqr6dcYYkwMfmA7e4r0cRR9rHzJy3G/V58svhZ77p80kU3LLsYAjjoa6q3mXCf3a4DQL6Oe2hJkDIRkMOc11Flcg/KW5B4NfGYyi09T9AoTU46HVW0CTxtBu+8C6Meoap9LcOBDKdrDismxu/wB4Pm+YVpOymPzY/lkU5DAV58bS92W5FWL1T6kV3DLDdsc5So7jDPgD0qxBePHqCyNt4wQGXcD+B7VSvpPJdRvbYG4brxW8tVytDpuTdma+l3Qhk2yc55qt4z0qx8Q6dLZ6jD5kROVccNG3ZlPY/wA+9U7e7VkUkjJ6etTy3ZK9iBwM1zxpzpvnp7mVTDc07tHgHiXwfq2iXjR7WurdsvHPGuFIUFm3f3SACeeOtZUGtXRtILeSeSW3g3GOJ2JWPcQWKj+HOBnHpX0Ldqs6BZQGUgggjgj0xXnHif4fW8rNcaVttpmyTGP9W34dvwr6TCZtGolDEKz7nn1ssqQfPQd/L/IxdA1dAEV2Ax0zzivqX9nq4afwhf7zkrqD45zwURv618evY3umXCpqFu8HdT1VvoelfTX7KeoyXem+I4XbKpcQyL+Me3/2SvUoU4qspw2Z5maVHLCuE1Zpo95ooor1D5Yq6lZQajp9xZ3aB4J0Mbqe4Ir5g8S6dcaTqV5pt0+2W2Yrn++Oqkf7wIP5ivqmvI/j/okf9kReIkGGtMQ3OB96Nmwp/wCAsfyY15OZ4X2sVUjuvyPcyPHLD1XSn8MvzPCLm3klZkt42ndVZ2VBuIVRknA7AVhXOqCDRGsre2hWaSYyy3ZOXZMfLGvYKOpPUn0q/Lr9lbNcefbG5Z4Gji2zNC0Eh6SAr1I/ung1xHiPXImkluEhggMh+SCAEIpAHQEkgd+veuXC0JO10fQ4vEwgm27FHxBqSwRKsWPNcfL/ALI9TXMMx82Zs85Jz+NMmkeaRpJG3OxyTSt9+b/PcV7tOCgrHxeJxEq8+Z7G1od6DcqCApPBwevvXbTw77ISD0ya8sRmRgynDDoa9Q8D6lHq9qbeQ/6TEvzJ/eH94VyYyDVqi6HqZXiU06Mt+hvaM15e2twpt5c2IQ3O5cGIFgqlgfViBV1JzFExDbiTnNc/dajq3hq+1N7O5lRdUge2unb5vOjf7wJPfrg9Rmlsb1bmJSp+UcYPauV0048y6npQqyjJxkdLc6mZZogFXcrEyIw4GO2Kkijcr9qUTGNmMZlKYQt1KqfUDrWDDyVmTkdOO49a1rZpWRPKdtqncUycbiME49cADNcM4KDsj0qU+ZamjsgNzD5QDEHJ9VPrXQRxRsIxLlVK5BI556H8awbW2ea+hECHzXJBRf4jjP58V3fwz0C61/VbgwMRpwi8u4uXXlAwHyRg9HxwG/hHPcVjKhUxHLCA54iGHi6k3oi94H8KXviGSFZbiePTbcFZXA2kfMcRIf4uOS3Yk967Lxv4gtdL0GfStJitvsyBbPaZMbmbIKIMHdgA7icDqM5BFb3iO6TS9IfTtKzarHGA8sQ/1CH0/wBs9vzPv4vrKAzlvLVI3ULGgGRGoHCj6fqSTXpzUMDQdOn8T3f6niUJTzXEKc9Kcdl8zIuZGuJy0pMsx5PO4HPf2z1+uahsLWJb6WBlUGQgbl5MZJGWA+mc9ePetvVL3SYdHUaXo6W9zMr5uSSfKkGVwo6k7SrcnAPQdah8JapNaSXdteol3b3LiV4bgZRnz95T1U9enr0rzI0oxW+57irzqK6jZLvpp/XcszwQSXM5LRGISyRRrCCqhFC/MASTtbdkZPUGqradGitnLNgEEjhfYCtHVrzfdFooog3zARwRBFXPbAHt35rMmllbAywGRjI5/GqbTLSajZnN65atGzFEIJxtcDnjmqWjapNBMTux83OemcZ5/KuhvUZlZn3FiMHPpXJ6vYslwXhbBJGGwcH61pFRkuVmUpOOqPS9J8UR3EaI2EJGDgdP85rbj1IFVBCc/Nu7keleHWOpvAADkPg7vUnOK6e11ljGuyQhgv41E6LjohqUJK7R3puwJJOQB39MVh+NfGll4Y0FprjDuPljgBw0r9gPQdyewrmdZ8Qxadpb3dzMVhThuOW9APUmvBvFXiC88R6m13eNhR8sUQPEa+g/qe9XhcA8RL3vh6/5HFmWYww0LQ+J7f5lfxDrN5r+rz6jqUm+4mOeOijsoHYAVm0UV9LGKilFbHxcpOTcpbsv/Z4v7v6mj7PF/d/U0UUxHe/DZ2KXcBZjFHhkUn7pOc4r0fSCTI+STgetFFeDmEVzy0Ps8nnL2ENf6udBZKBdpjPPvW/AoA44696KK+Yqpcx79Rszp+LtgM4Ax1qKf5gY25TPSiitkldegJsrwqA2B0z61oRqMYooppamjbJniQqh28nP9KRYkZeVzzRRWNZLnIu7FW7sraSMrJCjKTyCMg12nwJ06003VteWxgWBJYbdmVc4JzJzjtRRXrZXJquknoeTniTwkm/L80ew0UUV9cfBBXM/E2JJ/h34lSVdy/2dOce4QkfqKKKiprFlQdpJo+GpIkkkiDgndjPJ5rlNdgjGrXKBflRyqjJ4A7UUVhQ+L5Hs5k7016/oUPs8X939TVeYBZ7kDoCR/wCPUUV1HiEFTWl1PZ3Cz2k0kMy/deNtpH40UUNX0Y02ndFy513VbqPZc6hdSrno8hNQR6jeR/cupl+jmiipUYrRIr2s97snj1zVIxhNQulHoJDUieItZU5XU7wH1Epooo9nF9BqtUW0n95IPFGvAgjWL8EHIInYEH161o2PxE8Y2NssFl4m1aCFSSEjuWUZPJPBoooUIx2QpVJyVpNsW4+I/jO5QJceKNYkUHdhrtyM/nVN/GfiV1w+u6kRnPNw3+NFFEoRl8SuEak4aRbRGfFniAgg6zfkHr+/b/GgeK/ECsGGs34YDAPntwPzoopeyh/KvuL+sVf5397Hx+MfEacJrmoqOvFw3+NJ/wAJh4jz/wAhzUeuf+Phv8aKKPZQ7IX1ir/M/vY1/FniCT7+tag31nb/ABqNvEutuuG1W9I9DM1FFHs4dkHt6v8AM/vK51nUmYsb65JPU+YacNc1QYxqF0Mf9NTRRT5I9g9tUX2n95De6lfX0apeXc86qcgSOWANU6KKaSSsjOUnJ3buFFFFMR//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Large smooth polyp on a long pedicle; (B) Endoloop placed deep on to the pedicle, the head of the polyp is at 12 o'clock; (C) Snare placed on the pedicle above the endoloop; (D) Polyp pedicle with endoloop for hemostasis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jerome D Waye, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_35_25139=[""].join("\n");
var outline_f24_35_25139=null;
var title_f24_35_25140="Botulism immune globulin (intravenous human): Pediatric drug information";
var content_f24_35_25140=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Botulism immune globulin (intravenous human): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?12/39/12916?source=see_link\">",
"    see \"Botulism immune globulin (intravenous human): Drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F142084\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      BabyBIG&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1045616\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Immune Globulin",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11442089\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.: Dosage is specific to the manufactured lot, as of March 2012 (Lot 4 production): Total dose is 75 mg/kg as a single I.V. infusion. Start as soon as diagnosis of infant botulism is made; refer to product specific information.",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1045609\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/39/12916?source=see_link\">",
"      see \"Botulism immune globulin (intravenous human): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.: Infants: Dosage is specific to the manufactured lot, as of March 2012 (Lot 4 production): Total dose is 75 mg/kg as a single I.V. infusion. Start as soon as diagnosis of infant botulism is made; refer to product specific information.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F142070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     BabyBIG&reg;: ~ 100 mg [contains albumin (human), sucrose; supplied with diluent]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F142058\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11217339\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Access to botulism immune globulin is restricted through the Infant Botulism Treatment and Prevention Program (IBTPP). Healthcare providers must contact the IBTPP on-call physician at (510) 231-7600 to review treatment indications and to obtain the medication.  For more information, refer to file://www.infantbotulism.org or contact IBTPP@infantbotulism.org.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1045620\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Do not administer I.M. or SubQ",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V. infusion: Add 2 mL SWI to 100 mg vial, resulting in 50 mg/mL solution; rotate vial gently to wet all the powder and avoid foaming. Do not shake vial. Allow solution to stand 30 minutes until it clears. Infusion should be started within 2 hours of reconstitution and be completed within 4 hours of reconstitution. Use low volume tubing for administration via a separate line. If this is not possible, piggyback BabyBIG&reg; into a pre-existing line containing either NS or a dextrose solution (D",
"     <sub>",
"      2.5",
"     </sub>",
"     W, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W, or D",
"     <sub>",
"      20",
"     </sub>",
"     W) with or without added NaCl. Do not dilute more than 1:2 with any of the above solutions. Drug concentration should be no less than 25 mg/mL. Administer via an in-line 18 micron filter.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Initial:",
"     </b>",
"     Administer slowly at 25 mg/kg/hour (0.5 mL/kg/hour using the 50 mg/mL concentration) for the first 15 minutes; after 15 minutes, rate may be increased to the maximum infusion rate of 50 mg/kg/hour (1 mL/kg/hour using the 50 mg/mL concentration) to the end of the infusion (infusion should conclude within 4 hours of reconstitution unless infusion rate is decreased due to an adverse reaction).",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F142099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administration with other medications is not recommended. If necessary, may be piggybacked into an existing I.V. line containing NS or the following dextrose solutions with or without sodium chloride: D",
"     <sub>",
"      2.5",
"     </sub>",
"     W, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W, D",
"     <sub>",
"      20",
"     </sub>",
"     W; do not dilute more than 1:2.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1045612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store between 2&deg;C to 8&deg;C (35.6&deg;F to 46.4&deg;F). Since BabyBIG&reg; does not contain a preservative, reconstituted vials should be used within 2 hours. Do not mix with other drugs.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1045619\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of infant botulism caused by toxin type A or B (FDA approved in ages &lt;1 year)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F6049723\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       BabyBIG&reg; may be confused with HBIG",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F142098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Blood pressure increased/decreased, cardiac murmur, edema, pallor, peripheral coldness, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, body temperature decreased, irritability, pyrexia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Contact dermatitis, erythematous rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Dehydration, hyponatremia, metabolic acidosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal distension, dysphagia, loose stools, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Anemia, hemoglobin decreased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site erythema, injection site reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Otic: Otitis media",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Neurogenic bladder",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Atelectasis, breath sounds decreased cough, dyspnea, lower respiratory tract infection, nasal congestion, oxygen saturation decreased, rales, rhonchi, stridor, tachypnea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Infusion rate reactions (includes back pain, chills, fever, muscle cramps, nausea, vomiting, wheezing), oral candidiasis, intubation",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1045624\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to immune globulin or any component; IgA deficiency (BabyBIG&reg; contains trace amounts of immunoglobulin A)",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1045608\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients at increased risk for developing acute renal failure (patients with pre-existing renal insufficiency, diabetes mellitus, volume depletion, sepsis, paraproteinemia, and concomitant nephrotoxic drugs). Assure that patients are not volume depleted prior to the initiation of BabyBIG&reg;. If a minor reaction occurs during infusion (eg, flushing), decrease infusion rate; if anaphylaxis or significant hypotension occurs, discontinue infusion.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1045607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Renal dysfunction and/or acute renal failure has been reported with the administration of immune globulin intravenous (IGIV); 88% of the cases were associated with the administration of sucrose-containing IGIV products at doses of 400 mg/kg or greater. BabyBIG&reg; contains sucrose as a stabilizer. BabyBIG&reg; is made from human plasma which carries the risk of blood-borne virus transmission, including the disease-causing agent for Creutzfeldt-Jakob disease. Like any other blood product, the risks and benefits of this agent should be discussed between the patient's legal guardian and the attending physician.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     An aseptic meningitis syndrome has been reported to occur with high total doses of other I.V. immune globulin products (eg, 2 g/kg of IGIV). Symptoms usually present within hours to days of treatment. Signs and symptoms may include severe headache, nuchal rigidity, photophobia, nausea, vomiting, painful eye movement, and fever. Cerebrospinal fluid may be positive with pleocytosis and increased protein concentrations. IGIV has been associated with antiglobulin hemolysis; monitor for signs of hemolytic anemia.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hyperproteinemia, increased serum viscosity, and hyponatremia may occur following administration of IGIV products; distinguish hyponatremia from pseudohyponatremia to prevent volume depletion, a further increase in serum viscosity, and a higher risk of thrombotic events. These adverse events have not been reported with botulism immune globulin. Thrombotic events have been reported with administration of IGIV; use with caution in patients with a history of atherosclerosis or cardiovascular and/or thrombotic risk factors or patients with known/suspected hyperviscosity. Consider a baseline assessment of blood viscosity in patients at risk for hyperviscosity. Infuse at lowest practical rate in patients at risk for thrombotic events. Noncardiogenic pulmonary edema has been reported with IGIV use. Monitor for transfusion-related acute lung injury (TRALI). TRALI is characterized by severe respiratory distress, pulmonary edema, hypoxemia, and fever in the presence of normal left ventricular function and usually occurs within 1-6 hours after infusion.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298879\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F142065\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immune Globulins may diminish the therapeutic effect of Vaccines (Live).  Management: Live organism vaccination should be withheld for up to 6 months following immune globulin administration.  Live vaccine given immediately prior to immune globulin may require repeat vaccination.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Yellow Fever Vaccine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F142076\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Botulism immune globulin is only indicated for use in neonates.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1045615\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Vital signs and blood pressure monitored continuously during the infusion. BUN and serum creatinine should be monitored prior to initial infusion. Periodic monitoring of renal function tests and urine output in patients at risk for developing renal failure.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1045606\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     BabyBIG&reg; contains antibody titers against botulinum toxin type A of at least 15 international units/mL and botulinum toxin type B of at least 4 international units/mL at concentrations sufficient to neutralize circulating neurotoxin.",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1045622\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Duration: ~6 months with a single infusion",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1045623\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Half-life: Infants: &sim;28 days",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F11277184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Once the patient is approved and purchase agreement is faxed, the original copy of the purchase agreement must be returned to the IBTPP via overnight courier, and payment must be wired within 5 business days. Arrange for courier pick-up of BabyBIG&reg; from FFF Enterprises in Temecula, CA.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Prior to March 2012, dosing recommendations were for",
"     <b>",
"      Lot 3",
"     </b>",
"     for a total dose of 100 mg/kg/dose .",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Arnon SS, Schechter R, Maslanka SE, et al, \"Human Botulism Immune Globulin for the Treatment of Infant Botulism,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2006, 354(5):462-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/35/25140/abstract-text/16452558/pubmed\" id=\"16452558\" target=\"_blank\">",
"        16452558",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Infant Botulism Treatment and Prevention Program, Department of Communicable Disease Control, California Department of Health Services, file://infantbotulism.org",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Underwood K, Rubin S, Deakers T, et al, \"Infant Botulism: A 30-Year Experience Spanning the Introduction of Botulism Immune Globulin Intravenous in the Intensive Care Unit at Childrens Hospital Los Angeles,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2007, 120(6):e1380-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/35/25140/abstract-text/18055655/pubmed\" id=\"18055655\" target=\"_blank\">",
"        18055655",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13285 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.69.132.100-4DCBBA35C4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_35_25140=[""].join("\n");
var outline_f24_35_25140=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142084\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045616\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11442089\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045609\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142070\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142058\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11217339\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045620\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142099\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045612\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045619\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6049723\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142098\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045624\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045608\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045607\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298879\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142065\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142076\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045615\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045606\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045622\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1045623\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11277184\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13285\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13285|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?12/39/12916?source=related_link\">",
"      Botulism immune globulin (intravenous human): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_35_25141="Plication technique for Peyronies disease";
var content_f24_35_25141=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F67079&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F67079&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 532px\">",
"   <div class=\"ttl\">",
"    Plication technique for Peyronies disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 512px; height: 691px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Straightening the penis with plication is achieved by shortening the convex side of the penis (ie, opposite the plaque). Plication is generally performed in men with adequate penile length.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_35_25141=[""].join("\n");
var outline_f24_35_25141=null;
var title_f24_35_25142="Congenital lobar emphysema histology section";
var content_f24_35_25142=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F77991&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F77991&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Histology section in congenital lobar emphysema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 264px; height: 387px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Histology section from&nbsp;a two-year-old girl with congenital lobar emphysema. The junction of the affected and unaffected lobules is shown. In the affected region (lower portion), airspaces and terminal bronchioles are enlarged; their walls are normal and resemble those in the adjacent uninvolved lobules.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Claire Langston, MD, and Christopher Oermann, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_35_25142=[""].join("\n");
var outline_f24_35_25142=null;
var title_f24_35_25143="Histology and pathogenesis of uterine leiomyomas (fibroids)";
var content_f24_35_25143=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"19\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Histology and pathogenesis of uterine leiomyomas (fibroids)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/35/25143/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/35/25143/contributors\">",
"     Elizabeth A Stewart, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/35/25143/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/35/25143/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/35/25143/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/35/25143/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/35/25143/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine leiomyomas (fibroids) are the most common pelvic tumor in women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. They are benign monoclonal tumors arising from the smooth muscle cells of the myometrium. The pathogenesis of leiomyomas is not well understood. Genetic predisposition, environmental factors, steroid hormones, and growth factors important in fibrotic processes and angiogenesis all play a role in the formation and growth of uterine fibroids [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/3\">",
"     3",
"    </a>",
"    ]. The disease is heterogeneous and different fibroids may have different etiologies; many may have multifactorial pathogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/4\">",
"     4",
"    </a>",
"    ]. Leiomyoma-related effects on the function and structure of the endometrium are the final common pathways in the pathogenesis of excessive bleeding in myomatous uteri and there is evidence of both histological changes in the endometrium and endometrial vasculature in these uteri [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathogenesis of uterine leiomyomas is reviewed here. The diagnosis and management of leiomyomas as well as variants of leiomyomas are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/17/6426?source=see_link\">",
"     \"Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/14/18666?source=see_link\">",
"     \"Overview of treatment of uterine leiomyomas (fibroids)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/3/17465?source=see_link\">",
"     \"Variants of uterine leiomyomas (fibroids)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30310927\">",
"    <span class=\"h1\">",
"     HISTOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine leiomyomas are benign monoclonal tumors arising from the smooth muscle cells of the myometrium. They contain a large amount of extracellular matrix (ECM, collagen, proteoglycan, fibronectin) and are surrounded by a thin pseudocapsule of areolar tissue and compressed muscle fibers.",
"   </p>",
"   <p>",
"    Leiomyomas are benign lesions. However, there is a heterogeneous group of lesions which have some, but not all, characteristics of malignant disease termed leiomyoma variants. Leiomyoma variants are classified as benign or malignant based upon histologic features. Some leiomyoma variants have histologic findings that make it difficult to define them as benign or malignant (eg, smooth muscle tumors of uncertain malignant potential). This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/3/17465?source=see_link&amp;anchor=H23338835#H23338835\">",
"     \"Variants of uterine leiomyomas (fibroids)\", section on 'Smooth muscle tumors of uncertain malignant potential'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LEIOMYOMA FORMATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least two distinct components contribute to leiomyoma development:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Transformation of normal myocytes into abnormal myocytes",
"     </li>",
"     <li>",
"      Growth of abnormal myocytes into clinically apparent tumors.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The first process appears to be quite common, in view of the high prevalence of microscopic myomas [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/7\">",
"     7",
"    </a>",
"    ]. The subsequent growth of the neoplasm occurs via clonal expansion from a single cell and will likely be a better target for new therapeutic interventions [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     GENETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine leiomyomas are monoclonal tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Somatic mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine leiomyomas are a common phenotype with many underlying genotypes. Approximately 60 percent of leiomyomas have an abnormal karyotype [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/11\">",
"     11",
"    </a>",
"    ]. There are a variety of specific karyotypic subgroups that characterize these myomas, but the evolution of a cytogenetic abnormality appears to be a late event and not the initiating event in myoma formation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/9\">",
"     9",
"    </a>",
"    ]. Even the 40 percent of leiomyomas with apparently normal 46,XX karyotypes may harbor genetic abnormalities, such as point mutations or changes in the regulatory regions of genes that are not detectable with current cytogenetic techniques.",
"   </p>",
"   <p>",
"    Specific karyotypic abnormalities frequently reported in leiomyomas include trisomy 12, translocations between chromosomes 12 and 14, deletions of 7q, 3q, and 1p, and rearrangements of 6p,10q and 13q [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/12\">",
"     12",
"    </a>",
"    ]. One gene, high mobility group A2,",
"    <em>",
"     HMGA2",
"    </em>",
"    (formerly called",
"    <em>",
"     HMGI-C",
"    </em>",
"    ), appears to be dysregulated in the subgroup of myomas characterized by acquired 12q14-15 rearrangements [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. Myomas with this abnormality tend to be larger than those with a normal karyotype [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/15\">",
"     15",
"    </a>",
"    ]. Specific karyotypic abnormalities have also been correlated with myoma location within the uterus [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The major discordance between the karyotypic abnormalities found in fibroids and leiomyosarcomas suggests that benign and malignant uterine neoplasms generally arise via distinct pathogenic pathways, rather than from evolution of a benign to a malignant neoplasm [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/17\">",
"     17",
"    </a>",
"    ]. There are two exceptions to this observation. Both involve chromosome 1: cellular leiomyomas with a loss of 1p and individuals with hereditary leiomyomatosis and renal cell cancer syndrome and a mutation of the fumarate hydratase gene on chromosome 1q [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35910?source=see_link&amp;anchor=H3#H3\">",
"     \"Hereditary kidney cancer syndromes\", section on 'Hereditary leiomyomatosis and renal cell cancer syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Genetic polymorphisms",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is also increasing evidence that genetic polymorphisms may predispose to leiomyomas. Polymorphisms that have been related to development of leiomyoma involve the estrogen receptor gene, androgen receptor gene, insulin-like growth factor II gene, and possibly some cytokine genes [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/21-24\">",
"     21-24",
"    </a>",
"    ]. One study suggested that a polymorphism in the estrogen receptor gene plays a role in both leiomyoma formation and extent of disease in black women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/25\">",
"     25",
"    </a>",
"    ]. A genome-wide association study of over 2000 women did not identify a specific polymorphism associated with leiomyomas in black women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Familial predisposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Twin studies and family studies imply a familial predisposition to leiomyomas in some women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/27-29\">",
"     27-29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     STEROID HORMONES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Steroid hormones are an important influence in leiomyoma pathogenesis. However, the relationship is complex. For exogenous steroids, the specific hormonal compound, the timing and duration of exposure, the delivery method (endogenous, oral, transdermal, depot, local) and other factors may all be important. Additionally, for endogenous steroids, the regularity of menstrual cyclicity is likely important. As an example, although there are high levels of both estrogen and progesterone during pregnancy and with estrogen-progestin contraceptive use, both decrease the risk of developing new fibroids.",
"   </p>",
"   <p>",
"    The gene expression profiles of leiomyoma and myometrium are different and each varies based on the time in the menstrual cycle from which the tissue is collected [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/30-33\">",
"     30-33",
"    </a>",
"    ]. Leiomyomas appear to have an estrogen responsive pattern of gene expression similar to that seen in normal myometrium during pregnancy and parturition [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Gonadotropin-releasing hormone analogue therapy, which greatly reduces gonadal steroid levels and decreases leiomyoma size, also abolishes differences in gene expression between myomas and normal myometrium [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/36\">",
"     36",
"    </a>",
"    ]. In addition, many genes not related to steroid hormones appear to be actively regulated in leiomyomas [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/30-33\">",
"     30-33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Biologically, the enzyme aromatase (coded for by the gene",
"    <em>",
"     CYP19",
"    </em>",
"    ), which converts androgens to estrogens, appears to be an important regulator of estrogen response in leiomyomas. Aromatase is upregulated in leiomyoma cells compared with normal myometrium [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. The transcription of",
"    <em>",
"     CYP19",
"    </em>",
"    is controlled by a variety of promoters and there appear to be differences in the promoter across ethnic and racial groups [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. As an example, African American women differentially use the proximal II aromatase promoter that appears to be correlated with higher expression of",
"    <em>",
"     CYP19",
"    </em>",
"    mRNA [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other elements of the estrogenic response also come into play since myomas appear to have a modest increase in the type 1 isotype of 17&szlig; hydroxysteroid dehydrogenase [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/42\">",
"     42",
"    </a>",
"    ]. Additionally, estrogen receptor alpha appears upregulated in all leiomyomas and estrogen receptor &szlig; is sometimes upregulated in various ethnic groups [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/41,43\">",
"     41,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Progesterone receptors are also upregulated in leiomyomas compared to normal myometrium, although the truncated PR-A isoform appears to predominate in both leiomyomas and myometrium [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. While initial studies postulated progesterone acted on leiomyomas as a smooth muscle cell mitogen, more recent studies suggest it inhibits apoptosis by inducing the antiapoptotic factor Bcl2 through interaction with its promoter [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There may also be a role for gonadotropins, particularly luteinizing hormone as a modulating influence of gonadal steroids. One clinical study demonstrated luteinizing hormone to be associated with myoma formation but not growth, and this stimulation was independent of the patient's age [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/49\">",
"     49",
"    </a>",
"    ]. In vitro work has shown direct effects of gonadotropins on uterine tissue and modulation of the effect by the endogenous hormonal milieu [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     VASCULAR ABNORMALITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities in uterine blood vessels and angiogenic growth factors appear to play a role in the pathobiology of myoma formation. The myomatous uterus has increased numbers of arterioles and venules, as well as venular ectasia (dilation) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/52\">",
"     52",
"    </a>",
"    ]. Molecular alterations leading to increased vessel number or abnormal function are the likely mechanisms for these abnormalities, although the venous changes were originally thought to be induced by physical compression of the vascular structures by bulky myomas [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is possible that myoma formation is a response to injury, much like an atherosclerotic plaque that forms in response to hypoxia of arterial muscle [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/53\">",
"     53",
"    </a>",
"    ]. Hypoxia of myometrial cells during menstruation may promote transformation of normal myocytes to abnormal myocytes and subsequently to leiomyomas. The fact that atherogenic risk factors appear to be more common in women with leiomyomas supports this hypothesis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effect of vascular factors is also demonstrated at a molecular level. The angiogenic growth factor fibroblast growth factor-2 (FGF-2, also called basic fibroblast growth factor) and its receptor appear significantly altered in the leiomyomatous uterus, as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is more FGF-2 mRNA in leiomyomas than in normal myometrium [",
"      <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The extracellular matrix of myomas contains a large reservoir of FGF-2 protein [",
"      <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      There is abnormal expression of FGF-2 receptor in the endometrium of women with leiomyoma-related bleeding compared to normally cycling women [",
"      <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      FGF-2 stimulates proliferation of leiomyoma cells in culture. This process is inhibited by interferon-alpha, a factor known to block the actions of FGF-2 in other systems [",
"      <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     FIBROTIC FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Leiomyomas can be viewed as a fibrotic process with abnormalities of the extracellular matrix (ECM) at many levels. There is upregulation of the mRNA and protein for major extracellular matrix components, particularly type I and III collagen [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/58\">",
"     58",
"    </a>",
"    ]. Decreased expression of the collagen-binding protein dermatopontin is seen both in leiomyomas and in keloid scars, possibly suggesting a link between both of these abnormalities in black women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/59\">",
"     59",
"    </a>",
"    ]. There is also increasing information that the morphologic arrangement of extracellular components is abnormal in myomas and that the increased stiffness of these ECM alterations leads to altered gene expression through solid-state signalling [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/60,61\">",
"     60,61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fibrotic growth factors are also dysregulated in leiomyomas. Transforming growth factor-beta (TGF-beta) and granulocyte-macrophage colony-stimulating factor (GM-CSF), which are involved in other fibrotic processes, may also contribute to the pathophysiology of leiomyomas. When obtained from the secretory phase of the menstrual cycle, leiomyomas appear to have higher levels of TGF-beta and TGF-beta receptor mRNA and protein than myometrium [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/62\">",
"     62",
"    </a>",
"    ]. In addition, there is a substantial reduction in TGF-beta levels in the leiomyomas of women treated with a gonadotropin-releasing hormone agonist to diminish the size of their tumors prior to surgical extirpation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    GM-CSF may differentially stimulate leiomyomas and normal myometrium both on its own and through an increase in expression of TGF-beta [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/63\">",
"     63",
"    </a>",
"    ]. A TGF-beta homologue, endometrial bleeding-associated factor (EBAF, now called LEFTY-A), which is normally expressed in the endometrium only in the luteal phase of the menstrual cycle, is expressed throughout the cycle in women with abnormal uterine bleeding of various etiologies, including leiomyomas [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25143/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?20/20/20804?source=see_link\">",
"       \"Patient information: Uterine fibroids (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Uterine leiomyomas (fibroids) are benign monoclonal tumors arising from the smooth muscle cells of the myometrium. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Two distinct components contribute to leiomyoma development: transformation of normal myocytes into abnormal myocytes and growth of abnormal myocytes into clinically apparent tumors. Multiple factors likely play a role in both this transformation and growth acceleration for leiomyomas. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Leiomyoma formation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Uterine leiomyomas are a common phenotype with many underlying genotypes. Approximately 60 percent of leiomyomas have an abnormal karyotype. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Somatic mutations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Steroid hormone factors that influence leiomyoma development include upregulation of aromatase, estrogen and progesterone receptors, as well as a potential role of gonadotropins. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Steroid hormones'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The myomatous uterus has increased numbers of arterioles and venules, as well as venular ectasia (dilation). In addition, the angiogenic growth factor fibroblast growth factor-2 and its receptor appear significantly altered in the leiomyomatous uterus. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Vascular abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Leiomyomas can be viewed as a fibrotic process with abnormalities of the extracellular matrix at many levels. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Fibrotic factors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/1\">",
"      Buttram VC Jr, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 1981; 36:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/2\">",
"      Serden SP, Brooks PG. Treatment of abnormal uterine bleeding with the gynecologic resectoscope. J Reprod Med 1991; 36:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/3\">",
"      Stewart EA. Uterine fibroids. Lancet 2001; 357:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/4\">",
"      Peddada SD, Laughlin SK, Miner K, et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A 2008; 105:19887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/5\">",
"      Stewart EA, Nowak RA. Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era. Hum Reprod Update 1996; 2:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/6\">",
"      Patterson-Keels LM, Selvaggi SM, Haefner HK, Randolph JF Jr. Morphologic assessment of endometrium overlying submucosal leiomyomas. J Reprod Med 1994; 39:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/7\">",
"      Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990; 94:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/8\">",
"      Hashimoto K, Azuma C, Kamiura S, et al. Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene. Gynecol Obstet Invest 1995; 40:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/9\">",
"      Mashal RD, Fejzo ML, Friedman AJ, et al. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosomes Cancer 1994; 11:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/10\">",
"      Linder D, Gartler SM. Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas. Science 1965; 150:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/11\">",
"      Rein MS, Friedman AJ, Barbieri RL, et al. Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynecol 1991; 77:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/12\">",
"      Stewart EA, Morton CC. The genetics of uterine leiomyomata: what clinicians need to know. Obstet Gynecol 2006; 107:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/13\">",
"      Van de Ven WJ. Genetic basis of uterine leiomyoma: involvement of high mobility group protein genes. Eur J Obstet Gynecol Reprod Biol 1998; 81:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/14\">",
"      Gattas GJ, Quade BJ, Nowak RA, Morton CC. HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. Genes Chromosomes Cancer 1999; 25:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/15\">",
"      Hennig Y, Deichert U, Bonk U, et al. Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells. Mol Hum Reprod 1999; 5:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/16\">",
"      Brosens I, Deprest J, Dal Cin P, Van den Berghe H. Clinical significance of cytogenetic abnormalities in uterine myomas. Fertil Steril 1998; 69:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/17\">",
"      Hodge JC, Morton CC. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression. Hum Mol Genet 2007; 16 Spec No 1:R7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/18\">",
"      Christacos NC, Quade BJ, Dal Cin P, Morton CC. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features. Genes Chromosomes Cancer 2006; 45:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/19\">",
"      Taran FA, Weaver AL, Gostout BS, Stewart EA. Understanding cellular leiomyomas: a case-control study. Am J Obstet Gynecol 2010; 203:109.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/20\">",
"      Lehtonen HJ. Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Fam Cancer 2011; 10:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/21\">",
"      Hsieh YY, Chang CC, Tsai FJ, et al. Estrogen receptor thymine-adenine dinucleotide repeat polymorphism is associated with susceptibility to leiomyoma. Fertil Steril 2003; 79:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/22\">",
"      Fujimoto J, Hirose R, Sakaguchi H, Tamaya T. Expression of size-polymorphic androgen receptor gene in uterine leiomyoma according to the number of cytosine, adenine, and guanine repeats in androgen receptor alleles. Tumour Biol 2000; 21:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/23\">",
"      Hashimoto K, Azuma C, Kamiura S, et al. Maintenance of imprinting of the insulin-like growth factor II gene (IGF2) and the small nuclear ribonucleoprotein polypeptide N gene (SNRPN) in the human uterus and leiomyoma. Gynecol Obstet Invest 1996; 41:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/24\">",
"      Hsieh YY, Chang CC, Tsai CH, et al. Interleukin (IL)-12 receptor beta1 codon 378 G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3'-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma. Fertil Steril 2007; 87:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/25\">",
"      Al-Hendy A, Salama SA. Ethnic distribution of estrogen receptor-alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans. Fertil Steril 2006; 86:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/26\">",
"      Wise LA, Ruiz-Narvaez EA, Palmer JR, et al. African ancestry and genetic risk for uterine leiomyomata. Am J Epidemiol 2012; 176:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/27\">",
"      Snieder H, MacGregor AJ, Spector TD. Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab 1998; 83:1875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/28\">",
"      Okolo SO, Gentry CC, Perrett CW, Maclean AB. Familial prevalence of uterine fibroids is associated with distinct clinical and molecular features. Hum Reprod 2005; 20:2321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/29\">",
"      Van Voorhis BJ, Romitti PA, Jones MP. Family history as a risk factor for development of uterine leiomyomas. Results of a pilot study. J Reprod Med 2002; 47:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/30\">",
"      Tsibris JC, Segars J, Coppola D, et al. Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril 2002; 78:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/31\">",
"      Wang H, Mahadevappa M, Yamamoto K, et al. Distinctive proliferative phase differences in gene expression in human myometrium and leiomyomata. Fertil Steril 2003; 80:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/32\">",
"      Skubitz KM, Skubitz AP. Differential gene expression in uterine leiomyoma. J Lab Clin Med 2003; 141:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/33\">",
"      Hoffman PJ, Milliken DB, Gregg LC, et al. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis. Fertil Steril 2004; 82:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/34\">",
"      Andersen J, Barbieri RL. Abnormal gene expression in uterine leiomyomas. J Soc Gynecol Investig 1995; 2:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/35\">",
"      Cesen-Cummings K, Copland JA, Barrett JC, et al. Pregnancy, parturition, and prostaglandins: defining uterine leiomyomas. Environ Health Perspect 2000; 108 Suppl 5:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/36\">",
"      Chegini N, Verala J, Luo X, et al. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Investig 2003; 10:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/37\">",
"      Bulun SE, Simpson ER, Word RA. Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture. J Clin Endocrinol Metab 1994; 78:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/38\">",
"      Folkerd EJ, Newton CJ, Davidson K, et al. Aromatase activity in uterine leiomyomata. J Steroid Biochem 1984; 20:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/39\">",
"      Shozu M, Sumitani H, Segawa T, et al. Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19). J Clin Endocrinol Metab 2002; 87:2540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/40\">",
"      Imir AG, Lin Z, Yin P, et al. Aromatase expression in uterine leiomyomata is regulated primarily by proximal promoters I.3/II. J Clin Endocrinol Metab 2007; 92:1979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/41\">",
"      Ishikawa H, Reierstad S, Demura M, et al. High aromatase expression in uterine leiomyoma tissues of African-American women. J Clin Endocrinol Metab 2009; 94:1752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/42\">",
"      Kasai T, Shozu M, Murakami K, et al. Increased expression of type I 17beta-hydroxysteroid dehydrogenase enhances in situ production of estradiol in uterine leiomyoma. J Clin Endocrinol Metab 2004; 89:5661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/43\">",
"      Brandon DD, Erickson TE, Keenan EJ, et al. Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab 1995; 80:1876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/44\">",
"      Brandon DD, Bethea CL, Strawn EY, et al. Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol 1993; 169:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/45\">",
"      Stewart EA, Austin DJ, Jain P, et al. RU486 suppresses prolactin production in explant cultures of leiomyoma and myometrium. Fertil Steril 1996; 65:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/46\">",
"      Ishikawa H, Ishi K, Serna VA, et al. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology 2010; 151:2433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/47\">",
"      Matsuo H, Maruo T, Samoto T. Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone. J Clin Endocrinol Metab 1997; 82:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/48\">",
"      Yin P, Lin Z, Cheng YH, et al. Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells. J Clin Endocrinol Metab 2007; 92:4459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/49\">",
"      Baird DD, Kesner JS, Dunson DB. Luteinizing hormone in premenopausal women may stimulate uterine leiomyomata development. J Soc Gynecol Investig 2006; 13:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/50\">",
"      Stewart EA, Rein MS, Friedman AJ, et al. Glycoprotein hormones and their common alpha-subunit stimulate prolactin production by explant cultures of human leiomyoma and myometrium. Am J Obstet Gynecol 1994; 170:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/51\">",
"      Stewart EA, Jain P, Penglase MD, et al. The myometrium of postmenopausal women produces prolactin in response to human chorionic gonadotropin and alpha-subunit in vitro. Fertil Steril 1995; 64:972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/52\">",
"      Sampson, JA. The blood supply of uterine myomata. Surg Gynecol Obstet 1912; 14:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/53\">",
"      Stewart EA, Nowak RA. New concepts in the treatment of uterine leiomyomas. Obstet Gynecol 1998; 92:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/54\">",
"      Faerstein E, Szklo M, Rosenshein NB. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. Am J Epidemiol 2001; 153:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/55\">",
"      Mangrulkar RS, Ono M, Ishikawa M, et al. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium. Biol Reprod 1995; 53:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/56\">",
"      Anania CA, Stewart EA, Quade BJ, et al. Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding. Mol Hum Reprod 1997; 3:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/57\">",
"      Lee BS, Stewart EA, Sahakian M, Nowak RA. Interferon-alpha is a potent inhibitor of basic fibroblast growth factor-stimulated cell proliferation in human uterine cells. Am J Reprod Immunol 1998; 40:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/58\">",
"      Stewart EA, Friedman AJ, Peck K, Nowak RA. Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle. J Clin Endocrinol Metab 1994; 79:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/59\">",
"      Catherino WH, Leppert PC, Stenmark MH, et al. Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chromosomes Cancer 2004; 40:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/60\">",
"      Leppert PC, Baginski T, Prupas C, et al. Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium. Fertil Steril 2004; 82 Suppl 3:1182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/61\">",
"      Rogers R, Norian J, Malik M, et al. Mechanical homeostasis is altered in uterine leiomyoma. Am J Obstet Gynecol 2008; 198:474.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/62\">",
"      Dou Q, Zhao Y, Tarnuzzer RW, et al. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab 1996; 81:3222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/63\">",
"      Chegini N, Tang XM, Ma C. Regulation of transforming growth factor-beta1 expression by granulocyte macrophage-colony-stimulating factor in leiomyoma and myometrial smooth muscle cells. J Clin Endocrinol Metab 1999; 84:4138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25143/abstract/64\">",
"      Kothapalli R, Buyuksal I, Wu SQ, et al. Detection of ebaf, a novel human gene of the transforming growth factor beta superfamily association of gene expression with endometrial bleeding. J Clin Invest 1997; 99:2342.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5431 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-201.77.166.39-C008A65255-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_35_25143=[""].join("\n");
var outline_f24_35_25143=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30310927\">",
"      HISTOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LEIOMYOMA FORMATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      GENETICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Somatic mutations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Genetic polymorphisms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Familial predisposition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      STEROID HORMONES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      VASCULAR ABNORMALITIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      FIBROTIC FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/17/6426?source=related_link\">",
"      Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35910?source=related_link\">",
"      Hereditary kidney cancer syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/14/18666?source=related_link\">",
"      Overview of treatment of uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?20/20/20804?source=related_link\">",
"      Patient information: Uterine fibroids (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/3/17465?source=related_link\">",
"      Variants of uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_35_25144="Exercise physiology";
var content_f24_35_25144=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Exercise physiology",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/35/25144/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/35/25144/contributors\">",
"     David M Systrom, MD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/35/25144/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/35/25144/contributors\">",
"     James K Stoller, MS, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/35/25144/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/35/25144/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/35/25144/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 14, 2008.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skeletal muscle metabolism can rise quickly to fifty times its resting rate during heavy exercise. To preserve cellular oxygenation and acid-base homeostasis, cardiovascular and respiratory responses must adapt rapidly to these dramatic changes in tissue metabolism. Dysfunction of various aspects of this exercise response may occur as the result of many different disease processes, with subsequent effects on exercise tolerance.",
"   </p>",
"   <p>",
"    Multiparameter exercise testing yields detailed information on the response to exercise and is helpful in determining the etiology of dyspnea, evaluating pulmonary disability, assessing the relative importance of cardiac and pulmonary limitations to activity, and stratifying the risk of lung resection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/40/32391?source=see_link\">",
"     \"Evaluation of pulmonary disability\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/2/15400?source=see_link\">",
"     \"Preoperative evaluation for lung resection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Physiologic data, including oxygen uptake, CO2 output, tidal volume, minute ventilation, electrocardiographic (ECG) tracings, and pulse oximetry are measured throughout a symptom-limited, graded exercise test. In certain circumstances, more extensive monitoring is required and arterial",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pulmonary artery catheters are placed prior to exercise testing.",
"   </p>",
"   <p>",
"    Analysis of exercise performance should include an assessment of overall exercise capacity as well as determinations of the adequacy of responses by skeletal muscle, the heart, systemic and pulmonary vasculature, and the lungs. An overview of normal exercise physiology will be presented here. Abnormal exercise responses in specific cardiopulmonary diseases are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33398?source=see_link\">",
"     \"Functional exercise testing: Ventilatory gas analysis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The American Thoracic Society (ATS) and American College of Chest Physicians (ACCP) statement on cardiopulmonary exercise testing, as well as other ATS guidelines, can be accessed through the ATS web site at",
"    <a class=\"external\" href=\"file://www.thoracic.org/statements\">",
"     www.thoracic.org/statements",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERALL EXERCISE CAPACITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptom-limited maximum oxygen uptake attained during incremental bilateral leg exercise (VO2max) is used to provide an overall assessment of exercise capacity [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/1\">",
"     1",
"    </a>",
"    ]. A normal VO2max usually exonerates the pulmonary, cardiovascular, and neuromuscular systems of serious pathology, although intra- or inter-organ compensation for mild primary abnormalities can result in a relatively normal value [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with chronotropic disturbances of the heart provide an example of intraorgan compensation: near-normal values for cardiac output may be preserved during exercise by relative increases in stroke volume, via the Frank-Starling mechanism [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/2\">",
"     2",
"    </a>",
"    ]. Examples of inter-organ compensation include the elevation in cardiac output commonly seen in anemic individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/3\">",
"     3",
"    </a>",
"    ], and the improvement in systemic O2 extraction which occurs in some patients with cardiac dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    VO2 increases linearly versus work rate with a slope of approximately 10",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per watt in normal subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/5\">",
"     5",
"    </a>",
"    ]. This slope is not affected by age, sex, or training, but is shifted leftward in obese patients. A true maximal VO2, identified by a plateau of VO2 versus work, occurs only in a small subset of normal subjects and patients (",
"    <a class=\"graphic graphic_figure graphicRef64164 \" href=\"UTD.htm?21/0/21517\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/1\">",
"     1",
"    </a>",
"    ]. The normal VO2max is greater than 20",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per min, and can be predicted from age, gender, height, and lean body weight.",
"   </p>",
"   <p>",
"    The VO2max increases as a function of training and decreases with age [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/5\">",
"     5",
"    </a>",
"    ]. A young, world-class endurance athlete may have a VO2max greater than 80",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per minute. Historically, values in women have been considered less than those of age-matched men of similar size, but much of the difference has proved to be related to training status [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/6\">",
"     6",
"    </a>",
"    ]. Biomechanical efficiency for running and cycling may be less for women, but during certain endurance events, enhanced oxidation of fat by women is glycogen-sparing and may be advantageous [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another variable which has been used to evaluate overall exercise capacity is the maximum work (in watts) achieved during an incremental exercise test. However, relying on this variable can be misleading, because a significant amount of work can be performed by obese patients and those with obstructive airways disease beyond that which is imposed by the cycle ergometer or treadmill [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. As an example, the work of breathing in obstructive airways disease may be substantial. In such a situation, a spuriously low maximal work rate may be recorded even though the more meaningful value of VO2max is relatively normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SKELETAL MUSCLE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each motor unit consists of a single motor neuron which innervates between 10 and 2000 muscle fibers. The muscle fibers of each motor unit are homogeneous and may be either twitch type I (also called red or slow fibers) or twitch type II (also called white or fast fibers) based upon their myoglobin content and time-to-peak tension (",
"    <a class=\"graphic graphic_table graphicRef62260 \" href=\"UTD.htm?4/16/4363\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/9\">",
"     9",
"    </a>",
"    ]. Type I fibers have a high oxidative capacity, are fatigue-resistant, and are recruited for low-level endurance exercise; type II fibers have a high glycolytic capacity and are recruited for short bursts of rapid, heavy work.",
"   </p>",
"   <p>",
"    Fiber type varies considerably among muscles; as examples, the soleus consists predominantly of type I fibers, while the triceps is composed mainly of type II fibers. The fiber type mix within a given muscle is genetically determined. Training can result in a greater capillary density and an increased concentration of mitochondria within a fiber, but will not alter the proportion of fiber types within a given muscle.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Energy sources",
"    </span>",
"    &nbsp;&mdash;&nbsp;Actomyosin-ATPase hydrolysis of adenosine triphosphate (ATP) permits actin-myosin cross-bridge formation and release, with resultant muscular contraction. Intracellular stores of ATP are small and must be continually replenished. ATP concentration does not fall during dynamic exercise with unimpeded blood flow because three energy sources are sequentially utilized:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Phosphocreatine shuttle",
"     </li>",
"     <li>",
"      Anaerobic sources",
"     </li>",
"     <li>",
"      Oxidative phosphorylation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The first energetic \"buffer\" is the phosphocreatine (PCr) shuttle, whereby PCr splitting by creatine kinase maintains the ATP concentration in the proximity of actomyosin cross-bridging [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/10\">",
"     10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    PCr &nbsp;+ &nbsp;ADP &nbsp;&mdash;&gt; &nbsp;Cr &nbsp;+ &nbsp;ATP &nbsp;&lt;&mdash;&gt; &nbsp;ADP &nbsp;+ &nbsp;Pi",
"   </p>",
"   <p>",
"    Skeletal muscle PCr concentration, visible in the 31P magnetic resonance spectrum, falls and recovers monoexponentially with incremental exercise and can be used to assess mitochondrial phosphorylation potential [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Training and oral loading of carbohydrates or creatine improve PCr kinetics and exercise performance [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/11,13-15\">",
"     11,13-15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The next most immediate source of ATP production is also anaerobic and includes anaerobic Embden-Meyerhoff glycolysis and the adenylate kinase reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/16\">",
"     16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    &nbsp;Glucose + 2Pi + 2ADP &nbsp;&lt;&mdash;&gt; &nbsp;2 Lactate + 2H2O + 2ATP",
"   </p>",
"   <p>",
"    &nbsp;ADP &nbsp;+ &nbsp;ADP &nbsp;&mdash;&gt; &nbsp;ATP &nbsp;+ &nbsp;AMP",
"   </p>",
"   <p>",
"    Anaerobic glycolysis is an important ATP source when the capacity of pyruvate dehydrogenase to metabolize glucosyl units is exceeded and pyruvate is oxidized via mass action to lactate [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/17\">",
"     17",
"    </a>",
"    ]. These conditions are fostered by the rapid glycogenolysis associated with elevated plasma catecholamines during heavy exercise and when there is an imbalance between mitochondrial oxygen supply and demand during ischemic and hypoxic exercise or at the onset of intense exercise.",
"   </p>",
"   <p>",
"    The third and most efficient skeletal muscle ATP source is the oxidative phosphorylation of intracellular glycogen and free fatty acids [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/16\">",
"     16",
"    </a>",
"    ]. With more prolonged exercise, blood-borne glucose and free fatty acids become quantitatively important fuels. Training increases the capacity of skeletal muscle to oxidize fat, which spares glycogen and improves performance [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/18\">",
"     18",
"    </a>",
"    ]. Branched-chain amino acids may be catabolized and contribute to ATP production during exercise, especially when muscle glycogen is depleted [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Fatigue",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fatigue during exercise has both central (nervous system) and peripheral components, of which the latter is better understood [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. The development of peripheral fatigue depends upon the intensity and duration of exercise and is influenced by:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Accumulation of metabolic byproducts",
"     </li>",
"     <li>",
"      Depletion of high energy phosphates",
"     </li>",
"     <li>",
"      Depletion of glycogen substrate",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    During brief, intense exercise, skeletal muscle intracellular pH falls because of the accumulation of cytosolic lactate and loss of potassium [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/22\">",
"     22",
"    </a>",
"    ]. Increased concentration of hydrogen ion in the myocyte may contribute to fatigue through inhibition of glucosyl flux and muscle contraction [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. With acute exercise to exhaustion, for example, the intracellular lactate concentration can exceed 40",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    and the pH may fall below 6.40 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ammonia, generated from deamination of AMP to inosine monophosphate in the stressed type 2 muscle fiber, has also been implicated in peripheral fatigue, possibly via inhibition of oxidative phosphorylation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/26\">",
"     26",
"    </a>",
"    ]. Training is associated with decreased muscle and blood lactate and ammonia during exercise and with less fatigue at a given metabolic rate [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/21,27,28\">",
"     21,27,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Depletion of high energy phosphate compounds also probably plays a role in peripheral fatigue with short-term exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/11\">",
"     11",
"    </a>",
"    ]. Evidence for the importance of this phenomenon is provided by patients with McArdle's disease, who are incapable of producing significant quantities of lactate but who fatigue quickly during exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/29\">",
"     29",
"    </a>",
"    ]. In contrast, fatigue during endurance events appears related to the depletion of glycogen stores rather than high energy phosphates. This is thought to be responsible for the phenomenon of the marathon runner \"hitting the wall.\" Muscle metabolism rarely is the critical factor in determining maximal exercise tolerance, but may affect an individual's ability to sustain high levels of exertion (see below) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Lactate threshold",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heavy workloads are associated with an increase in blood lactate concentration (",
"    <a class=\"graphic graphic_figure graphicRef78425 \" href=\"UTD.htm?4/9/4253\">",
"     figure 2",
"    </a>",
"    ). The metabolic rate at which a sustained rise in blood lactate is detected is called the lactate threshold (LT) or the anaerobic threshold.",
"   </p>",
"   <p>",
"    For many years the lactic acidemia of exercise was assumed to be secondary to inadequate oxygen (O2) delivery to muscle with resultant increases in anaerobic glycolysis to produce ATP. However, since the 1980s, it has been appreciated that the skeletal muscle mitochondrial redox state is actually higher when working muscle is producing lactate than at rest, implying that oxygen supply is not the critical factor [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/17,31,32\">",
"     17,31,32",
"    </a>",
"    ]. Currently, the LT is considered to be the VO2 at which pyruvate, and therefore lactate, production exceeds its ability to be metabolized via the Krebs cycle [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At a VO2 just below LT, steady state metabolic conditions remain preserved, and exercise can be sustained for prolonged periods [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/33\">",
"     33",
"    </a>",
"    ]. The LT varies with cardiovascular fitness and is a useful clinical index [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. Some studies have found LT to be a more powerful predictor of sustained exercise performance than is the VO2max [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The LT occurs at greater than 40 percent of the predicted VO2max in normal individuals but earlier in the course of exercise among patients with cardiovascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/4/7241?source=see_link\">",
"     \"Exercise capacity and VO2 in heart failure\"",
"    </a>",
"    .) Exercise intensity must approach the LT for optimal training effects to occur [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/27\">",
"     27",
"    </a>",
"    ]. An endurance athlete will not reach an LT until 80 to 90 percent of the VO2max and usually competes at a metabolic rate just below the LT.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CIRCULATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The importance of circulatory function during exercise is demonstrated by the Fick equation:",
"   </p>",
"   <p>",
"    &nbsp;VO2 &nbsp;= &nbsp;Qt &nbsp;x &nbsp;(CaO2 &nbsp;- &nbsp;CvO2)",
"   </p>",
"   <p>",
"    where Qt = cardiac output and (CaO2 &nbsp;- &nbsp;CvO2) is the difference in O2 content between arterial and mixed venous blood.",
"   </p>",
"   <p>",
"    Maximal cardiac output, which facilitates transport of oxygen from the alveolus to skeletal muscle, determines the maximal oxygen uptake and aerobic capacity to a large degree. Maintenance of CaO2 and depression of CvO2 during exercise are also circulatory functions, requiring exquisite matching of blood flow to ventilation and tissue metabolism, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Cardiac output",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac output increases during incremental exercise through changes in both heart rate (HR) and stroke volume (SV). Maximal HR decreases as a function of age, and is predicted by the following equation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/40\">",
"     40",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    &nbsp;Maximal HR &nbsp;= &nbsp;220 &nbsp;- &nbsp;age (in years)",
"   </p>",
"   <p>",
"    However, a meta-analysis of 18,712 subjects found that this equation underestimates the maximal heart rate in older subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/41\">",
"     41",
"    </a>",
"    ]. The following equation was more accurate for predicting maximal HR in healthy adults:",
"   </p>",
"   <p>",
"    &nbsp; Maximal HR &nbsp;= &nbsp;208 - 0.7 x age (in years)",
"   </p>",
"   <p>",
"    Normally, the difference between achieved and maximal HR (called the heart rate reserve) is less than 15 beats per minute [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rise in HR is linear versus VO2, initially due to withdrawal of vagal tone, and subsequently due to increased sympathetic activity [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/43\">",
"     43",
"    </a>",
"    ]. HRmax also appears directly related to lean body mass [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/44\">",
"     44",
"    </a>",
"    ]. Thus, the malnourished or myopathic patient may have a reduced heart rate (versus the normal individual) at peak exercise. Training results in a lower HR at rest and at any given VO2 (",
"    <a class=\"graphic graphic_figure graphicRef77997 \" href=\"UTD.htm?13/9/13469\">",
"     figure 3",
"    </a>",
"    ), but does not affect maximal HR [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Stroke volume (SV) increases in a hyperbolic fashion versus VO2, and maximum values can be augmented by up to 50 percent with training [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. The rise in SV during exercise is mediated in part by increased contractility, reflected by a 0.10 increase in left ventricular ejection fraction (LVEF) from rest to peak exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/48\">",
"     48",
"    </a>",
"    ]. Left ventricular end-diastolic volume (LVEDV) also increases by 20 to 40 percent, augmenting SV by the Frank-Starling mechanism [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23076?source=see_link\">",
"     \"Pathophysiology of heart failure: Left ventricular pressure-volume relationships\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    LV filling is enhanced during exercise by capacitance venoconstriction, greater negative intrathoracic pressures, and the pumping action of exercising limbs [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/50\">",
"     50",
"    </a>",
"    ]. In a heart with normal lusitropic properties, LV end-diastolic pressure increases to approximately 20 mmHg [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/51\">",
"     51",
"    </a>",
"    ]. Diastolic filling is limited by the physical constraints of the pericardium; maximum cardiac output and VO2 are enhanced following pericardiectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cardiac output generally limits VO2max in healthy adults. Cardiac output normally increases by approximately 5",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    for every 1",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    increase in VO2 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/53\">",
"     53",
"    </a>",
"    ]. This slope is not altered by training, but maximum cardiac output improves with conditioning to four to five times resting values (up to levels of approximately 25",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    in a young healthy individual). Maximum cardiac outputs above 40",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    have been reported in elite athletes, and elite athletes may exhaust their breathing reserve before attaining maximal cardiac output [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Systemic circulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systolic blood pressure (BP) increases via the muscle chemoreflex during exercise but is attenuated by arterial baroreceptor function; the net effect is that diastolic pressure generally remains near resting values [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/43,50,55\">",
"     43,50,55",
"    </a>",
"    ]. The rise in mean systemic BP with exertion is normally much less than the increment in cardiac output, reflecting a decrease in systemic vascular resistance (SVR) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/43\">",
"     43",
"    </a>",
"    ]. The ability to decrease SVR has been correlated with exercise performance [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Blood flow during exercise is preferentially directed to working muscle and away from less metabolically active tissues such as gut and kidney (",
"    <a class=\"graphic graphic_table graphicRef62660 \" href=\"UTD.htm?17/24/17803\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/53\">",
"     53",
"    </a>",
"    ]. Distribution of blood flow is influenced by sympathetic arterial vasoconstriction and skeletal muscle vasodilation due to local decreases in pH and PO2, and local increases in potassium, adenosine, and nitric oxide (NO) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. Systemic vasodilation by endogenous NO is enhanced by training [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Normal peripheral vasoregulation and a rightward shift of the oxyhemoglobin dissociation curve with acidosis increase skeletal muscle oxygen extraction, yielding a femoral venous PO2 near 20 mmHg and a systemic O2 extraction ratio ([CaO2 &nbsp;- &nbsp;CvO2] &nbsp;&divide; &nbsp;CaO2) as high as 0.75 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/60,61\">",
"     60,61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Pulmonary circulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pulmonary circulation normally receives &gt;95 percent of the cardiac output, and does so with minimal resistance. Mean pulmonary artery pressure rarely exceeds 30 mmHg at peak exercise in normal subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/51\">",
"     51",
"    </a>",
"    ]. Similar to the systemic circulation, the pressure gradient across the pulmonary vascular bed during exercise increases by a smaller factor than the increase in blood flow, due to a fall in pulmonary vascular resistance (PVR) from approximately 96 to 60 dynes*sec*cm(-5) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/53\">",
"     53",
"    </a>",
"    ]. The decrease in PVR during exercise is a consequence of both passive distention of a compliant circulation and active vasodilation mediated in part by NO [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/62\">",
"     62",
"    </a>",
"    ]. Pulmonary capillary wedge pressure increases about 1.4 mmHg for every 1.0 mmHg increase in right atrial pressure, suggesting interdependence of right and left ventricular filling [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     VENTILATION AND PULMONARY GAS EXCHANGE",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the most remarkable aspects of exercise physiology is the maintenance of arterial oxygenation and PaCO2 within narrow ranges in the face of the large, rapid increases in metabolic rate that characterize vigorous exertion. These indices are preserved largely because of adaptations in ventilation and",
"    <span class=\"nowrap\">",
"     ventilation/perfusion",
"    </span>",
"    matching.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Ventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Minute ventilation (VE) normally rises during incremental exercise as a result of a linear increase in breathing frequency (up to about 50",
"    <span class=\"nowrap\">",
"     breaths/minute",
"    </span>",
"    in normal adults) and a hyperbolic increase in tidal volume (Vt) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/7\">",
"     7",
"    </a>",
"    ]. Vt reaches a plateau at approximately 50 percent of the resting vital capacity, above which the elastic work of breathing is prohibitive [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/64\">",
"     64",
"    </a>",
"    ]. As the patient approaches the lactate threshold and metabolic acidemia ensues, VE increases out of proportion to VO2, a point called the ventilatory threshold. The ventilatory threshold can be used as a noninvasive marker of the LT because these two events normally occur at a nearly identical level of exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The ratio of VE at peak exercise (VEmax) to the maximal voluntary ventilation (MVV) at rest has been termed the breathing reserve index [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/66\">",
"     66",
"    </a>",
"    ]. Maximal voluntary ventilation can be measured by a 12 second voluntary effort, but also can be estimated from the FEV1 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/67\">",
"     67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=see_link\">",
"     \"Overview of pulmonary function testing in adults\"",
"    </a>",
"    .) A breathing reserve index of 0.70 can be sustained for 15 minutes in normal individuals, but values above 0.75 are usually not attained even at peak exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/68\">",
"     68",
"    </a>",
"    ], leading to the inference that VO2max in normal individuals is limited by cardiac factors, not ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/69-71\">",
"     69-71",
"    </a>",
"    ]. Elite athletes may reach such a high level of cardiovascular fitness that a pulmonary mechanical limitation to exercise is approached, but this is distinctly unusual [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The VE requirement during exercise is dictated by:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Carbon dioxide output",
"     </li>",
"     <li>",
"      PaCO2 \"set-point\"",
"     </li>",
"     <li>",
"      The physiologic",
"      <span class=\"nowrap\">",
"       dead-space/tidal",
"      </span>",
"      volume ratio (including both anatomic dead space and lung units that are ventilated but not perfused)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The mechanisms by which VE is regulated during exercise are incompletely understood. As an example, the increase in VE during submaximal exercise perfectly matches carbon dioxide production without any detectable antecedent changes in arterial pH or PaCO2 to initiate the process. Lactic acidemic stimulation of the carotid bodies has been proposed to drive ventilation during intense exercise, but patients with McArdle's syndrome regulate ventilation normally during exercise despite minimal lactate production [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/72\">",
"     72",
"    </a>",
"    ]. The observation that denervation of the carotid bodies in dogs actually increases the exercise ventilatory response provides further evidence that the chemoreceptors may not be necessary for the hyperpnea of heavy exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Functional magnetic resonance imaging studies of the human central nervous system suggest stimuli for autonomic ventilatory control are integrated in the ventrolateral medulla [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. A feed-forward locomotor-linked mechanism emanating from the hypothalamus is capable of stimulating both ventilation and exercise motion in parallel [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/76\">",
"     76",
"    </a>",
"    ]. In addition, a muscle chemoreflex, stimulated by the local accumulation of metabolic products of exercise, can also drive ventilation during exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/77,78\">",
"     77,78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Training decreases VE for any given VO2, but its effects are most pronounced at levels of exercise beyond the lactate threshold [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/79\">",
"     79",
"    </a>",
"    ]. Lactate levels at VO2max are decreased with training, and the lower VEmax observed with training appears to be a function of this adaptation rather than changes in the control of respiration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Carbon dioxide elimination",
"    </span>",
"    &nbsp;&mdash;&nbsp;For normal individuals, PaCO2 is regulated at isocapnic levels until respiratory compensation for metabolic acidosis occurs late in exercise and PaCO2 falls [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/7,80\">",
"     7,80",
"    </a>",
"    ]. Maximum exercise produces a partially compensated metabolic acidosis, with an arterial pH of 7.20 to 7.30 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/5,81\">",
"     5,81",
"    </a>",
"    ], while short-term exercise to exhaustion can reduce the arterial pH to 7.15 or less [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CO2 elimination by the lungs becomes more efficient during exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/80\">",
"     80",
"    </a>",
"    ]. Anatomic dead space increases because of a tethering effect on conducting airways at high Vt, whereas alveolar dead space decreases because of augmented blood flow to the lung apices, giving the net effect of a slight increase in total (physiologic) dead space (VD). However, this effect is more than offset by the increased Vt, which produces a decrease in upright",
"    <span class=\"nowrap\">",
"     VD/Vt",
"    </span>",
"    from 0.45 at rest to less than 0.29 at maximum exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Oxygenation",
"    </span>",
"    &nbsp;&mdash;&nbsp;During exercise, the partial pressure of oxygen in arterial blood (PaO2) remains near resting values despite marked reductions in mixed venous oxygen tension (PvO2) and an abbreviated red cell transit time through the pulmonary capillaries. Arterial oxygenation is maintained by several adaptations, including increased alveolar PO2, a decreased number of low",
"    <span class=\"nowrap\">",
"     V/Q",
"    </span>",
"    units, increased surface area for O2 diffusion, and a smaller right-to-left shunt fraction.",
"   </p>",
"   <p>",
"    The driving pressure for O2 diffusion across the alveolar-capillary membrane is the alveolar pressure of oxygen (PAO2), which is defined by the equation:",
"   </p>",
"   <p>",
"    &nbsp;PAO2 &nbsp;= &nbsp;PiO2 &nbsp;- &nbsp;(PACO2 &nbsp;&divide; &nbsp;RER)",
"   </p>",
"   <p>",
"    where PiO2 is the inspired partial pressure of O2, PACO2 is the alveolar PCO2 (which is roughly equal to arterial PCO2), and RER is the respiratory exchange ratio. PAO2 increases in normal persons exercising above the lactate threshold at sea level because of hyperventilation (which lowers PACO2) and an increased RER, due to bicarbonate buffering of lactic acid and \"non-metabolic\" CO2 production. The excess CO2 is often referred to as \"non-metabolic\" because it is not produced by metabolism, per se.",
"   </p>",
"   <p>",
"    Oxygenation also improves in the lung with exercise because of a decrease in the number of",
"    <span class=\"nowrap\">",
"     low-ventilation/perfusion",
"    </span>",
"    units at the bases due to larger tidal breaths. Improved distribution of pulmonary blood flow also results in augmentation of the diffusing surface area at high cardiac outputs. Finally, in a manner analogous to",
"    <span class=\"nowrap\">",
"     VD/Vt,",
"    </span>",
"    the right-to-left shunt fraction",
"    <span class=\"nowrap\">",
"     (Qs/Qt)",
"    </span>",
"    falls because of the large increase in Qt.",
"   </p>",
"   <p>",
"    Some well-trained individuals manifest arterial O2 desaturation at extremely high metabolic rates. This has been attributed to reduced compensatory hyperventilation and a diffusion limitation resulting from rapid red cell transit time through the pulmonary capillaries [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25144/abstract/83,84\">",
"     83,84",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intense exercise can elicit a rapid, 15-fold increase in whole body oxygen uptake. This is accomplished by 10-fold increase in minute ventilation, a 5-fold increase in cardiac output, and a 3-fold increase in systemic O2 extraction along with microvascular adaptations which serve to increase the delivery of oxygen to muscles where it is most needed. Cardiopulmonary adaptations are tightly coupled to changes in skeletal muscle metabolism via incompletely understood mechanisms. Maximal cardiac output normally limits aerobic exercise capacity, while unused ventilatory and skeletal muscle function is measurable at peak exercise. Training enhances virtually every step of exercise gas exchange from the lung to the skeletal muscle mitochondrion.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/1\">",
"      Bassett DR Jr, Howley ET. Maximal oxygen uptake: \"classical\" versus \"contemporary\" viewpoints. Med Sci Sports Exerc 1997; 29:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/2\">",
"      Salahi, F, Systrom, DM, DiCola, VC, et al. Cardiopulmonary exercise testing in DDD compared to VVI pacing modes. Am J Noninvas Cardiol 1987; 1:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/3\">",
"      Woodson RD, Wills RE, Lenfant C. Effect of acute and established anemia on O2 transport at rest, submaximal and maximal work. J Appl Physiol 1978; 44:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/4\">",
"      Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation 1984; 69:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/5\">",
"      Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis 1984; 129:S49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/6\">",
"      Whipp BJ, Ward SA. Will women soon outrun men? Nature 1992; 355:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/7\">",
"      Wasserman K, Whipp BJ. Excercise physiology in health and disease. Am Rev Respir Dis 1975; 112:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/8\">",
"      Loke J, Mahler DA, Man SF, et al. Exercise impairment in chronic obstructive pulmonary disease. Clin Chest Med 1984; 5:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/9\">",
"      Pette D. Metabolic heterogeneity of muscle fibres. J Exp Biol 1985; 115:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/10\">",
"      Meyer RA, Sweeney HL, Kushmerick MJ. A simple analysis of the \"phosphocreatine shuttle\". Am J Physiol 1984; 246:C365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/11\">",
"      Larson DE, Hesslink RL, Hrovat MI, et al. Dietary effects on exercising muscle metabolism and performance by 31P-MRS. J Appl Physiol 1994; 77:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/12\">",
"      Thompson CH, Kemp GJ, Sanderson AL, Radda GK. Skeletal muscle mitochondrial function studied by kinetic analysis of postexercise phosphocreatine resynthesis. J Appl Physiol 1995; 78:2131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/13\">",
"      Minotti JR, Johnson EC, Hudson TL, et al. Forearm metabolic asymmetry detected by 31P-NMR during submaximal exercise. J Appl Physiol 1989; 67:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/14\">",
"      Maughan RJ, Greenhaff PL, Leiper JB, et al. Diet composition and the performance of high-intensity exercise. J Sports Sci 1997; 15:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/15\">",
"      Greenhaff PL. Creatine supplementation: recent developments. Br J Sports Med 1996; 30:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/16\">",
"      Kemp GJ, Sanderson AL, Thompson CH, Radda GK. Regulation of oxidative and glycogenolytic ATP synthesis in exercising rat skeletal muscle studied by 31P magnetic resonance spectroscopy. NMR Biomed 1996; 9:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/17\">",
"      Putman CT, Jones NL, Lands LC, et al. Skeletal muscle pyruvate dehydrogenase activity during maximal exercise in humans. Am J Physiol 1995; 269:E458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/18\">",
"      Phillips SM, Green HJ, Tarnopolsky MA, et al. Effects of training duration on substrate turnover and oxidation during exercise. J Appl Physiol 1996; 81:2182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/19\">",
"      MacLean DA, Graham TE, Saltin B. Stimulation of muscle ammonia production during exercise following branched-chain amino acid supplementation in humans. J Physiol 1996; 493 ( Pt 3):909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/20\">",
"      Fitts RH. Cellular mechanisms of muscle fatigue. Physiol Rev 1994; 74:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/21\">",
"      Hainaut K, Duchateau J. Muscle fatigue, effects of training and disuse. Muscle Nerve 1989; 12:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/22\">",
"      Systrom DM, Kanarek DJ, Kohler SJ, Kazemi H. 31P nuclear magnetic resonance spectroscopy study of the anaerobic threshold in humans. J Appl Physiol 1990; 68:2060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/23\">",
"      Lindinger MI. Origins of [H+] changes in exercising skeletal muscle. Can J Appl Physiol 1995; 20:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/24\">",
"      Metzger JM, Fitts RH. Role of intracellular pH in muscle fatigue. J Appl Physiol 1987; 62:1392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/25\">",
"      Lindinger MI, Heigenhauser GJ, McKelvie RS, Jones NL. Blood ion regulation during repeated maximal exercise and recovery in humans. Am J Physiol 1992; 262:R126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/26\">",
"      Meyer RA, Dudley GA, Terjung RL. Ammonia and IMP in different skeletal muscle fibers after exercise in rats. J Appl Physiol 1980; 49:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/27\">",
"      Casaburi R. Physiologic responses to training. Clin Chest Med 1994; 15:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/28\">",
"      Graham TE, Turcotte LP, Kiens B, Richter EA. Effect of endurance training on ammonia and amino acid metabolism in humans. Med Sci Sports Exerc 1997; 29:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/29\">",
"      Lewis SF, Haller RG, Cook JD, Nunnally RL. Muscle fatigue in McArdle's disease studied by 31P-NMR: effect of glucose infusion. J Appl Physiol 1985; 59:1991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/30\">",
"      Klausen K, Secher NH, Clausen JP, et al. Central and regional circulatory adaptations to one-leg training. J Appl Physiol 1982; 52:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/31\">",
"      Stainsby WN, Brechue WF, O'Drobinak DM, Barclay JK. Oxidation/reduction state of cytochrome oxidase during repetitive contractions. J Appl Physiol 1989; 67:2158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/32\">",
"      Graham TE, Saltin B. Estimation of the mitochondrial redox state in human skeletal muscle during exercise. J Appl Physiol 1989; 66:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/33\">",
"      Whipp BJ, Wasserman K. Oxygen uptake kinetics for various intensities of constant-load work. J Appl Physiol 1972; 33:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/34\">",
"      Poole DC, Gaesser GA. Response of ventilatory and lactate thresholds to continuous and interval training. J Appl Physiol 1985; 58:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/35\">",
"      Gaesser GA, Poole DC. Lactate and ventilatory thresholds: disparity in time course of adaptations to training. J Appl Physiol 1986; 61:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/36\">",
"      Phillips SM, Green HJ, Tarnopolsky MA, et al. Progressive effect of endurance training on metabolic adaptations in working skeletal muscle. Am J Physiol 1996; 270:E265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/37\">",
"      Powers, SK, Dodd, S, Deason, R, et al. Ventilatory threshold, running economy and distance running performance of trained athletes. Res Q Exerc Sports 1983; 54:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/38\">",
"      Sue DY, Hansen JE. Normal values in adults during exercise testing. Clin Chest Med 1984; 5:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/39\">",
"      WASSERMAN K, MCILROY MB. DETECTING THE THRESHOLD OF ANAEROBIC METABOLISM IN CARDIAC PATIENTS DURING EXERCISE. Am J Cardiol 1964; 14:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/40\">",
"      Gerstenblith G, Lakatta EG, Weisfeldt ML. Age changes in myocardial function and exercise response. Prog Cardiovasc Dis 1976; 19:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/41\">",
"      Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. J Am Coll Cardiol 2001; 37:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/42\">",
"      Weisman IM, Zeballos RJ. An integrated approach to the interpretation of cardiopulmonary exercise testing. Clin Chest Med 1994; 15:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/43\">",
"      Francis GS. Hemodynamic and neurohumoral responses to dynamic exercise: normal subjects versus patients with heart disease. Circulation 1987; 76:VI11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/44\">",
"      Shephard RJ, Bouhlel E, Vandewalle H, Monod H. Muscle mass as a factor limiting physical work. J Appl Physiol 1988; 64:1472.",
"     </a>",
"    </li>",
"    <li>",
"     Astrand, PO, Rodahl, K. Textbook of Work Physiology. 3rd ed, New York, McGraw-Hill, 1986.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/46\">",
"      Weber KT, Janicki JS. Cardiopulmonary exercise testing for evaluation of chronic cardiac failure. Am J Cardiol 1985; 55:22A.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/47\">",
"      Blomqvist CG, Saltin B. Cardiovascular adaptations to physical training. Annu Rev Physiol 1983; 45:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/48\">",
"      Mahler DA, Matthay RA, Snyder PE, et al. Volumetric responses of right and left ventricles during upright exercise in normal subjects. J Appl Physiol 1985; 58:1818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/49\">",
"      Manyari DE, Kostuk WJ. Left and right ventricular function at rest and during bicycle exercise in the supine and sitting positions in normal subjects and patients with coronary artery disease. Assessment by radionuclide ventriculography. Am J Cardiol 1983; 51:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/50\">",
"      Shepherd JT. Circulatory response to exercise in health. Circulation 1987; 76:VI3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/51\">",
"      Reeves JT, Moon RE, Grover RF, Groves BM. Increased wedge pressure facilitates decreased lung vascular resistance during upright exercise. Chest 1988; 93:97S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/52\">",
"      Stray-Gundersen J, Musch TI, Haidet GC, et al. The effect of pericardiectomy on maximal oxygen consumption and maximal cardiac output in untrained dogs. Circ Res 1986; 58:523.",
"     </a>",
"    </li>",
"    <li>",
"     Wade, OL, Bishop, JM. Cardiac output and regional blood flow. Philadelphia, FA Davis, 1962.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/54\">",
"      Dempsey JA. J.B. Wolffe memorial lecture. Is the lung built for exercise? Med Sci Sports Exerc 1986; 18:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/55\">",
"      Rowell LB, O'Leary DS. Reflex control of the circulation during exercise: chemoreflexes and mechanoreflexes. J Appl Physiol 1990; 69:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/56\">",
"      Clausen JP. Circulatory adjustments to dynamic exercise and effect of physical training in normal subjects and in patients with coronary artery disease. Prog Cardiovasc Dis 1976; 18:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/57\">",
"      Hickner, RC, Fisher, JS, Ehsani, AA, et al. Role of nitric oxide in skeletal muscle blood flow at rest and during dynamic exercise in humans. Am J Physiol 1997; 82:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/58\">",
"      Skinner NS Jr, Costin JC. Role of O2 and K+ in abolition of sympathetic vasoconstriction in dog skeletal muscle. Am J Physiol 1969; 217:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/59\">",
"      Koller A, Huang A, Sun D, Kaley G. Exercise training augments flow-dependent dilation in rat skeletal muscle arterioles. Role of endothelial nitric oxide and prostaglandins. Circ Res 1995; 76:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/60\">",
"      Stringer W, Wasserman K, Casaburi R, et al. Lactic acidosis as a facilitator of oxyhemoglobin dissociation during exercise. J Appl Physiol 1994; 76:1462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/61\">",
"      Roca J, Hogan MC, Story D, et al. Evidence for tissue diffusion limitation of VO2max in normal humans. J Appl Physiol 1989; 67:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/62\">",
"      Kane DW, Tesauro T, Koizumi T, et al. Exercise-induced pulmonary vasoconstriction during combined blockade of nitric oxide synthase and beta adrenergic receptors. J Clin Invest 1994; 93:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/63\">",
"      Reeves JT, Groves BM, Cymerman A, et al. Operation Everest II: cardiac filling pressures during cycle exercise at sea level. Respir Physiol 1990; 80:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/64\">",
"      Hey EN, Lloyd BB, Cunningham DJ, et al. Effects of various respiratory stimuli on the depth and frequency of breathing in man. Respir Physiol 1966; 1:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/65\">",
"      Caiozzo VJ, Davis JA, Ellis JF, et al. A comparison of gas exchange indices used to detect the anaerobic threshold. J Appl Physiol 1982; 53:1184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/66\">",
"      Medoff BD, Oelberg DA, Kanarek DJ, Systrom DM. Breathing reserve at the lactate threshold to differentiate a pulmonary mechanical from cardiovascular limit to exercise. Chest 1998; 113:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/67\">",
"      Carter R, Peavler M, Zinkgraf S, et al. Predicting maximal exercise ventilation in patients with chronic obstructive pulmonary disease. Chest 1987; 92:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/68\">",
"      Rochester DF. Tests of respiratory muscle function. Clin Chest Med 1988; 9:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/69\">",
"      Olafsson S, Hyatt RE. Ventilatory mechanics and expiratory flow limitation during exercise in normal subjects. J Clin Invest 1969; 48:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/70\">",
"      Kanarek DJ, Hand RW. The response of cardiac and pulmonary disease to exercise testing. Clin Chest Med 1984; 5:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/71\">",
"      Blackie SP, Fairbarn MS, McElvaney NG, et al. Normal values and ranges for ventilation and breathing pattern at maximal exercise. Chest 1991; 100:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/72\">",
"      Hagberg JM, King DS, Rogers MA, et al. Exercise and recovery ventilatory and VO2 responses of patients with McArdle's disease. J Appl Physiol 1990; 68:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/73\">",
"      Dempsey JA. Exercise hyperpnea. Chairman's introduction. Adv Exp Med Biol 1995; 393:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/74\">",
"      Evans, A, Oelberg, D, Pappagianopoulos, P, et al. Central ventilatory control centers during hypercapnic challenge in man: A functional magnetic resonance imaging study. Am J Respir Crit Care Med 1996; 153:A157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/75\">",
"      Gozal D, Hathout GM, Kirlew KA, et al. Localization of putative neural respiratory regions in the human by functional magnetic resonance imaging. J Appl Physiol 1994; 76:2076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/76\">",
"      Eldridge FL. Central integration of mechanisms in exercise hyperpnea. Med Sci Sports Exerc 1994; 26:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/77\">",
"      Evans AB, Tsai LW, Oelberg DA, et al. Skeletal muscle ECF pH error signal for exercise ventilatory control. J Appl Physiol 1998; 84:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/78\">",
"      Oelberg DA, Evans AB, Hrovat MI, et al. Skeletal muscle chemoreflex and pHi in exercise ventilatory control. J Appl Physiol 1998; 84:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/79\">",
"      Casaburi R, Storer TW, Wasserman K. Mediation of reduced ventilatory response to exercise after endurance training. J Appl Physiol 1987; 63:1533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/80\">",
"      Jones NL. Normal values for pulmonary gas exchange during exercise. Am Rev Respir Dis 1984; 129:S44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/81\">",
"      Casaburi R, Daly J, Hansen JE, Effros RM. Abrupt changes in mixed venous blood gas composition after the onset of exercise. J Appl Physiol 1989; 67:1106.",
"     </a>",
"    </li>",
"    <li>",
"     Wasserman, K, Hansen, JE, Sue, DY, et al. Principles of exercise testing and interpretation. 2nd ed, Malvern, Lea &amp; Febiger, 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/83\">",
"      Dempsey JA, Hanson PG, Henderson KS. Exercise-induced arterial hypoxaemia in healthy human subjects at sea level. J Physiol 1984; 355:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25144/abstract/84\">",
"      Hsia CC. Respiratory function of hemoglobin. N Engl J Med 1998; 338:239.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1433 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-210.101.131.231-DF96EE1385-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_35_25144=[""].join("\n");
var outline_f24_35_25144=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERALL EXERCISE CAPACITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SKELETAL MUSCLE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Energy sources",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Fatigue",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Lactate threshold",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CIRCULATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Cardiac output",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Systemic circulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Pulmonary circulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      VENTILATION AND PULMONARY GAS EXCHANGE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Ventilation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Carbon dioxide elimination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Oxygenation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/1433\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1433|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/0/21517\" title=\"figure 1\">",
"      O2 consumption during exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/9/4253\" title=\"figure 2\">",
"      Blood lactate during exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/9/13469\" title=\"figure 3\">",
"      Heart rate and O2 at exercise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1433|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/16/4363\" title=\"table 1\">",
"      Muscle fiber characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/24/17803\" title=\"table 2\">",
"      Blood flow at rest and exercise",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/40/32391?source=related_link\">",
"      Evaluation of pulmonary disability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/4/7241?source=related_link\">",
"      Exercise capacity and VO2 in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33398?source=related_link\">",
"      Functional exercise testing: Ventilatory gas analysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/53/4952?source=related_link\">",
"      Overview of pulmonary function testing in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23076?source=related_link\">",
"      Pathophysiology of heart failure: Left ventricular pressure-volume relationships",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/2/15400?source=related_link\">",
"      Preoperative evaluation for lung resection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_35_25145="Prenatal screening and diagnosis of neural tube defects";
var content_f24_35_25145=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prenatal screening and diagnosis of neural tube defects",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/35/25145/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/35/25145/contributors\">",
"     Lauri Hochberg, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/35/25145/contributors\">",
"     Joanne Stone, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/35/25145/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/35/25145/contributors\">",
"     Louise Wilkins-Haug, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/35/25145/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/35/25145/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/35/25145/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neural tube defects (NTD) are the second most prevalent congenital anomaly in the United States, second only to cardiac malformations. Three factors have played a significant role in the assessment and prevention of this disorder in developed countries:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The widespread use of maternal screening programs to identify pregnancies at high risk [",
"      <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/1\">",
"       1",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Sonographic imaging combined with amniocentesis for diagnosis of affected fetuses [",
"      <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/2,3\">",
"       2,3",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      supplements for prevention of the disorder [",
"      <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/4,5\">",
"       4,5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Prenatal screening and diagnosis of NTDs will be reviewed here. Prevention of NTDs is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=see_link\">",
"     \"Folic acid for prevention of neural tube defects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE AND EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the incidence of NTDs is commonly cited as one in 1000 pregnancies in the United States, the incidence is highly variable and depends upon ethnic and geographic factors. For example, studies performed before the availability of prenatal screening and prophylactic vitamin supplementation reported the birth incidence of both spina bifida and anencephaly were higher in Hispanic and nonHispanic white persons than in blacks and Asian persons [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/6\">",
"     6",
"    </a>",
"    ]. In the United States, higher rates of NTDs were observed in the East and South than in the West [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prenatal maternal serum screening programs for alpha fetoprotein (instituted in the 1970s and 1980s) combined with periconceptional",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    supplementation and food fortification (instituted in the 1990s) have led to a decrease in the prevalence of NTDs where these interventions are practiced [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/4,5,8-12\">",
"     4,5,8-12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=see_link\">",
"     \"Folic acid for prevention of neural tube defects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For example, the incidence of NTDs in England and Wales declined by 96 percent between 1970 and 1997: from approximately 3.2 per 1000 births to 0.1 per 1000 births [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/8\">",
"     8",
"    </a>",
"    ]. Forty percent of the decline was attributed to antenatal screening with termination of affected pregnancies and 56 percent was attributed to a decline in incidence, due at least in part to an increase in dietary folate intake. In the United States in 2006, the combined incidence of spina bifida and anencephaly, which represent a large proportion of NTDs, was about 0.3 per 1000 births (anencephaly",
"    <span class=\"nowrap\">",
"     11.6/100,000",
"    </span>",
"    live births, spina",
"    <span class=\"nowrap\">",
"     bifida/meningomyelocele",
"    </span>",
"    <span class=\"nowrap\">",
"     17.8/100,000",
"    </span>",
"    live births) and significantly less than incidence reported a few decades ago (1 in 1000 births) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EMBRYOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The central nervous system appears as a plate of thickened ectoderm called the neural plate at the beginning of the third week of embryonic life. The lateral edges of the neural plate become elevated to form the neural folds. These folds subsequently become further elevated, approach each other, and fuse to form the neural tube; the fusion begins in the cervical region and proceeds in both the cephalad and caudal directions. Since fusion is delayed at the cranial and caudal ends of the embryo, the cranial and caudal neuropores form temporary open communications between the lumen of the neural tube and the amniotic cavity until closure of the cranial neuropore on the 25th day after conception and closure of the caudal neuropore about two days later [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/14\">",
"     14",
"    </a>",
"    ]. NTDs result from failure of the neural tube to close normally between the third and fourth weeks after conception (the fifth and sixth weeks of gestation).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     TYPES OF NTDS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several anatomic types of NTDs, which affect either the spine or cranium. They can be classified as open (neural tissue exposed) or closed (neural tissue not exposed). Open NTDs often involve both the spine and cranium, while closed NTDs are usually localized and confined to the spine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Spinal defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spina bifida refers to a cleft in the spinal column. Spina bifida may be closed (the skin covering the defect is intact) or open (not covered by skin) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef78078 graphicRef58063 graphicRef68832 graphicRef77490 \" href=\"UTD.htm?34/15/35066\">",
"     image 1A-D",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Spina bifida occulta is the simplest form in which there is a failure of the dorsal portions of the vertebrae to fuse with one another. This abnormality, usually localized to the sacrolumbar region, is covered by skin and is not noticeable on the surface except for the presence of a small tuft of hair or other dermal lesion over the affected area. It is diagnosed, usually incidentally, by radiographs of the spinal vertebrae.",
"   </p>",
"   <p>",
"    A meningocele develops if more than one or two vertebrae are involved in the defect and only the meninges of the spinal cord herniates through the opening. It is not associated with hydrocephalus or neurologic defects, but may be contiguous with a subcutaneous lipoma (ie, lipomeningocele).",
"   </p>",
"   <p>",
"    A meningomyelocele or myelomeningocele occurs when both the meninges and the spinal cord herniate through the vertebral defect. It is often associated with hydrocephalus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33767?source=see_link\">",
"     \"Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Cranial defects",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Anencephaly &mdash; Anencephaly is the congenital absence of a major portion of the brain, skull, and scalp due to failure of the cephalic part of the neural tube to close. It is the most common NTD and is readily detected antenatally. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/62/11237?source=see_link\">",
"       \"Anencephaly\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/57/3991?source=see_link\">",
"       \"Primary (congenital) encephalocele\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Exencephaly &mdash; In exencephaly the skull and scalp are absent, with exteriorization of the abnormally formed brain.",
"     </li>",
"     <li>",
"      Encephalocele &mdash; Encephalocele refers to the herniation of cranial contents through a defect in the skull. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/57/3991?source=see_link\">",
"       \"Primary (congenital) encephalocele\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/62/11237?source=see_link\">",
"       \"Anencephaly\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Iniencephaly &mdash; Iniencephaly is a rare malformation characterized by the triad of an occipital bone defect, cervical dysraphism (ie, defective fusion), and fixed retroflexion of the fetal head.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ETIOLOGY AND RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of NTDs are isolated malformations of multifactorial origin (ie,",
"    <span class=\"nowrap\">",
"     traits/conditions",
"    </span>",
"    influenced by both environmental and genetic factors):",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Folic acid deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adequate folate is critical for cell division due to its essential role in the synthesis of nucleic and certain amino acids.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     Folic acid",
"    </a>",
"    deficiency, which may be due to inadequate intake or abnormal metabolism from mutations in folate-related enzymes (see",
"    <a class=\"local\" href=\"#H10\">",
"     'Genetic factors'",
"    </a>",
"    below), has been implicated in the development of NTDs (folate sensitive NTDs) and folate supplementation has been shown to reduce the risk of NTDs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=see_link&amp;anchor=H7#H7\">",
"     \"Folic acid for prevention of neural tube defects\", section on 'Folic acid supplementation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Environmental factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of NTDs is increased with exposure to certain environmental factors, such as drugs (valproic acid,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/10/25770?source=see_link\">",
"     carbamazepine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    antagonists eg, [",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    , aminopterin], excessive vitamin A intake), hyperthermia, maternal diabetes mellitus, obesity, and folate deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/15-20\">",
"     15-20",
"    </a>",
"    ]. While some of the environmental associations are weak, or suffer from poor methodological studies, others (valproic acid) are quite strong. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22633?source=see_link&amp;anchor=H4#H4\">",
"     \"Risks associated with epilepsy and pregnancy\", section on 'Effect of antiepileptic drugs on the fetus'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/13/7386?source=see_link&amp;anchor=H29#H29\">",
"     \"Genetic and environmental causes of birth defects\", section on 'Fever/hyperthermia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Genetic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The genetic factors in the pathogenesis of NTDs are not well defined. A genetic factor is suggested by observations that NTDs have a high concordance rate in monozygotic twins, are more frequent among first degree relatives, and are more common in females than males [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/21\">",
"     21",
"    </a>",
"    ]. NTDs also occur as part of several genetic syndromes (eg, Meckel-Gruber) and in association with polymorphic variants in genes in the folate and homocysteine pathways (C677T variant in the methylenetetrahydrofolate reductase [MTHFR] gene) and in the VANGL1 gene [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/22\">",
"     22",
"    </a>",
"    ], but not the MTHFR A1298C polymorphism [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=see_link&amp;anchor=H5#H5\">",
"     \"Folic acid for prevention of neural tube defects\", section on 'MTHFR polymorphisms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is some evidence that abnormal folate metabolism related to the 677C--&gt;T polymorphism in the MTHFR gene may also be a risk factor for Down syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. Interestingly, one epidemiologic study found that families with a child with Down syndrome appeared to be at increased risk for having a subsequent child with a NTD, while families with a child with NTD appeared to be at increased risk for having a subsequent child with Down syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/27\">",
"     27",
"    </a>",
"    ]. The association of low folate levels and Down syndrome has not been conclusively demonstrated, nor is there evidence that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    supplementation will reduce the risk of aneuploidy. Further investigation is required.",
"   </p>",
"   <p>",
"    The risk of recurrence for NTDs is approximately 2 to 4 percent when there is one affected sibling [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/28-32\">",
"     28-32",
"    </a>",
"    ]. With two affected siblings, the risk is approximately 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/33\">",
"     33",
"    </a>",
"    ]. The risk of NTD according to family history is illustrated in the table (",
"    <a class=\"graphic graphic_table graphicRef63266 \" href=\"UTD.htm?22/33/23068\">",
"     table 1",
"    </a>",
"    ). The risk of recurrence appears to be higher in countries such as Ireland where the prevalence of NTDs is high [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The recurrence risk for anencephaly is estimated at 2 to 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/35\">",
"     35",
"    </a>",
"    ]. Isolated encephaloceles have not been shown to be familial. However, encephaloceles may be part of specific genetic syndromes if there are associated anomalies; the inheritance pattern is autosomal recessive in these cases. As an example, the risk of recurrence for an encephalocele with Meckel Gruber syndrome (posterior encephalocoele, cleft palate, and polydactyly) is 25 percent.",
"   </p>",
"   <p>",
"    There is a high prevalence of karyotypic abnormalities among fetuses with NTDs, especially in the presence of other congenital anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/36-39\">",
"     36-39",
"    </a>",
"    ]. As an example, a series evaluating the frequency of chromosomal abnormalities in pregnancies with fetal NTDs found these abnormalities in 6.5 percent of affected cases",
"    <span class=\"nowrap\">",
"     (4/167",
"    </span>",
"    fetuses with an isolated NTD and",
"    <span class=\"nowrap\">",
"     9/33",
"    </span>",
"    fetuses with a NTD and associated anomalies) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/36\">",
"     36",
"    </a>",
"    ]. Other series reported a similar (7 percent) or higher (13 percent) rate of chromosomal abnormalities in fetuses with NTDs, particularly when there were associated anomalies [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/37-39\">",
"     37-39",
"    </a>",
"    ]. Trisomy 18 was the most common aneuploidy detected. These data support the use of fetal karyotyping as an aid in diagnostic evaluation and recurrence risk counseling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Deformation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some cases of encephalocele may be due to disruptive factors, such as amniotic bands.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Vitamin B12 deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum vitamin B12 levels have also been noted to be lower in pregnancies complicated by NTDS [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. A systematic review found serum vitamin B12 concentration was 38",
"    <span class=\"nowrap\">",
"     ng/L",
"    </span>",
"    lower in such pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/40\">",
"     40",
"    </a>",
"    ]. A relationship between vitamin B12 deficiency and NTDS may result from a vitamin B12 associated functional state of folate deficiency or hyperhomocysteinemia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. The relationship between maternal vitamin B12 status and NTDs needs further study before any clinical recommendations can be made.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend offering screening for NTDs to all pregnant women. Early diagnosis of affected pregnancies allows couples the option of pregnancy termination or an opportunity to prepare for the birth of a child.",
"   </p>",
"   <p>",
"    A study that surveyed national screening policies for 18 European countries in 2004 reported the overall prenatal detection rate for NTD was 88 percent (range 25 to 94 percent) and detection rates were highest in those countries with standards determined by a national screening policy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The American College of Medical Genetics recommends use of maternal serum alpha-fetoprotein",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ultrasound for detection of neural tube defects between 15 and 20 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Alpha-fetoprotein",
"    </span>",
"    &nbsp;&mdash;&nbsp;Historically, maternal serum alpha-fetoprotein (AFP) has been used as a screening test for open NTDs. AFP is a fetal specific globulin, synthesized by the fetal yolk sac, gastrointestinal tract, and liver. The function of AFP is unknown, although data suggest that it may be involved in immunoregulation during pregnancy. Another function may be as an intravascular transport protein because of its similarity to albumin.",
"   </p>",
"   <p>",
"    AFP can be measured in maternal serum, amniotic fluid, and fetal plasma. The maternal serum AFP (MSAFP) concentration is much lower than that in amniotic fluid or fetal plasma. It rises in early pregnancy, peaks between 28 and 32 weeks of gestation, and then falls (",
"    <a class=\"graphic graphic_figure graphicRef65872 \" href=\"UTD.htm?4/36/4686\">",
"     figure 1",
"    </a>",
"    ). Increasing fetoplacental permeability and advancing gestation may explain the rise in MSAFP that occurs when amniotic fluid and fetal serum concentrations are declining.",
"   </p>",
"   <p>",
"    AFP is secreted by the fetal kidney into the urine and then excreted into the amniotic fluid. The concentration of amniotic fluid AFP (AFAFP) is highest early in pregnancy, peaks between 12 and 14 weeks of gestation, then declines until it becomes undetectable at term (",
"    <a class=\"graphic graphic_figure graphicRef61170 \" href=\"UTD.htm?10/58/11183\">",
"     figure 2",
"    </a>",
"    ). Amniotic fluid AFP levels are measured to aid in diagnosis of NTDs (see",
"    <a class=\"local\" href=\"#H19\">",
"     'Prenatal diagnosis'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    The concentration of fetal plasma AFP peaks between 10 and 13 weeks of gestation, then declines exponentially from 14 to 32 weeks, and falls even more dramatically near term (",
"    <a class=\"graphic graphic_figure graphicRef65276 \" href=\"UTD.htm?30/5/30814\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/47\">",
"     47",
"    </a>",
"    ]. The fall in AFP can be explained by both decreased fetal synthesis and a dilution effect due to increasing fetal blood volume. There is no clinical role for measurement of AFP in fetal plasma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Screening protocol",
"    </span>",
"    &nbsp;&mdash;&nbsp;MSAFP screening at 15 to 20 weeks of gestation should be offered to all pregnant women as it is an effective method for detecting NTDs [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/16\">",
"     16",
"    </a>",
"    ]. AFP screening is primarily intended for the detection of open spina bifida and anencephaly, but can also uncover several nonneural fetal abnormalities (eg, ventral wall defects, tumors, dermatologic disorders, congenital nephrosis, aneuploidy). It does not detect closed spina bifida. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/57/18329?source=see_link\">",
"     \"Pregnancy outcomes predicted by serum markers assayed in Down syndrome screening\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MSAFP results are expressed as multiples of the median (MoM) for each gestational week because these values are easy to derive, more stable, and allow for interlaboratory variation. The median value, rather than the mean, is used because it is not influenced by occasional outlying values. A value above 2.0 to 2.5 MoM is designated an abnormal result, depending upon the laboratory's preference for balancing the detection and false-positive rates in their population.",
"   </p>",
"   <p>",
"    A first elevated test may be repeated because as many as 30 percent of moderately elevated MSAFP results will be below the threshold level upon repeating the test and such findings are not associated with an increased frequency of false-negative NTD diagnoses [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/48\">",
"     48",
"    </a>",
"    ]. If the elevation persists, then the next step is to obtain a specialized ultrasound examination to further assess whether a NTD, or other anomaly, is present [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/16\">",
"     16",
"    </a>",
"    ]. An advanced gestational age, patient anxiety, or a significantly elevated value may preclude repetition of the test, in which case sonography should be obtained expeditiously (see",
"    <a class=\"local\" href=\"#H20\">",
"     'Ultrasound examination'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Sensitivity and specificity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies have consistently demonstrated the utility of MSAFP screening for detection of fetuses with NTDs. A meta-analysis of 22 studies including 684,112 second trimester women calculated overall sensitivity and specificity of 75.1 and 97.7, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/49\">",
"     49",
"    </a>",
"    ]. The detection rate for anencephaly is even higher: greater than 95 percent.",
"   </p>",
"   <p>",
"    The risk of an affected fetus when the MSAFP is &gt;2.5 MoMs is 4.5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/50\">",
"     50",
"    </a>",
"    ]. The positive predictive value of an MSAFP level between 2.5 and 2.9 MoMs for NTDs is 1.45 percent; with an MSAFP level greater than 7 MoMs, the positive predictive value goes up to 13.5 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Factors affecting interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many factors influence the correct interpretation of MSAFP results. These include: gestational age, maternal weight, ethnicity, maternal diabetes mellitus, fetal viability, exclusion of other anomalies, and multiple pregnancy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gestational age &mdash; Screening can be performed between 15 to 20 weeks of gestation; however, optimal detection of NTDs is between 16 and 18 weeks. Knowledge of gestational age is critical to interpretation of MSAFP (",
"      <a class=\"graphic graphic_figure graphicRef81256 \" href=\"UTD.htm?6/61/7120\">",
"       figure 4",
"      </a>",
"      ). An incorrect gestational age will falsely raise or lower the reported MoM, which is based upon gestational age (see",
"      <a class=\"local\" href=\"#H20\">",
"       'Ultrasound examination'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Maternal weight &mdash; Maternal weight affects MSAFP screening because of dilution of AFP in the larger blood volume of heavier women. Correction for maternal weight increases the detection rate for NTDs [",
"      <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/51\">",
"       51",
"      </a>",
"      ]. Maternal weight should be measured and reported to the MSAFP laboratory on the day of testing.",
"     </li>",
"     <li>",
"      Diabetes mellitus &mdash; The prevalence of NTDs is higher in women with diabetes mellitus and their MSAFP level is 15 percent lower than in nondiabetics. For these reasons, there is a lower threshold MSAFP value (eg, approximately 1.5 MoM) to obtain the same sensitivity of detection of NTDS as in nondiabetic women. The presence of maternal diabetes should always be noted on the MSAFP laboratory requisition.",
"     </li>",
"     <li>",
"      Fetal anomalies &mdash; NonNTD fetal defects can be associated with an elevated MSAFP. There is direct correlation between the degree of MSAFP elevation and the frequency of anomalies. In one study, the risk was 3 percent at a level of 2.5 MoMs and 40 percent at a level &gt;7.0 MoMs [",
"      <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/52\">",
"       52",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Abdominal wall defects are commonly associated with elevated MSAFP levels. One representative series reported MSAFP was raised in 89 percent of fetuses with omphalocele and in 100 percent of fetuses with gastroschisis [",
"      <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/53\">",
"       53",
"      </a>",
"      ]. Fetal congenital nephrosis, teratomas, and benign obstructive uropathy can also be associated with elevated MSAFP levels.",
"     </li>",
"     <li>",
"      Multiple gestation &mdash; The concentration of MSAFP is proportional to the number of fetuses, thus the upper limit for a twin pregnancy is twice (eg, 4 to 5 MoMs) that of a singleton gestation.",
"     </li>",
"     <li>",
"      Race &mdash; The MSAFP level is 10 percent higher in black women. Thus, an adjustment based upon race should be made by the laboratory when calculating MSAFP results.",
"     </li>",
"     <li>",
"      Fetal viability &mdash; Fetal death raises the MSAFP value. This is not of diagnostic concern except in cases of multiple gestation with a viable and a nonviable fetus. MSAFP results are not interpretable in this situation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Ultrasound",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound is also an effective technique for detecting NTDs, and can potentially detect more NTDs than MSAFP [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/54\">",
"     54",
"    </a>",
"    ]. In fact, in many places, traditional two-dimensional ultrasound has superseded MSAFP testing as a screening tool.",
"   </p>",
"   <p>",
"    Detection rates are influenced by gestational age and type of NTD. For example, first trimester studies generally have reported detection rates greater than 90 percent for anencephaly and 80 percent for encephalocele, but lower rates for spina bifida (44 percent). Second trimester ultrasound scanning increases the detection rate of spina bifida to approximately 92 to 95 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     PRENATAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancies that screen positive (a value above 2.0 to 2.5 MoM) require further evaluation to determine whether a NTD, or other abnormality, is present. All such pregnancies should undergo ultrasound examination to confirm gestational age, fetal viability, number of fetuses (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Factors affecting interpretation'",
"    </a>",
"    above) and to perform a detailed fetal anatomic survey.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Ultrasound examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of anencephaly is based upon the absence of brain and calvarium superior to the orbits on coronal views of the fetal head. The sonographic diagnosis of this condition is highly accurate and should not be missed on any routine second or third trimester ultrasound examination. The sensitivity of sonographic diagnosis of other NTDS is high, but depends in part upon the size and location of the defect, the position of the fetus, the volume of amniotic fluid, maternal habitus, and the skill and equipment of the sonographer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/46/35560?source=see_link\">",
"     \"Ultrasound diagnosis of neural tube defects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Amniocentesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed above, the vast majority of NTDs can be seen by ultrasound assessment. However, due to considerable variability in ultrasound training and experience, as well as the factors previously mentioned, ultrasound findings may be uncertain or show an apparently normal fetus. In these cases, further evaluation is usually indicated.",
"   </p>",
"   <p>",
"    Amniotic fluid AFP (AFAFP) and amniotic fluid acetylcholinesterase (AChE) are the primary biochemical tests performed on amniotic fluid for detection of open neural tube defects. AChE is an enzyme contained in blood cells, muscle, and nerve tissue. An elevation of",
"    <strong>",
"     both",
"    </strong>",
"    AFP and AChE values suggests an open fetal NTD with 96 percent accuracy and a false positive rate of 0.14 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/3\">",
"     3",
"    </a>",
"    ]. Blood contamination of the amniotic fluid sample is responsible for one-half of false-positive AChE results. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/11/16570?source=see_link\">",
"     \"Diagnostic amniocentesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Sonographic versus amniotic fluid diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some authors have suggested that the rate of detection of NTDs by ultrasound examination alone may preclude the need for amniocentesis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/56-59\">",
"     56-59",
"    </a>",
"    ]. These findings are illustrated by the following examples.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study of over 2000 women with an elevated MSAFP, sonography alone was 97 percent (66 of 68 cases) sensitive and 100 percent (2189 cases) specific in diagnosing an open NTD [",
"      <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/57\">",
"       57",
"      </a>",
"      ]. Suspicious findings on sonography led to an amniocentesis for confirmation of NTD in the two cases of NTD not specifically diagnosed on ultrasound examination.",
"     </li>",
"     <li>",
"      A second series of 905 pregnancies found that 49 neural tube defects were correctly diagnosed by ultrasound alone; one was not [",
"      <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/58\">",
"       58",
"      </a>",
"      ]. The sensitivity, specificity, and positive and negative predictive values of ultrasound evaluation for the detection of NTDs were 98, 100, 100, and 99.9 percent, respectively. Forty-three other abnormal fetuses were also detected in patients with an elevated MSAFP, including 19 with abdominal wall defects, seven with findings suggestive of chromosomal abnormalities, five with urinary tract abnormalities, one with a cardiac abnormality, and 11 others; two fetuses with chromosomal abnormalities were not detected. The authors felt that ultrasound could be used reliably to detect NTDs, thereby avoiding the risks of amniocentesis.",
"     </li>",
"     <li>",
"      A review of the ultrasound findings in 51 consecutive fetuses with pathologically confirmed spina bifida, encephalocele, gastroschisis, or omphalocele calculated the sensitivity of ultrasonography for these diagnoses and the probability of an affected fetus in women with a given level of MSAFP and a normal second trimester sonogram at their facility [",
"      <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/56\">",
"       56",
"      </a>",
"      ]. These four types of anomalies were correctly identified in all 51 cases, yielding a sensitivity of 100 percent. The probability of an affected fetus ranged from 0.01 to 0.15 percent for MSAFP levels ranging from 2.0 to 3.5 MoMs, respectively. The authors concluded that this level of risk was less than the reported risk of a procedure related spontaneous abortion after amniocentesis (0.3 to 0.5 percent) and, therefore may lead some women with an elevated MSAFP to decide not to proceed with amniocentesis.",
"     </li>",
"     <li>",
"      Cost-benefit analyses have revealed savings of approximately $36 to $49 million dollars in annual savings if ultrasound examination replaced amniocentesis for the diagnosis of NTD [",
"      <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/60\">",
"       60",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast to these findings, a series of 161 cases of open spina bifida identified by the California Maternal Serum Alpha-Fetoprotein Screening Program reported 8 percent of NTDs were not diagnosed by the initial ultrasonographic evaluation and three defects were not recognized until birth [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/61\">",
"     61",
"    </a>",
"    ]. The authors concluded that ultrasonography was not sufficiently sensitive to forego amniocentesis. Small encephaloceles and spina bifida may be missed with ultrasonography and factors cited above, such as large maternal body habitus, fetal position, and lack of experience of the sonographer contribute to the difficulty of sonographic diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/61,62\">",
"     61,62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Fetal magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although sonography remains the primary imaging technique for evaluation of NTDs, significant limitations may hamper accurate diagnosis. Such limitations include reverberation causing suboptimal visualization of the brain, maternal obesity, and oligohydramnios. Magnetic resonance imaging (MRI) does not suffer from these restraints and, in some cases, may have an important role in prenatal diagnosis.",
"   </p>",
"   <p>",
"    This was illustrated in a study that evaluated the role of MRI in 19 fetuses with ultrasound findings suspicious for NTDs, and in whom the ultrasound examination was deemed to be inadequate [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/63\">",
"     63",
"    </a>",
"    ]. Fetal MRI of these 19 cases correctly ruled out the ultrasound diagnosis of cephalocele in one fetus with oligohydramnios, and documented a NTD in the other 18 fetuses. Fetal MRI also detected new findings unsuspected at ultrasound that changed the ultrasound diagnosis in 3 of the 19 cases and detected previously occult findings that caused a minor change in the classification of the anomaly in 5 of the 19 cases. MRI did not influence the ultrasound diagnosis in the other 11 of 19 fetuses. Further studies are needed to evaluate the diagnostic capability and accuracy of MRI for the diagnosis of NTDs, but this modality certainly should be considered in those cases in which ultrasound imaging is not optimal or is uncertain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Discussion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon review of existing data, the most sensitive approach to the prenatal diagnosis of NTDs is MSAFP screening followed (if the MSAFP is elevated) by a combination of ultrasound examination and amniocentesis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/16\">",
"     16",
"    </a>",
"    ]. Detection rates for NTDs are greater than 95 percent with rare false positives with both of these modalities. If one is certain of the diagnosis based upon the elevated MSAFP level and the ultrasound findings, an amniocentesis for confirmation may not be necessary. However, if there is any uncertainty about the diagnosis, or if the patient wishes to find out the karyotype (given the association with chromosomal abnormalities) an amniocentesis is warranted. The information may be particularly useful for diagnosis and estimating recurrence risk if there are associated anomalies.",
"   </p>",
"   <p>",
"    We, and others, feel that a fetal karyotype should be obtained at the time of amniocentesis since this test adds no additional risk to the procedure, there is an elevated risk of chromosomal abnormalities with NTDs, and this information assists in accurate diagnosis of the current pregnancy and may be important for counseling regarding recurrence risks [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/39,64\">",
"     39,64",
"    </a>",
"    ]. However, other authors have not recommended chromosome analysis in women under 35 years of age in the presence of a normal sonogram because of the cost and low risk of abnormality (0.3 to 0.6 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/65,66\">",
"     65,66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     MANAGEMENT AND PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of fetal surgery, route of delivery, pediatric management, and prognosis for children with these abnormalities are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/57/3991?source=see_link\">",
"     \"Primary (congenital) encephalocele\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33767?source=see_link\">",
"     \"Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/46/26344?source=see_link\">",
"     \"Overview of the management of myelomeningocele (spina bifida)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/62/11237?source=see_link\">",
"     \"Anencephaly\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pregnancy termination is an option. In a systematic review of studies from the past two decades, the overall frequency of pregnancy termination following prenatal diagnosis was 83 percent for anencephaly (range 59&ndash;100 percent) and 63 percent for spina bifida (range 31&ndash;97 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Pregnancy complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;An elevated MSAFP level in the second trimester of pregnancy that cannot be explained (eg, presence of a fetal anomaly, maternal hepatocellular or ovarian tumor) is associated with an increased risk of subsequent fetal death. As an example, a case-control study of 612 women whose pregnancies ended in fetal death and 2501 women who gave birth to live infants reported that women with an MSAFP level &ge;3.0 MoM had a 10-fold increase in risk of fetal death as compared to women who had a normal level and the risk remained high until term [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/68\">",
"     68",
"    </a>",
"    ]. Elevated AFP levels were especially likely to be associated with fetal death in pregnancies complicated by hypertension.",
"   </p>",
"   <p>",
"    In another series, a high MSAFP value was associated with the following adverse outcomes: neural tube defects (relative risk = 224), other major congenital defects (relative risk = 4.7), fetal deaths (relative risk = 8.1), neonatal death (relative risk = 4.7), low birth weight (relative risk = 4.0), newborn complications (relative risk = 3.6), oligohydramnios (relative risk = 3.4), abruptio placentae (relative risk = 3.0), and preeclampsia (relative risk = 2.3) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/35/25145/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanism for poor pregnancy outcome in these cases may relate to defective placentation leading to higher than normal fetal to maternal AFP transport. Increased fetal surveillance has been suggested for these pregnancies, although the benefit of this intervention has not been demonstrated in controlled trials. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/57/18329?source=see_link\">",
"     \"Pregnancy outcomes predicted by serum markers assayed in Down syndrome screening\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;(see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=see_link\">",
"     \"Folic acid for prevention of neural tube defects\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/15/13555?source=see_link\">",
"       \"Patient information: Spina bifida (myelomeningocele) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neural tube defects are the second most prevalent congenital anomaly in the United States, second only to cardiac malformations. Prenatal maternal serum screening programs for alpha fetoprotein (instituted in the 1970s and 1980s) combined with periconceptional",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      supplementation and food fortification (instituted in the 1990s) have led to a decrease in the prevalence of neural tube defects where these interventions are practiced. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Incidence and epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Occurrence of neural tube defects may be related to maternal folate deficiency (folate sensitive neural tube defects) or unrelated to maternal folate levels (chromosomal abnormalities, deformations, teratogens). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Etiology and risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend screening for neural tube defects be offered to all pregnant women at 15 to 20 weeks of gestation (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Maternal serum alpha-fetoprotein and ultrasound are both effective methods for screening. Early detection allows women the option of termination of an affected pregnancy or the opportunity to prepare for the birth of an affected child. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Screening'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      AFP screening is primarily intended for the detection of open spina bifida and anencephaly, but can also uncover several nonneural fetal abnormalities (eg, ventral wall defects, tumors, dermatologic disorders, congenital nephrosis, aneuploidy). It does not detect closed spina bifida. A value above 2.0 to 2.5 MoM is designated an abnormal result.",
"     </li>",
"     <li>",
"      A combination of ultrasound examination and amniocentesis (for acetylcholinesterase, alpha-fetoprotein, karyotype) is performed in women with positive screen results. Detection rates for neural tube defects are greater than 95 percent with rare false positives with both of these modalities. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Prenatal diagnosis'",
"      </a>",
"      above.) However, this standard is becoming increasingly controversial, as some experts advocate that ultrasound alone may be sufficient for ruling out neural tube defects.",
"     </li>",
"     <li>",
"      Magnetic resonance imaging also provides useful diagnostic information. Further studies are needed to evaluate its diagnostic capability and accuracy for the diagnosis of neural tube defects, but this modality should be considered in those cases in which ultrasound imaging is not optimal or is uncertain. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Fetal magnetic resonance imaging'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/1\">",
"      Wald NJ, Cuckle H, Brock JH, et al. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects. Lancet 1977; 1:1323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/2\">",
"      Nicolaides KH, Campbell S, Gabbe SG, Guidetti R. Ultrasound screening for spina bifida: cranial and cerebellar signs. Lancet 1986; 2:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/3\">",
"      Wald N, Cuckle H, Nanchahal K. Amniotic fluid acetylcholinesterase measurement in the prenatal diagnosis of open neural tube defects. Second report of the Collaborative Acetylcholinesterase Study. Prenat Diagn 1989; 9:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/4\">",
"      Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991; 338:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/5\">",
"      Czeizel AE, Dud&aacute;s I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327:1832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/6\">",
"      Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med 1999; 341:1509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/7\">",
"      Harmon JP, Hiett AK, Palmer CG, Golichowski AM. Prenatal ultrasound detection of isolated neural tube defects: is cytogenetic evaluation warranted? Obstet Gynecol 1995; 86:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/8\">",
"      Morris JK, Wald NJ. Quantifying the decline in the birth prevalence of neural tube defects in England and Wales. J Med Screen 1999; 6:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/9\">",
"      Centers for Disease Control and Prevention (CDC). Neural tube defect surveillance and folic acid intervention--Texas-Mexico border, 1993-1998. MMWR Morb Mortal Wkly Rep 2000; 49:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/10\">",
"      Murphy M, Whiteman D, Stone D, et al. Dietary folate and the prevalence of neural tube defects in the British Isles: the past two decades. BJOG 2000; 107:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/11\">",
"      Klusmann A, Heinrich B, St&ouml;pler H, et al. A decreasing rate of neural tube defects following the recommendations for periconceptional folic acid supplementation. Acta Paediatr 2005; 94:1538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/12\">",
"      Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999; 341:1485.",
"     </a>",
"    </li>",
"    <li>",
"     Martin, JA, Hamilton, BE, Ventura SJ, et al. Births: Final data for 2009. Natl Vital Stat Rep 2009. file://www.cdc.gov/nchs/data/nvsr/nvsr60/nvsr60_01.pdf (Accessed on November 29, 2011).",
"    </li>",
"    <li>",
"     Sadler, TW. Langman's Medical Embryology. Williams &amp; Wilkins, 1990: 352.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/15\">",
"      Shaw GM, Todoroff K, Velie EM, Lammer EJ. Maternal illness, including fever and medication use as risk factors for neural tube defects. Teratology 1998; 57:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/16\">",
"      ACOG Committee on Practice Bulletins. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 44, July 2003. (Replaces Committee Opinion Number 252, March 2001). Obstet Gynecol 2003; 102:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/17\">",
"      Mitchell LE. Epidemiology of neural tube defects. Am J Med Genet C Semin Med Genet 2005; 135C:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/18\">",
"      Nau H. Valproic acid-induced neural tube defects. Ciba Found Symp 1994; 181:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/19\">",
"      Watkins ML, Rasmussen SA, Honein MA, et al. Maternal obesity and risk for birth defects. Pediatrics 2003; 111:1152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/20\">",
"      Rasmussen SA, Chu SY, Kim SY, et al. Maternal obesity and risk of neural tube defects: a metaanalysis. Am J Obstet Gynecol 2008; 198:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/21\">",
"      Windham GC, Bjerkedal T, Sever LE. The association of twinning and neural tube defects: studies in Los Angeles, California, and Norway. Acta Genet Med Gemellol (Roma) 1982; 31:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/22\">",
"      Kibar Z, Torban E, McDearmid JR, et al. Mutations in VANGL1 associated with neural-tube defects. N Engl J Med 2007; 356:1432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/23\">",
"      Wang XW, Luo YL, Wang W, et al. Association between MTHFR A1298C polymorphism and neural tube defect susceptibility: a metaanalysis. Am J Obstet Gynecol 2012; 206:251.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/24\">",
"      James SJ, Pogribna M, Pogribny IP, et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 1999; 70:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/25\">",
"      O'Leary VB, Parle-McDermott A, Molloy AM, et al. MTRR and MTHFR polymorphism: link to Down syndrome? Am J Med Genet 2002; 107:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/26\">",
"      Hobbs CA, Sherman SL, Yi P, et al. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet 2000; 67:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/27\">",
"      Barkai G, Arbuzova S, Berkenstadt M, et al. Frequency of Down's syndrome and neural-tube defects in the same family. Lancet 2003; 361:1331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/28\">",
"      Cowchock S, Ainbender E, Prescott G, et al. The recurrence risk for neural tube defects in the United States: a collaborative study. Am J Med Genet 1980; 5:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/29\">",
"      Toriello HV, Higgins JV. Occurrence of neural tube defects among first-, second-, and third-degree relatives of probands: results of a United States study. Am J Med Genet 1983; 15:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/30\">",
"      Seller MJ. Recurrence risks for neural tube defects in a genetic counseling clinic population. J Med Genet 1981; 18:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/31\">",
"      Czeizel A, M&eacute;tneki J. Recurrence risk after neural tube defects in a genetic counselling clinic. J Med Genet 1984; 21:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/32\">",
"      Koch M, Fuhrmann W. Sibs of probands with neural tube defects--a study in the Federal Republic of Germany. Hum Genet 1985; 70:74.",
"     </a>",
"    </li>",
"    <li>",
"     Nussbaum, R, McInnes, RR, Willard, HF. Genetics of disorders with complex inheritance. In: Thompson &amp; Thompson genetics in medicine, 6th edition, WB Saunders, Philadelphia, 2001, pp 289-310.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/34\">",
"      MacCarthy PA, Dalrymple IJ, Duignan NM, et al. Recurrence rates of neural tube defects in Dublin maternity hospitals. Ir Med J 1983; 76:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/35\">",
"      The infant with anencephaly. The Medical Task Force on Anencephaly. N Engl J Med 1990; 322:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/36\">",
"      Kennedy D, Chitayat D, Winsor EJ, et al. Prenatally diagnosed neural tube defects: ultrasound, chromosome, and autopsy or postnatal findings in 212 cases. Am J Med Genet 1998; 77:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/37\">",
"      Hume RF Jr, Drugan A, Reichler A, et al. Aneuploidy among prenatally detected neural tube defects. Am J Med Genet 1996; 61:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/38\">",
"      Sepulveda W, Corral E, Ayala C, et al. Chromosomal abnormalities in fetuses with open neural tube defects: prenatal identification with ultrasound. Ultrasound Obstet Gynecol 2004; 23:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/39\">",
"      Drugan A, Johnson MP, Dvorin E, et al. Aneuploidy with neural tube defects: another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoprotein. Fetal Ther 1989; 4:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/40\">",
"      Wald NJ, Hackshaw AD, Stone R, Sourial NA. Blood folic acid and vitamin B12 in relation to neural tube defects. Br J Obstet Gynaecol 1996; 103:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/41\">",
"      Adams MJ Jr, Khoury MJ, Scanlon KS, et al. Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects. Teratology 1995; 51:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/42\">",
"      Groenen PM, van Rooij IA, Peer PG, et al. Marginal maternal vitamin B12 status increases the risk of offspring with spina bifida. Am J Obstet Gynecol 2004; 191:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/43\">",
"      Scott JM, Weir DG. The methyl folate trap. A physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid induced exacerbation of subacute combined degeneration in pernicious anaemia. Lancet 1981; 2:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/44\">",
"      Carmel R, Melnyk S, James SJ. Cobalamin deficiency with and without neurologic abnormalities: differences in homocysteine and methionine metabolism. Blood 2003; 101:3302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/45\">",
"      Boyd PA, Devigan C, Khoshnood B, et al. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome. BJOG 2008; 115:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/46\">",
"      Driscoll DA, Gross SJ, Professional Practice Guidelines Committee. Screening for fetal aneuploidy and neural tube defects. Genet Med 2009; 11:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/47\">",
"      Gitlin D, Perricelli A, Gitlin GM. Synthesis of -fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus. Cancer Res 1972; 32:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/48\">",
"      U.K. Collaborative Study on Alpha-Retoprotein in Relation to Neural-Tube Defects. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Lancet 1977; 1:1324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/49\">",
"      Wang ZP, Li H, Hao LZ, Zhao ZT. The effectiveness of prenatal serum biomarker screening for neural tube defects in second trimester pregnant women: a meta-analysis. Prenat Diagn 2009; 29:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/50\">",
"      Evans MI, Llurba E, Landsberger EJ, et al. Impact of folic acid fortification in the United States: markedly diminished high maternal serum alpha-fetoprotein values. Obstet Gynecol 2004; 103:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/51\">",
"      Wald N, Cuckle H, Boreham J, et al. The effect of maternal weight on maternal serum alpha-fetoprotein levels. Br J Obstet Gynaecol 1981; 88:1094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/52\">",
"      Reichler A, Hume RF Jr, Drugan A, et al. Risk of anomalies as a function of level of elevated maternal serum alpha-fetoprotein. Am J Obstet Gynecol 1994; 171:1052.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/53\">",
"      Morrow RJ, Whittle MJ, McNay MB, et al. Prenatal diagnosis and management of anterior abdominal wall defects in the west of Scotland. Prenat Diagn 1993; 13:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/54\">",
"      Norem CT, Schoen EJ, Walton DL, et al. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening. Obstet Gynecol 2005; 106:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/55\">",
"      Cameron M, Moran P. Prenatal screening and diagnosis of neural tube defects. Prenat Diagn 2009; 29:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/56\">",
"      Nadel AS, Green JK, Holmes LB, et al. Absence of need for amniocentesis in patients with elevated levels of maternal serum alpha-fetoprotein and normal ultrasonographic examinations. N Engl J Med 1990; 323:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/57\">",
"      Lennon CA, Gray DL. Sensitivity and specificity of ultrasound for the detection of neural tube and ventral wall defects in a high-risk population. Obstet Gynecol 1999; 94:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/58\">",
"      Morrow RJ, McNay MB, Whittle MJ. Ultrasound detection of neural tube defects in patients with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1991; 78:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/59\">",
"      Hogge WA, Thiagarajah S, Ferguson JE 2nd, et al. The role of ultrasonography and amniocentesis in the evaluation of pregnancies at risk for neural tube defects. Am J Obstet Gynecol 1989; 161:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/60\">",
"      Vintzileos AM, Ananth CV, Fisher AJ, et al. Cost-benefit analysis of targeted ultrasonography for prenatal detection of spina bifida in patients with an elevated concentration of second-trimester maternal serum alpha-fetoprotein. Am J Obstet Gynecol 1999; 180:1227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/61\">",
"      Platt LD, Feuchtbaum L, Filly R, et al. The California Maternal Serum alpha-Fetoprotein Screening Program: the role of ultrasonography in the detection of spina bifida. Am J Obstet Gynecol 1992; 166:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/62\">",
"      Hersey, DW. Sensitivity of ultrasound in detecting spina bifida. N Engl J Med 1991; 324:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/63\">",
"      Saleem SN, Said AH, Abdel-Raouf M, et al. Fetal MRI in the evaluation of fetuses referred for sonographically suspected neural tube defects (NTDs): impact on diagnosis and management decision. Neuroradiology 2009; 51:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/64\">",
"      Warner AA, Pettenati MJ, Burton BK. Risk of fetal chromosomal anomalies in patients with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1990; 75:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/65\">",
"      Barth WH Jr, Frigoletto FD Jr, Krauss CM, et al. Ultrasound detection of fetal aneuploidy in patients with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1991; 77:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/66\">",
"      Megerian G, Godmilow L, Donnenfeld AE. Ultrasound-adjusted risk and spectrum of fetal chromosomal abnormality in women with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1995; 85:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/67\">",
"      Johnson CY, Honein MA, Dana Flanders W, et al. Pregnancy termination following prenatal diagnosis of anencephaly or spina bifida: a systematic review of the literature. Birth Defects Res A Clin Mol Teratol 2012; 94:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/68\">",
"      Waller DK, Lustig LS, Cunningham GC, et al. Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death. N Engl J Med 1991; 325:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/35/25145/abstract/69\">",
"      Milunsky A, Jick SS, Bruell CL, et al. Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol 1989; 161:291.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 460 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-92133E1D40-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_35_25145=[""].join("\n");
var outline_f24_35_25145=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE AND EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EMBRYOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      TYPES OF NTDS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Spinal defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Cranial defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ETIOLOGY AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Folic acid deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Environmental factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Genetic factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Deformation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Vitamin B12 deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SCREENING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Alpha-fetoprotein",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Screening protocol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Sensitivity and specificity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Factors affecting interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Ultrasound",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      PRENATAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Ultrasound examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Amniocentesis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Sonographic versus amniotic fluid diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Fetal magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Discussion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      MANAGEMENT AND PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Pregnancy complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/460\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/460|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/13/24786\" title=\"diagnostic image 1A\">",
"      Spina bifida A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/7/1139\" title=\"diagnostic image 1B\">",
"      Spina bifida B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/9/6291\" title=\"diagnostic image 1C\">",
"      Spina bifida C",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/48/21251\" title=\"diagnostic image 1D\">",
"      Spina bifida D",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/460|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/36/4686\" title=\"figure 1\">",
"      MSAFP by gestational age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/58/11183\" title=\"figure 2\">",
"      AFP levels in AF by GA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?30/5/30814\" title=\"figure 3\">",
"      Fetal AFP levels by GA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/61/7120\" title=\"figure 4\">",
"      Distribution of AFP with NTDs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/460|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/33/23068\" title=\"table 1\">",
"      Recurrence risk NTDs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/62/11237?source=related_link\">",
"      Anencephaly",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/11/16570?source=related_link\">",
"      Diagnostic amniocentesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/61/5081?source=related_link\">",
"      Folic acid for prevention of neural tube defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/13/7386?source=related_link\">",
"      Genetic and environmental causes of birth defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/46/26344?source=related_link\">",
"      Overview of the management of myelomeningocele (spina bifida)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/62/33767?source=related_link\">",
"      Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/15/13555?source=related_link\">",
"      Patient information: Spina bifida (myelomeningocele) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/57/18329?source=related_link\">",
"      Pregnancy outcomes predicted by serum markers assayed in Down syndrome screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/57/3991?source=related_link\">",
"      Primary (congenital) encephalocele",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22633?source=related_link\">",
"      Risks associated with epilepsy and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/46/35560?source=related_link\">",
"      Ultrasound diagnosis of neural tube defects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_35_25146="Lymphomatoid granuloma Low";
var content_f24_35_25146=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F74089%7EPULM%2F61309&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F74089%7EPULM%2F61309&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lymphomatoid granulomatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 392px; height: 294px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low magnification photomicrograph (original magnification 100x) illustrating zone of necrosis surrounded by a lymphocytic infiltrate with conspicuous vascular infiltration (right).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lymphomatoid granulomatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 392px; height: 294px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High magnification photomicrograph (original magnification 600x) demonstrates the presence of polymorphic lymphocytic infiltrate with occasional large atypical cells (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_35_25146=[""].join("\n");
var outline_f24_35_25146=null;
var title_f24_35_25147="Antibiotics C diff diarrhea";
var content_f24_35_25147=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F55479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F55479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Antimicrobial agents that may induce clostridium difficile diarrhea and colitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tr>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Frequently associated",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Fluoroquinolones",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Clindamycin",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Penicillins (broad spectrum)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Cephalosporins (broad spectrum)",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Occasionally associated",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Macrolides",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Trimethoprim",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Sulfonamides",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Rarely associated",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Aminoglycosides",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Tetracyclines",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Chloramphenicol",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Metronidazole",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Vancomycin",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_35_25147=[""].join("\n");
var outline_f24_35_25147=null;
var title_f24_35_25148="Cultural context DM";
var content_f24_35_25148=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72192&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72192&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Kleinman's explanatory model (adapted for diabetes)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Provider question",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clues to beliefs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        What do you think caused your diabetes?",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Is the cause biologically, spiritually or emotionally-based?",
"        </p>",
"        <p>",
"         &bull; External or internal source?",
"        </p>",
"        <p>",
"         &bull; Related to God's will, own behavior, environment, imbalance?",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Why do you think it started when it did?",
"       </td>",
"       <td>",
"        &bull; Does family believe there was a critical or triggering event?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         What do you think your diabetes does to you/your child?",
"        </p>",
"        <p>",
"         How does it work?",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Family's explanation of diabetes",
"        </p>",
"        <p>",
"         &bull; What symptoms does family relate to diabetes?",
"        </p>",
"        <p>",
"         &bull; Meaning family attaches to symptoms",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        How severe is your diabetes?",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Perception of seriousness",
"        </p>",
"        <p>",
"         &bull; Belief in the diagnosis",
"        </p>",
"        <p>",
"         &bull; Perceptions of duration of diabetes",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        What kind of treatment do you think you should receive?",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Types of treatment believed to be effective",
"        </p>",
"        <p>",
"         &bull; Western approaches?",
"        </p>",
"        <p>",
"         &bull; Alternative approaches?",
"        </p>",
"        <p>",
"         &bull; Thoughts about taking insulin",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        What are the most important results you hope to receive from this treatment?",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Highlights family priorities",
"        </p>",
"        <p>",
"         &bull; Symptoms and issues of less concern to family",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        What are the chief problems your diabetes has caused for you?",
"       </td>",
"       <td>",
"        &bull; May provide insight into patient's perceived barriers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        What do you fear most about your diabetes?",
"       </td>",
"       <td>",
"        <p>",
"         &bull; Quality of life as defined by the family",
"        </p>",
"        <p>",
"         &bull; May uncover feelings of hopelessness and being overwhelmed",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Nwankwo R, Tang T. Tailoring diabetes education and care to minority patients and families. In: Practical psychology for diabetes clinicians, 2nd ed, Anderson B, Rubin R (Eds), American Diabetes Association, Alexandria 2002. p.37.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_35_25148=[""].join("\n");
var outline_f24_35_25148=null;
var title_f24_35_25149="Radiopharmaceuticals B";
var content_f24_35_25149=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F82177&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F82177&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Activities of radiopharmaceuticals that require instructions and records when administered to patients who are breast-feeding an infant or child, continued",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        Radionuculide",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Column 1: Activity above which instructions are required",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Column 2: Activity above which a record is required",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        Column 3: Examples of recommended duration of interruption of breast-feeding",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        (MBq)",
"       </td>",
"       <td class=\"subtitle2\">",
"        (mCi)",
"       </td>",
"       <td class=\"subtitle2\">",
"        (MBq)",
"       </td>",
"       <td class=\"subtitle2\">",
"        (mCi)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tc-99m red blood cell in vivo labeling",
"       </td>",
"       <td>",
"        400",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        2000",
"       </td>",
"       <td>",
"        50",
"       </td>",
"       <td>",
"        6 hours for 740 MBq (20 mCi)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tc-99m red blood cell in vitro labeling",
"       </td>",
"       <td>",
"        1000",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        6000",
"       </td>",
"       <td>",
"        150",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tc-99m sulphur colloid",
"       </td>",
"       <td>",
"        300",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        1000",
"       </td>",
"       <td>",
"        35",
"       </td>",
"       <td>",
"        6 hours for 440 MBq (12 mCi)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tc-99m DTPA aerosol",
"       </td>",
"       <td>",
"        1000",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        6000",
"       </td>",
"       <td>",
"        150",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tc-99m MAG3",
"       </td>",
"       <td>",
"        1000",
"       </td>",
"       <td>",
"        30",
"       </td>",
"       <td>",
"        6000",
"       </td>",
"       <td>",
"        150",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Tc-99m white blood cells",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        100",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        4",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        600",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        15",
"       </td>",
"       <td>",
"        24 hours for 1,100 MBq (30 mCi)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        12 hours for 440 MBq (12 mCi)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Ga-67 citrate&bull;",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        1",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        0.04",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        7",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        0.2",
"       </td>",
"       <td>",
"        1 month for 150 MBq (4 mCi)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2 weeks for 50 MBq (1.3 mCi)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1 week for 7 MBq (0.2 mCi)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cr-51 EDTA",
"       </td>",
"       <td>",
"        60",
"       </td>",
"       <td>",
"        1.6",
"       </td>",
"       <td>",
"        300",
"       </td>",
"       <td>",
"        8",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        In-111 white blood cells&bull;",
"       </td>",
"       <td>",
"        10",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1 week for 20 MBq (0.5 mCi)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tl-201 chloride&bull;",
"       </td>",
"       <td>",
"        40",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        200",
"       </td>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        2 weeks for 110 MBq (3 mCi)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Activities are rounded to one significant figure, except when it was considered appropriate to use two significant figures. Details of the calculations are shown in NUREG-1492, \"Regulatory Analysis on Criteria for the Release of Patients Administered Radioactive Material.\" If there is no recommendation in Column 3 of this table, the maximum activity normally administered is below the activities that require instructions on interruption or discontinuation of breast-feeding. Although non-byproduct materials are not regulated by NRC, information on non-byproduct material is included for the convenience of the licensee. Agreement State regulations may vary. Agreement State licensees should check with their state regulations before using these values.",
"     <br>",
"      * The duration of interruption of breast-feeding is selected to reduce the maximum dose to a newborn infant to less than 1 millisievert (0.1 rem), although the regulatory limit is 5 millisieverts (0.5 rem). The actual doses that would be received by most infants would be far below 1 millisievert (0.1 rem). Of course, the physician may use discretion in the recommendation, increasing or decreasing the duration of interruption.",
"      <br>",
"       &bull; These radionuclides are not byproduct material and are not regulated by the NRC. Information is presented for the convenience of readers of this guide, who should be alert to differences that might exist between regulations of the NRC and state requirements for non-NRC regulated material.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Source: U.S. Nuclear Regulatory Commission: file://www.nrc.gove/reading-rm/doc- collections/nuregs/staff/sr1556/v9/nureg-1556-9.pdf#page=310",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_35_25149=[""].join("\n");
var outline_f24_35_25149=null;
var title_f24_35_25150="Choosing an antiinflammatory";
var content_f24_35_25150=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F81893&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F81893&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Choosing a nonsteroidal antiinflammatory drug",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 445px; height: 346px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     NSAID: nonsteroidal antiinflammatory drug; GI: gastrointestinal; PPI: proton pump inhibitor.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_35_25150=[""].join("\n");
var outline_f24_35_25150=null;
var title_f24_35_25151="Postop tracheobronchial changes";
var content_f24_35_25151=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F73229&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F73229&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Postpneumonectomy changes in tracheobronchial anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest CT after right sided pneumonectomy shows stretching and narrowing of the left main bronchus (arrows) consistent with the postpneumonectomy syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard Irwin, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_35_25151=[""].join("\n");
var outline_f24_35_25151=null;
